<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Prostate cancer - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Prostate_cancer" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Prostate_cancer&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Prostate_cancer&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Prostate_cancer" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Prostate_cancer" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Prostate_cancer","wgTitle":"Prostate cancer","wgCurRevisionId":671009944,"wgRevisionId":671009944,"wgArticleId":88078,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 French-language sources (fr)","CS1 Chinese-language sources (zh)","All articles with dead external links","Articles with dead external links from August 2011","CS1 Japanese-language sources (ja)","CS1 maint: Explicit use of et al.","Wikipedia articles needing page number citations from September 2010","Articles with contributors link","Articles containing potentially dated statements from 2009","All articles containing potentially dated statements","Articles with specifically marked weasel-worded phrases from July 2011","All articles with unsourced statements","Articles with unsourced statements from July 2011","Articles with DMOZ links","Articles that use a Medicine navs subtemplate","Wikipedia articles with GND identifiers","Male genital neoplasia","Neoplastic and hyperplastic prostate disorders","Histopathology","Prostate cancer","Infectious causes of cancer"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Prostate_cancer","wgRelevantArticleId":88078,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Prostate_cancer,_familial","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg/100px-Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg.png","wgULSAcceptLanguageList":[],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Prostate_cancer","wgWikibaseItemId":"Q181257"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.action.view.redirect","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Prostate_cancer skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Prostate cancer</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"><span class="mw-redirectedfrom">  (Redirected from <a href="/w/index.php?title=Prostate_cancer,_familial&amp;redirect=no" title="Prostate cancer, familial">Prostate cancer, familial</a>)</span></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Prostate cancer</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg" class="image"><img alt="Diagram showing the position of the prostate and rectum CRUK 358.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg/230px-Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg.png" width="230" height="223" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg/345px-Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg/460px-Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg.png 2x" data-file-width="349" data-file-height="339" /></a>
<div>Position of the prostate</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Specialty</a></th>
<td><a href="/wiki/Oncology" title="Oncology">Oncology</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/C61">C61</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=185">185</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/176807">176807</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb10780.htm">10780</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000380.htm">000380</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/radio/topic574.htm">radio/574</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/National_Cancer_Institute" title="National Cancer Institute">NCI</a></th>
<td><a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/types/prostate">Prostate cancer</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Patient_UK" title="Patient UK">Patient UK</a></th>
<td><a rel="nofollow" class="external text" href="http://patient.info/doctor/prostate-cancer-pro">Prostate cancer</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D011471">D011471</a></td>
</tr>
</table>
<p><b>Prostate cancer</b>, also known as <b>carcinoma of the prostate</b>, is the development of <a href="/wiki/Cancer" title="Cancer">cancer</a> in the <a href="/wiki/Prostate" title="Prostate">prostate</a>, a gland in the <a href="/wiki/Male_reproductive_system" title="Male reproductive system">male reproductive system</a>.<sup id="cite_ref-1" class="reference"><a href="#cite_note-1"><span>[</span>1<span>]</span></a></sup> Most prostate cancers are slow growing; however, some grow relatively fast.<sup id="cite_ref-WCR2014_2-0" class="reference"><a href="#cite_note-WCR2014-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-NCI2014TxPro_3-0" class="reference"><a href="#cite_note-NCI2014TxPro-3"><span>[</span>3<span>]</span></a></sup> The cancer cells may <a href="/wiki/Metastasis" title="Metastasis">spread</a> from the prostate to other parts of the body, particularly the <a href="/wiki/Bone" title="Bone">bones</a> and <a href="/wiki/Lymph_node" title="Lymph node">lymph nodes</a>.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4"><span>[</span>4<span>]</span></a></sup> It may initially cause no symptoms.<sup id="cite_ref-NCI2014TxPro_3-1" class="reference"><a href="#cite_note-NCI2014TxPro-3"><span>[</span>3<span>]</span></a></sup> In later stages it can cause difficulty <a href="/wiki/Urination" title="Urination">urinating</a>, blood in the urine, or <a href="/wiki/Pelvic_pain" title="Pelvic pain">pain in the pelvis</a>, back or when urinating.<sup id="cite_ref-NCI2013TxPt_5-0" class="reference"><a href="#cite_note-NCI2013TxPt-5"><span>[</span>5<span>]</span></a></sup> A disease known as <a href="/wiki/Benign_prostatic_hyperplasia" title="Benign prostatic hyperplasia">benign prostatic hyperplasia</a> may produce similar symptoms. Other late symptoms may include feeling tired due to <a href="/wiki/Anemia" title="Anemia">low levels of red blood cells</a>.<sup id="cite_ref-NCI2014TxPro_3-2" class="reference"><a href="#cite_note-NCI2014TxPro-3"><span>[</span>3<span>]</span></a></sup></p>
<p>Factors that increase the risk of prostate cancer include: older age, a family history of the disease, and <a href="/wiki/Race_(human_classification)" title="Race (human classification)">race</a>. About 99% of cases occur in those over the age of 50. Having a first degree relative with the disease increases the risk 2 to 3 fold. In the United States it is more common in the <a href="/wiki/African_American" title="African American">African American</a> population than the <a href="/wiki/White_American" title="White American">Caucasian</a> population. Other factors that may be involved include a <a href="/wiki/Diet_(nutrition)" title="Diet (nutrition)">diet</a> high in <a href="/wiki/Processed_meat" title="Processed meat" class="mw-redirect">processed meat</a>, <a href="/wiki/Red_meat" title="Red meat">red meat</a>, or <a href="/wiki/Milk_products" title="Milk products" class="mw-redirect">milk products</a> or low in certain <a href="/wiki/Vegetables" title="Vegetables" class="mw-redirect">vegetables</a>.<sup id="cite_ref-WCR2014_2-1" class="reference"><a href="#cite_note-WCR2014-2"><span>[</span>2<span>]</span></a></sup> An association with <a href="/wiki/Gonorrhea" title="Gonorrhea">gonorrhea</a> has been found, but a reason for this relationship has not been identified.<sup id="cite_ref-CainiGandini2014_6-0" class="reference"><a href="#cite_note-CainiGandini2014-6"><span>[</span>6<span>]</span></a></sup> Prostate cancer is diagnosed by <a href="/wiki/Biopsy" title="Biopsy">biopsy</a>. <a href="/wiki/Medical_imaging" title="Medical imaging">Medical imaging</a> may then be done to determine if the cancer has spread to other parts of the body.<sup id="cite_ref-NCI2013TxPt_5-1" class="reference"><a href="#cite_note-NCI2013TxPt-5"><span>[</span>5<span>]</span></a></sup></p>
<p><a href="/wiki/Prostate_cancer_screening" title="Prostate cancer screening">Prostate cancer screening</a> is controversial.<sup id="cite_ref-WCR2014_2-2" class="reference"><a href="#cite_note-WCR2014-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-NCI2014TxPro_3-3" class="reference"><a href="#cite_note-NCI2014TxPro-3"><span>[</span>3<span>]</span></a></sup> <a href="/wiki/Prostate-specific_antigen" title="Prostate-specific antigen">Prostate-specific antigen</a> testing increases cancer detection but does not decrease mortality.<sup id="cite_ref-BMJ2010_7-0" class="reference"><a href="#cite_note-BMJ2010-7"><span>[</span>7<span>]</span></a></sup> The <a href="/wiki/United_States_Preventive_Services_Task_Force" title="United States Preventive Services Task Force">United States Preventive Services Task Force</a> recommends against screening using the PSA testing, due to the risk of over-diagnosis and over-treatment as most cancer diagnosed would remain asymptomatic. The USPSTF concludes that the potential benefits of testing do not outweigh the expected harms.<sup id="cite_ref-USPTF2012_8-0" class="reference"><a href="#cite_note-USPTF2012-8"><span>[</span>8<span>]</span></a></sup> While <a href="/wiki/5%CE%B1-reductase_inhibitors" title="5α-reductase inhibitors" class="mw-redirect">5α-reductase inhibitors</a> appear to decrease low grade cancer risk they do not affect high grade cancer risk and thus are not recommended for prevention.<sup id="cite_ref-WCR2014_2-3" class="reference"><a href="#cite_note-WCR2014-2"><span>[</span>2<span>]</span></a></sup> Supplementation with <a href="/wiki/Vitamin" title="Vitamin">vitamins</a> or <a href="/wiki/Dietary_element" title="Dietary element">minerals</a> does not appear to affect the risk.<sup id="cite_ref-WCR2014_2-4" class="reference"><a href="#cite_note-WCR2014-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Strat2011_9-0" class="reference"><a href="#cite_note-Strat2011-9"><span>[</span>9<span>]</span></a></sup></p>
<p>Many cases can be safely followed with <a href="/wiki/Active_surveillance_of_prostate_cancer" title="Active surveillance of prostate cancer">active surveillance</a> or <a href="/wiki/Watchful_waiting" title="Watchful waiting">watchful waiting</a>. Other treatments may include a combination of surgery, <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a>, <a href="/wiki/Hormonal_therapy_(oncology)" title="Hormonal therapy (oncology)">hormone therapy</a> or <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a>.<sup id="cite_ref-NCI2013TxPt_5-2" class="reference"><a href="#cite_note-NCI2013TxPt-5"><span>[</span>5<span>]</span></a></sup> When it only occurs inside the prostate it may be curable.<sup id="cite_ref-NCI2014TxPro_3-4" class="reference"><a href="#cite_note-NCI2014TxPro-3"><span>[</span>3<span>]</span></a></sup> In those in whom the disease has spread to the bones, <a href="/wiki/Pain_medication" title="Pain medication" class="mw-redirect">pain medications</a>, <a href="/wiki/Bisphosphonate" title="Bisphosphonate">bisphosphonates</a> and targeted therapy, among others, may be useful. Outcomes depend on a person's age and other health problems as well as how aggressive and extensive the cancer is. Most people with prostate cancer do not end up dying from the disease.<sup id="cite_ref-NCI2013TxPt_5-3" class="reference"><a href="#cite_note-NCI2013TxPt-5"><span>[</span>5<span>]</span></a></sup> The <a href="/wiki/Five_year_survival_rate" title="Five year survival rate" class="mw-redirect">five year survival rate</a> in the United States is 99%.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup> Globally it is the second most common type of cancer and the fifth leading cause of cancer-related death in men.<sup id="cite_ref-WCR2014Epi_11-0" class="reference"><a href="#cite_note-WCR2014Epi-11"><span>[</span>11<span>]</span></a></sup> In 2012 it occurred in 1.1 million men and caused 307,000 deaths.<sup id="cite_ref-WCR2014Epi_11-1" class="reference"><a href="#cite_note-WCR2014Epi-11"><span>[</span>11<span>]</span></a></sup> It was the most common cancer in males in 84 countries,<sup id="cite_ref-WCR2014_2-5" class="reference"><a href="#cite_note-WCR2014-2"><span>[</span>2<span>]</span></a></sup> occurring more commonly in the <a href="/wiki/Developed_world" title="Developed world" class="mw-redirect">developed world</a>. Rates have been increasing in the <a href="/wiki/Developing_world" title="Developing world" class="mw-redirect">developing world</a>.<sup id="cite_ref-Baade2009_12-0" class="reference"><a href="#cite_note-Baade2009-12"><span>[</span>12<span>]</span></a></sup> Detection increased significantly in the 1980s and 1990s in many areas due to increased PSA testing.<sup id="cite_ref-WCR2014_2-6" class="reference"><a href="#cite_note-WCR2014-2"><span>[</span>2<span>]</span></a></sup> Studies of males who died from unrelated causes have found prostate cancer in 30% to 70% of those over age 60.<sup id="cite_ref-NCI2014TxPro_3-5" class="reference"><a href="#cite_note-NCI2014TxPro-3"><span>[</span>3<span>]</span></a></sup></p>
<div class="toclimit-3">
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Risk_factors"><span class="tocnumber">2</span> <span class="toctext">Risk factors</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Genetic"><span class="tocnumber">2.1</span> <span class="toctext">Genetic</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Dietary"><span class="tocnumber">2.2</span> <span class="toctext">Dietary</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Medication_exposure"><span class="tocnumber">2.3</span> <span class="toctext">Medication exposure</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#Infectious_disease"><span class="tocnumber">2.4</span> <span class="toctext">Infectious disease</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Sexual_factors"><span class="tocnumber">2.5</span> <span class="toctext">Sexual factors</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-8"><a href="#Pathophysiology"><span class="tocnumber">3</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#Diagnosis"><span class="tocnumber">4</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-10"><a href="#Prostate_imaging"><span class="tocnumber">4.1</span> <span class="toctext">Prostate imaging</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Biopsy"><span class="tocnumber">4.2</span> <span class="toctext">Biopsy</span></a>
<ul>
<li class="toclevel-3 tocsection-12"><a href="#Gleason_score"><span class="tocnumber">4.2.1</span> <span class="toctext">Gleason score</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-13"><a href="#Tumor_markers"><span class="tocnumber">4.3</span> <span class="toctext">Tumor markers</span></a></li>
<li class="toclevel-2 tocsection-14"><a href="#Staging"><span class="tocnumber">4.4</span> <span class="toctext">Staging</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-15"><a href="#Prevention"><span class="tocnumber">5</span> <span class="toctext">Prevention</span></a>
<ul>
<li class="toclevel-2 tocsection-16"><a href="#Diet_and_lifestyle"><span class="tocnumber">5.1</span> <span class="toctext">Diet and lifestyle</span></a></li>
<li class="toclevel-2 tocsection-17"><a href="#Medications"><span class="tocnumber">5.2</span> <span class="toctext">Medications</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-18"><a href="#Screening"><span class="tocnumber">6</span> <span class="toctext">Screening</span></a></li>
<li class="toclevel-1 tocsection-19"><a href="#Management"><span class="tocnumber">7</span> <span class="toctext">Management</span></a>
<ul>
<li class="toclevel-2 tocsection-20"><a href="#Surveillance"><span class="tocnumber">7.1</span> <span class="toctext">Surveillance</span></a></li>
<li class="toclevel-2 tocsection-21"><a href="#Aggressive_cancer"><span class="tocnumber">7.2</span> <span class="toctext">Aggressive cancer</span></a></li>
<li class="toclevel-2 tocsection-22"><a href="#Castration-resistant"><span class="tocnumber">7.3</span> <span class="toctext"> Castration-resistant</span></a></li>
<li class="toclevel-2 tocsection-23"><a href="#Palliative_care"><span class="tocnumber">7.4</span> <span class="toctext">Palliative care</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-24"><a href="#Prognosis"><span class="tocnumber">8</span> <span class="toctext">Prognosis</span></a>
<ul>
<li class="toclevel-2 tocsection-25"><a href="#Classification_systems"><span class="tocnumber">8.1</span> <span class="toctext">Classification systems</span></a></li>
<li class="toclevel-2 tocsection-26"><a href="#Life_expectancy"><span class="tocnumber">8.2</span> <span class="toctext">Life expectancy</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-27"><a href="#Epidemiology"><span class="tocnumber">9</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-28"><a href="#History"><span class="tocnumber">10</span> <span class="toctext">History</span></a>
<ul>
<li class="toclevel-2 tocsection-29"><a href="#Cell-of-origin"><span class="tocnumber">10.1</span> <span class="toctext">Cell-of-origin</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-30"><a href="#Society_and_culture"><span class="tocnumber">11</span> <span class="toctext">Society and culture</span></a></li>
<li class="toclevel-1 tocsection-31"><a href="#Research"><span class="tocnumber">12</span> <span class="toctext">Research</span></a>
<ul>
<li class="toclevel-2 tocsection-32"><a href="#Treatments"><span class="tocnumber">12.1</span> <span class="toctext">Treatments</span></a></li>
<li class="toclevel-2 tocsection-33"><a href="#Cancer_models"><span class="tocnumber">12.2</span> <span class="toctext">Cancer models</span></a></li>
<li class="toclevel-2 tocsection-34"><a href="#Diagnosis_2"><span class="tocnumber">12.3</span> <span class="toctext">Diagnosis</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-35"><a href="#References"><span class="tocnumber">13</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-36"><a href="#External_links"><span class="tocnumber">14</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
</div>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Diagram_showing_prostate_cancer_pressing_on_the_urethra_CRUK_182.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/59/Diagram_showing_prostate_cancer_pressing_on_the_urethra_CRUK_182.svg/220px-Diagram_showing_prostate_cancer_pressing_on_the_urethra_CRUK_182.svg.png" width="220" height="218" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/59/Diagram_showing_prostate_cancer_pressing_on_the_urethra_CRUK_182.svg/330px-Diagram_showing_prostate_cancer_pressing_on_the_urethra_CRUK_182.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/59/Diagram_showing_prostate_cancer_pressing_on_the_urethra_CRUK_182.svg/440px-Diagram_showing_prostate_cancer_pressing_on_the_urethra_CRUK_182.svg.png 2x" data-file-width="343" data-file-height="340" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Diagram_showing_prostate_cancer_pressing_on_the_urethra_CRUK_182.svg" class="internal" title="Enlarge"></a></div>
A diagram of prostate cancer pressing on the urethra, which can cause symptoms.</div>
</div>
</div>
<p>Early prostate cancer usually causes no symptoms. Sometimes, however, prostate cancer does cause symptoms, often similar to those of diseases such as <a href="/wiki/Benign_prostatic_hyperplasia" title="Benign prostatic hyperplasia">benign prostatic hyperplasia</a>. These include frequent urination, <a href="/wiki/Nocturia" title="Nocturia">nocturia</a> (increased urination at night), difficulty starting and maintaining a steady stream of urine, <a href="/wiki/Hematuria" title="Hematuria">hematuria</a> (blood in the urine), and <a href="/wiki/Dysuria" title="Dysuria">dysuria</a> (painful urination). A study based on the 1998 Patient Care Evaluation in the US found that about a third of patients diagnosed with prostate cancer had one or more such symptoms, while two thirds had no symptoms.<sup id="cite_ref-prostateCApresentation_13-0" class="reference"><a href="#cite_note-prostateCApresentation-13"><span>[</span>13<span>]</span></a></sup></p>
<p>Prostate cancer is associated with urinary dysfunction as the prostate gland surrounds the <a href="/wiki/Prostatic_urethra" title="Prostatic urethra">prostatic urethra</a>. Changes within the gland, therefore, directly affect urinary function. Because the <i><a href="/wiki/Vas_deferens" title="Vas deferens">vas deferens</a></i> deposits seminal fluid into the prostatic urethra, and secretions from the prostate gland itself are included in semen content, prostate cancer may also cause problems with sexual function and performance, such as difficulty achieving <a href="/wiki/Erection" title="Erection">erection</a> or painful <a href="/wiki/Ejaculation" title="Ejaculation">ejaculation</a>.<sup id="cite_ref-prostateCApresentation_13-1" class="reference"><a href="#cite_note-prostateCApresentation-13"><span>[</span>13<span>]</span></a></sup></p>
<p>Advanced prostate cancer can spread to other parts of the body, possibly causing additional symptoms. The most common symptom is <a href="/wiki/Bone_pain" title="Bone pain">bone pain</a>, often in the <a href="/wiki/Vertebrae" title="Vertebrae" class="mw-redirect">vertebrae</a> (bones of the spine), <a href="/wiki/Pelvis" title="Pelvis">pelvis</a>, or <a href="/wiki/Rib" title="Rib">ribs</a>. Spread of cancer into other bones such as the <a href="/wiki/Femur" title="Femur">femur</a> is usually to the <a href="/wiki/Anatomical_terms_of_location#Proximal_and_distal" title="Anatomical terms of location">proximal</a> part of the bone. Prostate cancer in the <a href="/wiki/Vertebral_column" title="Vertebral column">spine</a> can also compress the <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a>, causing leg weakness and <a href="/wiki/Urinary_incontinence" title="Urinary incontinence">urinary</a> and <a href="/wiki/Fecal_incontinence" title="Fecal incontinence">fecal incontinence</a>.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14"><span>[</span>14<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Risk_factors">Risk factors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=2" title="Edit section: Risk factors">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>A complete understanding of the causes of prostate cancer remains elusive.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup> The primary risk factors are obesity, age and family history. Prostate cancer is very uncommon in men younger than 45, but becomes more common with advancing age. The average age at the time of diagnosis is 70.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>16<span>]</span></a></sup> However, many men never know they have prostate cancer. Autopsy studies of Chinese, German, Israeli, Jamaican, Swedish, and Ugandan men who died of other causes have found prostate cancer in 30% of men in their 50s, and in 80% of men in their 70s.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17"><span>[</span>17<span>]</span></a></sup> Men who have <a href="/wiki/Degree_of_relationship" title="Degree of relationship" class="mw-redirect">first-degree family members</a> with prostate cancer appear to have double the risk of getting the disease compared to men without prostate cancer in the family.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup> This risk appears to be greater for men with an affected brother than for men with an affected father. In the United States in 2005, there were an estimated 230,000 new cases of prostate cancer and 30,000 deaths due to prostate cancer.<sup id="cite_ref-pmid15661684_19-0" class="reference"><a href="#cite_note-pmid15661684-19"><span>[</span>19<span>]</span></a></sup> Men with high blood pressure are more likely to develop prostate cancer.<sup id="cite_ref-pmid19949849_20-0" class="reference"><a href="#cite_note-pmid19949849-20"><span>[</span>20<span>]</span></a></sup> There is a small increased risk of prostate cancer associated with lack of exercise.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21"><span>[</span>21<span>]</span></a></sup> A 2010 study found that prostate basal cells were the most common site of origin for prostate cancers.<sup id="cite_ref-pmid20671189_22-0" class="reference"><a href="#cite_note-pmid20671189-22"><span>[</span>22<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Genetic">Genetic</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=3" title="Edit section: Genetic">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Genetic background may contribute to prostate cancer risk, as suggested by associations with race, family, and specific <a href="/wiki/Gene" title="Gene">gene</a> variants. Men who have a first-degree relative (father or brother) with prostate cancer have twice the risk of developing prostate cancer, and those with two first-degree relatives affected have a fivefold greater risk compared with men with no family history.<sup id="cite_ref-pmid2251225_23-0" class="reference"><a href="#cite_note-pmid2251225-23"><span>[</span>23<span>]</span></a></sup> In the United States, prostate cancer more commonly affects black men than white or Hispanic men, and is also more deadly in black men.<sup id="cite_ref-pmid9805030_24-0" class="reference"><a href="#cite_note-pmid9805030-24"><span>[</span>24<span>]</span></a></sup><sup id="cite_ref-pmid11238701_25-0" class="reference"><a href="#cite_note-pmid11238701-25"><span>[</span>25<span>]</span></a></sup> In contrast, the incidence and mortality rates for Hispanic men are one third lower than for non-Hispanic whites. <a href="/wiki/Twin_study" title="Twin study">Studies of twins</a> in <a href="/wiki/Scandinavia" title="Scandinavia">Scandinavia</a> suggest that 40% of prostate cancer risk can be explained by <a href="/wiki/Heritability" title="Heritability">inherited factors</a>.<sup id="cite_ref-pmid10891514_26-0" class="reference"><a href="#cite_note-pmid10891514-26"><span>[</span>26<span>]</span></a></sup></p>
<p>No single gene is responsible for prostate cancer; many different genes have been implicated. Mutations in <i><a href="/wiki/BRCA1" title="BRCA1">BRCA1</a></i> and <i><a href="/wiki/BRCA2" title="BRCA2">BRCA2</a></i>, important risk factors for <a href="/wiki/Ovarian_cancer" title="Ovarian cancer">ovarian cancer</a> and <a href="/wiki/Breast_cancer" title="Breast cancer">breast cancer</a> in women, have also been implicated in prostate cancer.<sup id="cite_ref-pmid9145676_27-0" class="reference"><a href="#cite_note-pmid9145676-27"><span>[</span>27<span>]</span></a></sup> Other linked genes include the <a href="/wiki/RNASEL" title="RNASEL" class="mw-redirect">Hereditary Prostate cancer gene 1</a> (HPC1), the androgen receptor, and the <a href="/wiki/Vitamin_D_receptor" title="Vitamin D receptor" class="mw-redirect">vitamin D receptor</a>.<sup id="cite_ref-pmid9805030_24-1" class="reference"><a href="#cite_note-pmid9805030-24"><span>[</span>24<span>]</span></a></sup> <a href="/wiki/TMPRSS2" title="TMPRSS2">TMPRSS2</a>-<a href="/wiki/ETS_transcription_factor_family" title="ETS transcription factor family">ETS gene family</a> <a href="/wiki/Fusion_gene" title="Fusion gene">fusion</a>, specifically TMPRSS2-<a href="/wiki/ERG_(gene)" title="ERG (gene)">ERG</a> or TMPRSS2-<a href="/wiki/ETV1" title="ETV1">ETV1</a>/4 promotes cancer cell growth.<sup id="cite_ref-pmid19945666_28-0" class="reference"><a href="#cite_note-pmid19945666-28"><span>[</span>28<span>]</span></a></sup></p>
<p>Two large <a href="/wiki/Genome-wide_association_studies" title="Genome-wide association studies" class="mw-redirect">genome-wide association studies</a> linking <a href="/wiki/Single_nucleotide_polymorphisms" title="Single nucleotide polymorphisms" class="mw-redirect">single nucleotide polymorphisms</a> (SNPs) to prostate cancer were published in 2008.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29"><span>[</span>29<span>]</span></a></sup><sup id="cite_ref-30" class="reference"><a href="#cite_note-30"><span>[</span>30<span>]</span></a></sup> These studies identified several SNPs which substantially affect the risk of prostate cancer. For example, individuals with TT allele pair at SNP rs10993994 were reported to be at 1.6 times higher risk of prostate cancer than those with the CC allele pair. This SNP explains part of the increased prostate cancer risk of African American men as compared to American men of European descent, since the C allele is much more prevalent in the latter; this SNP is located in the promoter region of the <i>MSMB</i> gene, thus affects the amount of <a href="/wiki/MSMB" title="MSMB">MSMB</a> protein synthesized and secreted by epithelial cells of the prostate.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31"><span>[</span>31<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Dietary">Dietary</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=4" title="Edit section: Dietary">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>While some dietary factors have been associated with prostate cancer the evidence is still tentative.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32"><span>[</span>32<span>]</span></a></sup> Evidence supports little role for dietary fruits and vegetables in prostate cancer occurrence.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33"><span>[</span>33<span>]</span></a></sup> Red meat and processed meat also appear to have little effect in human studies.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34"><span>[</span>34<span>]</span></a></sup> Higher meat consumption has been associated with a higher risk in some studies.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35"><span>[</span>35<span>]</span></a></sup></p>
<p>Lower <a href="/wiki/Blood" title="Blood">blood</a> levels of <a href="/wiki/Vitamin_D" title="Vitamin D">vitamin D</a> may increase the risk of developing prostate cancer.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36"><span>[</span>36<span>]</span></a></sup></p>
<p><a href="/wiki/Folic_acid" title="Folic acid">Folic acid</a> <a href="/wiki/Dietary_supplement" title="Dietary supplement">supplements</a> have no effect on the risk of developing prostate cancer.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37"><span>[</span>37<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Medication_exposure">Medication exposure</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=5" title="Edit section: Medication exposure">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>There are also some links between prostate cancer and medications, medical procedures, and medical conditions.<sup id="cite_ref-pmid15998950_38-0" class="reference"><a href="#cite_note-pmid15998950-38"><span>[</span>38<span>]</span></a></sup> Use of the <a href="/wiki/Hypolipidaemic_agent" title="Hypolipidaemic agent" class="mw-redirect">cholesterol-lowering drugs</a> known as the <a href="/wiki/Statin" title="Statin">statins</a> may also decrease prostate cancer risk.<sup id="cite_ref-pmid16014776_39-0" class="reference"><a href="#cite_note-pmid16014776-39"><span>[</span>39<span>]</span></a></sup></p>
<p><a href="/wiki/Infection" title="Infection">Infection</a> or <a href="/wiki/Inflammation" title="Inflammation">inflammation</a> of the prostate (<a href="/wiki/Prostatitis" title="Prostatitis">prostatitis</a>) may increase the chance for prostate cancer while another study shows infection may help prevent prostate cancer by increasing blood to the area. In particular, infection with the <a href="/wiki/Sexually_transmitted_infection" title="Sexually transmitted infection">sexually transmitted infections</a> <a href="/wiki/Chlamydia_infection" title="Chlamydia infection">chlamydia</a>, <a href="/wiki/Gonorrhea" title="Gonorrhea">gonorrhea</a>, or <a href="/wiki/Syphilis" title="Syphilis">syphilis</a> seems to increase risk.<sup id="cite_ref-pmid12100928_40-0" class="reference"><a href="#cite_note-pmid12100928-40"><span>[</span>40<span>]</span></a></sup> Finally, <a href="/wiki/Obesity" title="Obesity">obesity</a><sup id="cite_ref-pmid12711737_41-0" class="reference"><a href="#cite_note-pmid12711737-41"><span>[</span>41<span>]</span></a></sup> and elevated blood levels of <a href="/wiki/Testosterone" title="Testosterone">testosterone</a><sup id="cite_ref-pmid8757191_42-0" class="reference"><a href="#cite_note-pmid8757191-42"><span>[</span>42<span>]</span></a></sup> may increase the risk for prostate cancer. There is an association between vasectomy and prostate cancer however more research is needed to determine if this is a causative relationship.<sup id="cite_ref-bccancer.bc.ca_43-0" class="reference"><a href="#cite_note-bccancer.bc.ca-43"><span>[</span>43<span>]</span></a></sup></p>
<p>Research released in May 2007, found that US war veterans who had been exposed to <a href="/wiki/Agent_Orange" title="Agent Orange">Agent Orange</a> had a 48% increased risk of prostate cancer recurrence following surgery.<sup id="cite_ref-aorange_44-0" class="reference"><a href="#cite_note-aorange-44"><span>[</span>44<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Infectious_disease">Infectious disease</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=6" title="Edit section: Infectious disease">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>An association with <a href="/wiki/Gonorrhea" title="Gonorrhea">gonorrhea</a> has been found, but a mechanism for this relationship has not been identified.<sup id="cite_ref-CainiGandini2014_6-1" class="reference"><a href="#cite_note-CainiGandini2014-6"><span>[</span>6<span>]</span></a></sup></p>
<p>In 2006, a previously unknown retrovirus, <a href="/wiki/Xenotropic_MuLV-related_virus" title="Xenotropic MuLV-related virus" class="mw-redirect">Xenotropic MuLV-related virus</a> or XMRV, was associated with human prostate tumors,<sup id="cite_ref-pmid16609730_45-0" class="reference"><a href="#cite_note-pmid16609730-45"><span>[</span>45<span>]</span></a></sup> but subsequent reports on the virus were contradictory,<sup id="cite_ref-pmid19805305_46-0" class="reference"><a href="#cite_note-pmid19805305-46"><span>[</span>46<span>]</span></a></sup><sup id="cite_ref-pmid19835577_47-0" class="reference"><a href="#cite_note-pmid19835577-47"><span>[</span>47<span>]</span></a></sup> and the original 2006 finding was instead due to a previously undetected contamination.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span>[</span>48<span>]</span></a></sup> The journals <i>Science</i> and <i>PlosONE</i> both retracted XMRV related articles.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49"><span>[</span>49<span>]</span></a></sup><sup id="cite_ref-50" class="reference"><a href="#cite_note-50"><span>[</span>50<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Sexual_factors">Sexual factors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=7" title="Edit section: Sexual factors">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Several case-control studies have shown that having many lifetime sexual partners or starting sexual activity early in life substantially increases the risk of prostate cancer.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51"><span>[</span>51<span>]</span></a></sup><sup id="cite_ref-Rosenblatt_1152.E2.80.938_52-0" class="reference"><a href="#cite_note-Rosenblatt_1152.E2.80.938-52"><span>[</span>52<span>]</span></a></sup><sup id="cite_ref-53" class="reference"><a href="#cite_note-53"><span>[</span>53<span>]</span></a></sup></p>
<p>While the available evidence is weak,<sup id="cite_ref-54" class="reference"><a href="#cite_note-54"><span>[</span>54<span>]</span></a></sup> tentative results suggest that frequent <a href="/wiki/Ejaculation" title="Ejaculation">ejaculation</a> may decrease the risk of prostate cancer.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55"><span>[</span>55<span>]</span></a></sup> A study, over eight years, showed that those that ejaculated most frequently (over 21 times per month on average) were less likely to get prostate cancer.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56"><span>[</span>56<span>]</span></a></sup> The results were broadly similar to the findings of a smaller Australian study.<sup id="cite_ref-57" class="reference"><a href="#cite_note-57"><span>[</span>57<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=8" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Prostatelead.jpg" class="image"><img alt="Prostatelead.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a1/Prostatelead.jpg/220px-Prostatelead.jpg" width="220" height="420" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/a/a1/Prostatelead.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/a/a1/Prostatelead.jpg 2x" data-file-width="289" data-file-height="552" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Prostatelead.jpg" class="internal" title="Enlarge"></a></div>
</div>
</div>
</div>
<p>The <a href="/wiki/Prostate" title="Prostate">prostate</a> is a part of the male <a href="/wiki/Reproductive_system" title="Reproductive system">reproductive</a> system that helps make and store <a href="/wiki/Seminal_fluid" title="Seminal fluid" class="mw-redirect">seminal fluid</a>. In adult men, a typical prostate is about 3 centimeters long and weighs about 20 grams.<sup id="cite_ref-58" class="reference"><a href="#cite_note-58"><span>[</span>58<span>]</span></a></sup> It is located in the <a href="/wiki/Pelvis" title="Pelvis">pelvis</a>, under the <a href="/wiki/Urinary_bladder" title="Urinary bladder">urinary bladder</a> and in front of the <a href="/wiki/Rectum" title="Rectum">rectum</a>. The prostate surrounds part of the <a href="/wiki/Urethra" title="Urethra">urethra</a>, the tube that carries <a href="/wiki/Urine" title="Urine">urine</a> from the bladder during <a href="/wiki/Urination" title="Urination">urination</a> and semen during <a href="/wiki/Ejaculation" title="Ejaculation">ejaculation</a>.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59"><span>[</span>59<span>]</span></a></sup> Because of its location, prostate diseases often affect urination, ejaculation, and rarely <a href="/wiki/Defecation" title="Defecation">defecation</a>. The prostate contains many small <a href="/wiki/Gland" title="Gland">glands</a> which make about 20 percent of the fluid constituting <a href="/wiki/Semen" title="Semen">semen</a>.<sup id="cite_ref-60" class="reference"><a href="#cite_note-60"><span>[</span>60<span>]</span></a></sup> In prostate cancer, the cells of these prostate glands <a href="/wiki/Mutation" title="Mutation">mutate</a> into cancer cells. The prostate glands require male <a href="/wiki/Hormone" title="Hormone">hormones</a>, known as <a href="/wiki/Androgen" title="Androgen">androgens</a>, to work properly. Androgens include <a href="/wiki/Testosterone" title="Testosterone">testosterone</a>, which is made in the <a href="/wiki/Testes" title="Testes" class="mw-redirect">testes</a>; <a href="/wiki/Dehydroepiandrosterone" title="Dehydroepiandrosterone">dehydroepiandrosterone</a>, made in the <a href="/wiki/Adrenal_gland" title="Adrenal gland">adrenal glands</a>; and <a href="/wiki/Dihydrotestosterone" title="Dihydrotestosterone">dihydrotestosterone</a>, which is converted from testosterone within the prostate itself. Androgens are also responsible for <a href="/wiki/Secondary_sex_characteristic" title="Secondary sex characteristic">secondary sex characteristics</a> such as facial hair and increased muscle mass.</p>
<div class="thumb tleft">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Diagram_showing_prostate_cancer_that_has_spread_to_the_lymph_nodes_CRUK_184.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/88/Diagram_showing_prostate_cancer_that_has_spread_to_the_lymph_nodes_CRUK_184.svg/220px-Diagram_showing_prostate_cancer_that_has_spread_to_the_lymph_nodes_CRUK_184.svg.png" width="220" height="169" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/88/Diagram_showing_prostate_cancer_that_has_spread_to_the_lymph_nodes_CRUK_184.svg/330px-Diagram_showing_prostate_cancer_that_has_spread_to_the_lymph_nodes_CRUK_184.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/88/Diagram_showing_prostate_cancer_that_has_spread_to_the_lymph_nodes_CRUK_184.svg/440px-Diagram_showing_prostate_cancer_that_has_spread_to_the_lymph_nodes_CRUK_184.svg.png 2x" data-file-width="404" data-file-height="311" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Diagram_showing_prostate_cancer_that_has_spread_to_the_lymph_nodes_CRUK_184.svg" class="internal" title="Enlarge"></a></div>
Prostate cancer that has metastasized to the lymph nodes</div>
</div>
</div>
<div class="thumb tleft">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Diagram_showing_prostate_cancer_that_has_spread_to_the_bones_CRUK_183.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ec/Diagram_showing_prostate_cancer_that_has_spread_to_the_bones_CRUK_183.svg/220px-Diagram_showing_prostate_cancer_that_has_spread_to_the_bones_CRUK_183.svg.png" width="220" height="170" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ec/Diagram_showing_prostate_cancer_that_has_spread_to_the_bones_CRUK_183.svg/330px-Diagram_showing_prostate_cancer_that_has_spread_to_the_bones_CRUK_183.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ec/Diagram_showing_prostate_cancer_that_has_spread_to_the_bones_CRUK_183.svg/440px-Diagram_showing_prostate_cancer_that_has_spread_to_the_bones_CRUK_183.svg.png 2x" data-file-width="403" data-file-height="311" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Diagram_showing_prostate_cancer_that_has_spread_to_the_bones_CRUK_183.svg" class="internal" title="Enlarge"></a></div>
Prostate cancer that has metastasized to the bone</div>
</div>
</div>
<p>Prostate cancer is classified as an <a href="/wiki/Adenocarcinoma" title="Adenocarcinoma">adenocarcinoma</a>, or glandular cancer, that begins when normal semen-secreting prostate gland cells mutate into cancer cells. The region of prostate gland where the adenocarcinoma is most common is the peripheral zone. Initially, small clumps of cancer cells remain confined to otherwise normal prostate glands, a condition known as <a href="/wiki/Carcinoma_in_situ" title="Carcinoma in situ">carcinoma in situ</a> or <a href="/wiki/Prostatic_intraepithelial_neoplasia" title="Prostatic intraepithelial neoplasia" class="mw-redirect">prostatic intraepithelial neoplasia</a> (PIN). Although there is no proof that PIN is a cancer precursor, it is closely associated with cancer. Over time, these cancer cells begin to multiply and spread to the surrounding prostate tissue (the <a href="/wiki/Stroma_(animal_tissue)" title="Stroma (animal tissue)">stroma</a>) forming a <a href="/wiki/Tumor" title="Tumor" class="mw-redirect">tumor</a>. Eventually, the tumor may grow large enough to invade nearby organs such as the <a href="/wiki/Seminal_vesicles" title="Seminal vesicles" class="mw-redirect">seminal vesicles</a> or the <a href="/wiki/Rectum" title="Rectum">rectum</a>, or the tumor cells may develop the ability to travel in the <a href="/wiki/Blood" title="Blood">bloodstream</a> and <a href="/wiki/Lymphatic_system" title="Lymphatic system">lymphatic system</a>. Prostate cancer is considered a <a href="/wiki/Malignant" title="Malignant" class="mw-redirect">malignant</a> tumor because it is a mass of cells that can invade other parts of the body. This invasion of other organs is called <a href="/wiki/Metastasis" title="Metastasis">metastasis</a>. Prostate cancer most commonly metastasizes to the <a href="/wiki/Bone" title="Bone">bones</a>, <a href="/wiki/Lymph_node" title="Lymph node">lymph nodes</a>, and may invade rectum, <a href="/wiki/Bladder" title="Bladder" class="mw-redirect">bladder</a> and lower ureters after local progression. The route of metastasis to bone is thought to be venous as the <a href="/wiki/Prostatic_venous_plexus" title="Prostatic venous plexus">prostatic venous plexus</a> draining the prostate connects with the vertebral veins.<sup id="cite_ref-metastasis-route_61-0" class="reference"><a href="#cite_note-metastasis-route-61"><span>[</span>61<span>]</span></a></sup></p>
<p>The prostate is a zinc-accumulating, <a href="/wiki/Citrate" title="Citrate">citrate</a>-producing organ. The protein <a href="/wiki/ZIP1" title="ZIP1" class="mw-redirect">ZIP1</a> is responsible for the active transport of zinc into prostate cells. One of zinc's important roles is to change the metabolism of the cell in order to produce citrate, an important component of semen. The process of zinc accumulation, alteration of metabolism, and citrate production is energy inefficient, and prostate cells sacrifice enormous amounts of energy (ATP) in order to accomplish this task. Prostate cancer cells are generally devoid of zinc. This allows prostate cancer cells to save energy not making citrate, and utilize the new abundance of energy to grow and spread. The absence of zinc is thought to occur via a silencing of the gene that produces the transporter protein ZIP1. ZIP1 is now called a tumor suppressor gene product for the gene <a href="/wiki/SLC39A1" title="SLC39A1">SLC39A1</a>. The cause of the epigenetic silencing is unknown. Strategies which transport zinc into transformed prostate cells effectively eliminate these cells in animals. Zinc inhibits <a href="/wiki/NF-%CE%BAB" title="NF-κB">NF-κB</a> pathways, is anti-proliferative, and induces apoptosis in abnormal cells. Unfortunately, oral ingestion of zinc is ineffective since high concentrations of zinc into prostate cells is not possible without the active transporter, ZIP1.<sup id="cite_ref-62" class="reference"><a href="#cite_note-62"><span>[</span>62<span>]</span></a></sup></p>
<p>Loss of cancer suppressor genes, early in the prostatic carcinogenesis, have been localized to chromosomes <i>8p</i>, <i>10q</i>, <i>13q</i>, and <i>16q</i>. <a href="/wiki/P53" title="P53">P53</a> mutations in the primary prostate cancer are relatively low and are more frequently seen in metastatic settings, hence, <a href="/wiki/P53" title="P53">p53</a> mutations are late event in pathology of prostate cancer. Other tumor suppressor genes that are thought to play a role in prostate cancer include <a href="/wiki/PTEN_(gene)" title="PTEN (gene)">PTEN (gene)</a> and <a href="/wiki/KAI1" title="KAI1" class="mw-redirect">KAI1</a>. "Up to 70 percent of men with prostate cancer have lost one copy of the PTEN gene at the time of diagnosis"<sup id="cite_ref-63" class="reference"><a href="#cite_note-63"><span>[</span>63<span>]</span></a></sup> Relative frequency of loss of <a href="/wiki/E-cadherin" title="E-cadherin" class="mw-redirect">E-cadherin</a> and <a href="/wiki/CD44" title="CD44">CD44</a> has also been observed.</p>
<p><a href="/wiki/RUNX2" title="RUNX2">RUNX2</a> is a transcription factor that prevents cancer cells from undergoing apoptosis thereby contributing to the development of prostate cancer.<sup id="cite_ref-pmid19948822_64-0" class="reference"><a href="#cite_note-pmid19948822-64"><span>[</span>64<span>]</span></a></sup></p>
<p>The <a href="/wiki/PI3K/AKT_pathway" title="PI3K/AKT pathway" class="mw-redirect">PI3k/Akt signaling cascade</a> works with the <a href="/wiki/Transforming_growth_factor_beta" title="Transforming growth factor beta">transforming growth factor beta</a>/<a href="/wiki/SMAD_(protein)" title="SMAD (protein)">SMAD</a> signaling cascade to ensure prostate cancer cell survival and protection against apoptosis.<sup id="cite_ref-pmid19947572_65-0" class="reference"><a href="#cite_note-pmid19947572-65"><span>[</span>65<span>]</span></a></sup> X-linked inhibitor of apoptosis (<a href="/wiki/XIAP" title="XIAP">XIAP</a>) is hypothesized to promote prostate cancer cell survival and growth and is a target of research because if this inhibitor can be shut down then the <a href="/wiki/Apoptosis" title="Apoptosis">apoptosis</a> cascade can carry on its function in preventing cancer cell proliferation.<sup id="cite_ref-pmid19946707_66-0" class="reference"><a href="#cite_note-pmid19946707-66"><span>[</span>66<span>]</span></a></sup> <a href="/wiki/GDF15" title="GDF15">Macrophage inhibitory cytokine-1</a> (MIC-1) stimulates the <a href="/wiki/Focal_adhesion_kinase" title="Focal adhesion kinase" class="mw-redirect">focal adhesion kinase</a> (FAK) signaling pathway which leads to prostate cancer cell growth and survival.<sup id="cite_ref-pmid19946339_67-0" class="reference"><a href="#cite_note-pmid19946339-67"><span>[</span>67<span>]</span></a></sup></p>
<p>The <a href="/wiki/Androgen_receptor" title="Androgen receptor">androgen receptor</a> helps prostate cancer cells to survive and is a target for many anti cancer research studies; so far, inhibiting the androgen receptor has only proven to be effective in mouse studies.<sup id="cite_ref-pmid19946220_68-0" class="reference"><a href="#cite_note-pmid19946220-68"><span>[</span>68<span>]</span></a></sup> Prostate specific membrane antigen (PSMA) stimulates the development of prostate cancer by increasing folate levels for the cancer cells to use to survive and grow; PSMA increases available folates for use by hydrolyzing glutamated folates.<sup id="cite_ref-pmid19830782_69-0" class="reference"><a href="#cite_note-pmid19830782-69"><span>[</span>69<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=9" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The American Cancer Society's position regarding early detection is "Research has not yet proven that the potential benefits of testing outweigh the harms of testing and treatment. The American Cancer Society believes that men should not be tested without learning about what we know and don’t know about the risks and possible benefits of testing and treatment. Starting at age 50, (45 if African American or brother or father suffered from condition before age 65) talk to your doctor about the pros and cons of testing so you can decide if testing is the right choice for you."<sup id="cite_ref-70" class="reference"><a href="#cite_note-70"><span>[</span>70<span>]</span></a></sup></p>
<p>The only test that can fully confirm the diagnosis of prostate cancer is a <a href="/wiki/Biopsy" title="Biopsy">biopsy</a>, the removal of small pieces of the prostate for microscopic examination. However, prior to a biopsy, less invasive testing can be conducted.</p>
<p>There are also several other tests that can be used to gather more information about the prostate and the urinary tract. Digital <a href="/wiki/Rectal_examination" title="Rectal examination">rectal examination</a> (DRE) may allow a doctor to detect prostate abnormalities. <a href="/wiki/Cystoscopy" title="Cystoscopy">Cystoscopy</a> shows the urinary tract from inside the bladder, using a thin, flexible camera tube inserted down the <a href="/wiki/Urethra" title="Urethra">urethra</a>. <a href="/wiki/Transrectal_ultrasonography" title="Transrectal ultrasonography">Transrectal ultrasonography</a> creates a picture of the prostate using sound waves from a probe in the rectum.</p>
<h3><span class="mw-headline" id="Prostate_imaging">Prostate imaging</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=10" title="Edit section: Prostate imaging">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Ultrasound (US) and magnetic resonance imaging (MRI) are the two main imaging methods used for prostate cancer detection. Urologists use transrectal ultrasound during prostate biopsy and can sometimes see a hypoechoic area (tissues or structures that reflect relatively less of the ultrasound waves directed at them). But US has poor tissue resolution and thus, is generally not clinically used.</p>
<p>Prostate MRI has better soft tissue resolution than ultrasound.<sup id="cite_ref-pmid21571651_71-0" class="reference"><a href="#cite_note-pmid21571651-71"><span>[</span>71<span>]</span></a></sup></p>
<p>MRI in those who are at low risk might help people choose active surveillance, in those who are at intermediate risk it may help with determining the stage of disease, while in those who are at high risk it might help find bone disease.<sup id="cite_ref-pmid22322308_72-0" class="reference"><a href="#cite_note-pmid22322308-72"><span>[</span>72<span>]</span></a></sup></p>
<p>Currently (2011), MRI is used to identify targets for prostate biopsy using fusion MRI with ultrasound (US) or MRI-guidance alone. In men who are candidates for active surveillance, fusion MR/US guided prostate biopsy detected 33% of cancers compared to 7% with standard ultrasound guided biopsy.<sup id="cite_ref-pmid21555104_73-0" class="reference"><a href="#cite_note-pmid21555104-73"><span>[</span>73<span>]</span></a></sup></p>
<p>Prostate MRI is also used for surgical planning for men undergoing robotic prostatectomy. It has also shown to help surgeons decide whether to resect or spare the neurovascular bundle, determine return to urinary continence, and help assess surgical difficulty.<sup id="cite_ref-pmid21993567_74-0" class="reference"><a href="#cite_note-pmid21993567-74"><span>[</span>74<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Biopsy">Biopsy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=11" title="Edit section: Biopsy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="hatnote relarticle mainarticle">Main article: <a href="/wiki/Prostate_biopsy" title="Prostate biopsy">Prostate biopsy</a></div>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Prostatic_adenocarcinoma_with_perineural_invasion.JPG" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Prostatic_adenocarcinoma_with_perineural_invasion.JPG/220px-Prostatic_adenocarcinoma_with_perineural_invasion.JPG" width="220" height="147" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Prostatic_adenocarcinoma_with_perineural_invasion.JPG/330px-Prostatic_adenocarcinoma_with_perineural_invasion.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Prostatic_adenocarcinoma_with_perineural_invasion.JPG/440px-Prostatic_adenocarcinoma_with_perineural_invasion.JPG 2x" data-file-width="4272" data-file-height="2848" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Prostatic_adenocarcinoma_with_perineural_invasion.JPG" class="internal" title="Enlarge"></a></div>
<a href="/wiki/Micrograph" title="Micrograph">Micrograph</a> showing a prostate cancer (conventional adenocarcinoma) with <a href="/wiki/Perineural_invasion" title="Perineural invasion">perineural invasion</a>. <a href="/wiki/H%26E_stain" title="H&amp;E stain">H&amp;E stain</a>.</div>
</div>
</div>
<p>If cancer is suspected, a biopsy is offered expediently. During a biopsy a <a href="/wiki/Urology" title="Urology">urologist</a> or <a href="/wiki/Radiology" title="Radiology">radiologist</a> obtains tissue samples from the prostate via the rectum. A biopsy gun inserts and removes special hollow-core needles (usually three to six on each side of the prostate) in less than a second. Prostate biopsies are routinely done on an outpatient basis and rarely require hospitalization. Fifty-five percent of men report discomfort during prostate biopsy.<sup id="cite_ref-pmid9637143_75-0" class="reference"><a href="#cite_note-pmid9637143-75"><span>[</span>75<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="Gleason_score">Gleason score</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=12" title="Edit section: Gleason score">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<div class="hatnote relarticle mainarticle">Main article: <a href="/wiki/Gleason_score" title="Gleason score" class="mw-redirect">Gleason score</a></div>
<p>The tissue samples are then examined under a microscope to determine whether cancer cells are present, and to evaluate the microscopic features (or <a href="/wiki/Gleason_score" title="Gleason score" class="mw-redirect">Gleason score</a>) of any cancer found. <a href="/wiki/Prostate_specific_membrane_antigen" title="Prostate specific membrane antigen" class="mw-redirect">Prostate specific membrane antigen</a> is a <a href="/wiki/Transmembrane" title="Transmembrane" class="mw-redirect">transmembrane</a> <a href="/wiki/Carboxypeptidase" title="Carboxypeptidase">carboxypeptidase</a> and exhibits <a href="/wiki/Folate" title="Folate" class="mw-redirect">folate</a> <a href="/wiki/Hydrolase" title="Hydrolase">hydrolase</a> activity.<sup id="cite_ref-pmid19276452_76-0" class="reference"><a href="#cite_note-pmid19276452-76"><span>[</span>76<span>]</span></a></sup> This <a href="/wiki/Protein" title="Protein">protein</a> is overexpressed in prostate cancer <a href="/wiki/Tissue_(biology)" title="Tissue (biology)">tissues</a> and is associated with a higher <a href="/wiki/Gleason_score" title="Gleason score" class="mw-redirect">Gleason score</a>.<sup id="cite_ref-pmid19276452_76-1" class="reference"><a href="#cite_note-pmid19276452-76"><span>[</span>76<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Tumor_markers">Tumor markers</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=13" title="Edit section: Tumor markers">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Tissue samples can be stained for the presence of <a href="/wiki/Prostate-specific_antigen" title="Prostate-specific antigen">PSA</a> and other <a href="/wiki/Tumor_marker" title="Tumor marker">tumor markers</a> in order to determine the origin of malignant cells that have metastasized.<sup id="cite_ref-pmid17667550_77-0" class="reference"><a href="#cite_note-pmid17667550-77"><span>[</span>77<span>]</span></a></sup></p>
<p><a href="/wiki/Small_cell_carcinoma" title="Small cell carcinoma" class="mw-redirect">Small cell carcinoma</a> is a very rare (1%<sup id="cite_ref-pmid9227387_78-0" class="reference"><a href="#cite_note-pmid9227387-78"><span>[</span>78<span>]</span></a></sup>) type of prostate cancer that cannot be diagnosed using the PSA.<sup id="cite_ref-pmid9227387_78-1" class="reference"><a href="#cite_note-pmid9227387-78"><span>[</span>78<span>]</span></a></sup><sup id="cite_ref-pmid19947569_79-0" class="reference"><a href="#cite_note-pmid19947569-79"><span>[</span>79<span>]</span></a></sup> As of 2009<sup class="plainlinks noprint asof-tag update" style="display:none;"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Prostate_cancer&amp;action=edit">[update]</a></sup> researchers are trying to determine the best way to screen for this type of prostate cancer because it is a relatively unknown and rare type of prostate cancer but very serious and quick to spread to other parts of the body.<sup id="cite_ref-pmid19947569_79-1" class="reference"><a href="#cite_note-pmid19947569-79"><span>[</span>79<span>]</span></a></sup> Possible methods include chromatographic separation methods by mass spectrometry, or protein capturing by immunoassays or immunized antibodies. The test method will involve quantifying the amount of the biomarker <a href="/wiki/Protein_C_inhibitor" title="Protein C inhibitor">PCI</a>, with reference to the <a href="/wiki/Gleason_Score" title="Gleason Score" class="mw-redirect">Gleason Score</a>. Not only is this test quick, it is also sensitive. It can detect patients in the diagnostic grey zone, particularly those with a serum free to total <a href="/wiki/Prostate_Specific_Antigen" title="Prostate Specific Antigen" class="mw-redirect">Prostate Specific Antigen</a> ratio of 10-20%.<sup id="cite_ref-80" class="reference"><a href="#cite_note-80"><span>[</span>80<span>]</span></a></sup></p>
<p>The oncoprotein <a href="/wiki/BCL-2" title="BCL-2" class="mw-redirect">BCL-2</a>, has been associated with the development of androgen-independent prostate cancer due to its high levels of expression in androgen-independent tumours in advanced stages of the pathology. The upregulation of BCL-2 after androgen ablation in prostate carcinoma cell lines and in a castrated-male rat model further established a connection between BCL-2 expression and prostate cancer progression.<sup id="cite_ref-pmid12510149_81-0" class="reference"><a href="#cite_note-pmid12510149-81"><span>[</span>81<span>]</span></a></sup></p>
<p>The expression of Ki-67 by immunohistochemistry may be a significant predictor of patient outcome for men with prostate cancer.<sup id="cite_ref-82" class="reference"><a href="#cite_note-82"><span>[</span>82<span>]</span></a></sup></p>
<p>ERK5 is a protein that may be used as a marker. ERK5 is present in abnormally high levels of prostate cancer, including invasive cancer which has spread to other parts of the body. It is also present in relapsed cancer following previous hormone therapy. Research shows that reducing the amount of ERK5 found in cancerous cells reduces their invasiveness.<sup id="cite_ref-83" class="reference"><a href="#cite_note-83"><span>[</span>83<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Staging">Staging</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=14" title="Edit section: Staging">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="hatnote relarticle mainarticle">Main article: <a href="/wiki/Prostate_cancer_staging" title="Prostate cancer staging">Prostate cancer staging</a></div>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Diagram_showing_T1-3_stages_of_prostate_cancer_CRUK_278.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4e/Diagram_showing_T1-3_stages_of_prostate_cancer_CRUK_278.svg/220px-Diagram_showing_T1-3_stages_of_prostate_cancer_CRUK_278.svg.png" width="220" height="218" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4e/Diagram_showing_T1-3_stages_of_prostate_cancer_CRUK_278.svg/330px-Diagram_showing_T1-3_stages_of_prostate_cancer_CRUK_278.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4e/Diagram_showing_T1-3_stages_of_prostate_cancer_CRUK_278.svg/440px-Diagram_showing_T1-3_stages_of_prostate_cancer_CRUK_278.svg.png 2x" data-file-width="343" data-file-height="340" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Diagram_showing_T1-3_stages_of_prostate_cancer_CRUK_278.svg" class="internal" title="Enlarge"></a></div>
Diagram showing T1-3 stages of prostate cancer.</div>
</div>
</div>
<p>An important part of evaluating prostate cancer is determining the <a href="/wiki/Cancer_staging" title="Cancer staging">stage</a>, or how far the cancer has spread. Knowing the stage helps define <a href="/wiki/Prognosis" title="Prognosis">prognosis</a> and is useful when selecting therapies. The most common system is the four-stage <a href="/wiki/TNM_staging_system" title="TNM staging system">TNM system</a> (abbreviated from Tumor/Nodes/Metastases). Its components include the size of the tumor, the number of involved <a href="/wiki/Lymph_node" title="Lymph node">lymph nodes</a>, and the presence of any other <a href="/wiki/Metastasis" title="Metastasis">metastases</a>.<sup id="cite_ref-84" class="reference"><a href="#cite_note-84"><span>[</span>84<span>]</span></a></sup></p>
<p>The most important distinction made by any staging system is whether or not the cancer is still confined to the prostate. In the TNM system, clinical T1 and T2 cancers are found only in the prostate, while T3 and T4 cancers have spread elsewhere. Several tests can be used to look for evidence of spread. <a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Medical specialty</a> <a href="/wiki/Professional_organizations" title="Professional organizations" class="mw-redirect">professional organizations</a> recommend against the use of <a href="/wiki/Positron_emission_tomography" title="Positron emission tomography">PET scans</a>, <a href="/wiki/X-ray_computed_tomography" title="X-ray computed tomography" class="mw-redirect">CT scans</a>, or <a href="/wiki/Bone_scintigraphy" title="Bone scintigraphy">bone scans</a> when a physician stages early prostate cancer with low risk for metastasis.<sup id="cite_ref-ASCOfive_85-0" class="reference"><a href="#cite_note-ASCOfive-85"><span>[</span>85<span>]</span></a></sup> Those tests would be appropriate in such cases as when a CT scan evaluates spread within the pelvis, a bone scan look for spread to the bones, and <a href="/wiki/Endorectal_coil_magnetic_resonance_imaging" title="Endorectal coil magnetic resonance imaging">endorectal coil magnetic resonance imaging</a> to closely evaluate the prostatic capsule and the <a href="/wiki/Seminal_vesicles" title="Seminal vesicles" class="mw-redirect">seminal vesicles</a>. Bone scans should reveal <a href="/wiki/Osteoblast" title="Osteoblast">osteoblastic</a> appearance due to <i>increased</i> bone density in the areas of <a href="/wiki/Bone_metastasis" title="Bone metastasis">bone metastasis</a>—opposite to what is found in many other cancers that metastasize.</p>
<p>After a prostate biopsy, a <a href="/wiki/Pathology" title="Pathology">pathologist</a> looks at the samples under a microscope. If cancer is present, the pathologist reports the <a href="/wiki/Grading_(tumors)" title="Grading (tumors)">grade</a> of the tumor. The grade tells how much the tumor tissue differs from normal prostate tissue and suggests how fast the tumor is likely to grow. The Gleason system is used to grade prostate tumors from 2 to 10, where a <a href="/wiki/Gleason_score" title="Gleason score" class="mw-redirect">Gleason score</a> of 10 indicates the most abnormalities. The pathologist assigns a number from 1 to 5 for the most common pattern observed under the microscope, then does the same for the second-most-common pattern. The sum of these two numbers is the Gleason score. The <a href="/wiki/Whitmore-Jewett_stage" title="Whitmore-Jewett stage" class="mw-redirect">Whitmore-Jewett stage</a> is another method sometimes used.</p>
<h2><span class="mw-headline" id="Prevention">Prevention</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=15" title="Edit section: Prevention">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Diet_and_lifestyle">Diet and lifestyle</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=16" title="Edit section: Diet and lifestyle">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The data on the relationship between diet and prostate cancer is poor.<sup id="cite_ref-Masko2012_86-0" class="reference"><a href="#cite_note-Masko2012-86"><span>[</span>86<span>]</span></a></sup> In light of this the rate of prostate cancer is linked to the consumption of the Western diet.<sup id="cite_ref-Masko2012_86-1" class="reference"><a href="#cite_note-Masko2012-86"><span>[</span>86<span>]</span></a></sup> There is little if any evidence to support an association between trans fat, saturated fat and carbohydrate intake and risk of prostate cancer.<sup id="cite_ref-Masko2012_86-2" class="reference"><a href="#cite_note-Masko2012-86"><span>[</span>86<span>]</span></a></sup><sup id="cite_ref-87" class="reference"><a href="#cite_note-87"><span>[</span>87<span>]</span></a></sup> Evidence regarding the role of omega-3 fatty acids in preventing prostate cancer does not suggest that they reduce the risk of prostate cancer, although additional research is needed.<sup id="cite_ref-Masko2012_86-3" class="reference"><a href="#cite_note-Masko2012-86"><span>[</span>86<span>]</span></a></sup><sup id="cite_ref-88" class="reference"><a href="#cite_note-88"><span>[</span>88<span>]</span></a></sup> Vitamin supplements appear to have no effect and some may increase the risk.<sup id="cite_ref-Strat2011_9-1" class="reference"><a href="#cite_note-Strat2011-9"><span>[</span>9<span>]</span></a></sup><sup id="cite_ref-Masko2012_86-4" class="reference"><a href="#cite_note-Masko2012-86"><span>[</span>86<span>]</span></a></sup> High calcium intake has been linked to advanced prostate cancer.<sup id="cite_ref-89" class="reference"><a href="#cite_note-89"><span>[</span>89<span>]</span></a></sup> Consuming fish may lower prostate cancer deaths but does not appear to affect its occurrence.<sup id="cite_ref-90" class="reference"><a href="#cite_note-90"><span>[</span>90<span>]</span></a></sup> Some evidence supports lower rates of prostate cancer with a <a href="/wiki/Vegetarian" title="Vegetarian" class="mw-redirect">vegetarian</a> diet.<sup id="cite_ref-91" class="reference"><a href="#cite_note-91"><span>[</span>91<span>]</span></a></sup> There is some tentative evidence for foods containing <a href="/wiki/Lycopene" title="Lycopene">lycopene</a> and <a href="/wiki/Selenium" title="Selenium">selenium</a>.<sup id="cite_ref-WCR2007_92-0" class="reference"><a href="#cite_note-WCR2007-92"><span>[</span>92<span>]</span></a></sup> Diets rich in <a href="/wiki/Cruciferous" title="Cruciferous" class="mw-redirect">cruciferous</a> vegetables, soy, beans and other legumes may be associated with a lower risk of prostate cancer, especially more advanced cancers.<sup id="cite_ref-Cancer.org_93-0" class="reference"><a href="#cite_note-Cancer.org-93"><span>[</span>93<span>]</span></a></sup></p>
<p>Men who get regular exercise may have a slightly lower risk, especially vigorous activity and the risk of advanced prostate cancer.<sup id="cite_ref-Cancer.org_93-1" class="reference"><a href="#cite_note-Cancer.org-93"><span>[</span>93<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Medications">Medications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=17" title="Edit section: Medications">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In those who are being regularly screened <a href="/wiki/5-alpha-reductase_inhibitor" title="5-alpha-reductase inhibitor">5-alpha-reductase inhibitor</a> (<a href="/wiki/Finasteride" title="Finasteride">finasteride</a> and <a href="/wiki/Dutasteride" title="Dutasteride">dutasteride</a>) reduce the overall risk of being diagnosed with prostate cancer however there is insufficient data to determine if they have an effect on the risk of death and may increase the chance of more serious cases.<sup id="cite_ref-pmid18425978_94-0" class="reference"><a href="#cite_note-pmid18425978-94"><span>[</span>94<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Screening">Screening</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=18" title="Edit section: Screening">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="hatnote relarticle mainarticle">Main article: <a href="/wiki/Prostate_cancer_screening" title="Prostate cancer screening">Prostate cancer screening</a></div>
<p>Prostate cancer <a href="/wiki/Screening_(medicine)" title="Screening (medicine)">screening</a> is an attempt to find unsuspected cancers, and may lead to more invasive follow-up tests such as a <a href="/wiki/Biopsy" title="Biopsy">biopsy</a>, with cell samples taken for closer study. Options include the <a href="/wiki/Rectal_examination" title="Rectal examination">digital rectal exam</a> (DRE) and the <a href="/wiki/Prostate-specific_antigen" title="Prostate-specific antigen">prostate-specific antigen</a> (PSA) blood test. Such screening is controversial and, in some people, may lead to unnecessary, possibly harmful, consequences.<sup id="cite_ref-PSA-20111012_95-0" class="reference"><a href="#cite_note-PSA-20111012-95"><span>[</span>95<span>]</span></a></sup> Routine screening with either a DRE or PSA is not supported by the evidence as there is no <a href="/wiki/Mortality_rate" title="Mortality rate">mortality</a> benefit from screening.<sup id="cite_ref-BMJ2010_7-1" class="reference"><a href="#cite_note-BMJ2010-7"><span>[</span>7<span>]</span></a></sup></p>
<p>The <a href="/wiki/United_States_Preventive_Services_Task_Force" title="United States Preventive Services Task Force">United States Preventive Services Task Force</a> (<a href="/wiki/USPSTF" title="USPSTF" class="mw-redirect">USPSTF</a>) recommends against the PSA test for prostate cancer screening in healthy men regardless of age.<sup id="cite_ref-96" class="reference"><a href="#cite_note-96"><span>[</span>96<span>]</span></a></sup> They conclude that the potential benefit of testing does not outweigh the expected harms.<sup id="cite_ref-USPTF2012_8-1" class="reference"><a href="#cite_note-USPTF2012-8"><span>[</span>8<span>]</span></a></sup><sup id="cite_ref-USPSTF-20111007_97-0" class="reference"><a href="#cite_note-USPSTF-20111007-97"><span>[</span>97<span>]</span></a></sup> The <a href="/wiki/Centers_for_Disease_Control_and_Prevention" title="Centers for Disease Control and Prevention">Centers for Disease Control and Prevention</a> shared that conclusion.<sup id="cite_ref-CDC_98-0" class="reference"><a href="#cite_note-CDC-98"><span>[</span>98<span>]</span></a></sup> The <a href="/wiki/American_Society_of_Clinical_Oncology" title="American Society of Clinical Oncology">American Society of Clinical Oncology</a> and the <a href="/wiki/American_College_of_Physicians" title="American College of Physicians">American College of Physicians</a> recommends screening be discouraged in those who are expected to live less than ten to fifteen years, while in those with a greater life expectancy a decision should be made by the person in question based on the potential risks and benefits.<sup id="cite_ref-Qa2013_99-0" class="reference"><a href="#cite_note-Qa2013-99"><span>[</span>99<span>]</span></a></sup> In general, they conclude that based on recent research, "it is uncertain whether the benefits associated with PSA testing for prostate cancer screening are worth the harms associated with screening and subsequent unnecessary treatment."<sup id="cite_ref-100" class="reference"><a href="#cite_note-100"><span>[</span>100<span>]</span></a></sup> <a href="/wiki/American_Urological_Association" title="American Urological Association">American Urological Association</a> (AUA 2013) guidelines call for weighing the benefits of preventing prostate cancer mortality in 1 man for every 1,000 men screened over a ten-year period against the known harms associated with diagnostic tests and treatment. The AUA recommends screening decisions in those 55 to 69 be based on shared decision making, and that if screening is performed it should occur no more often than every two years.<sup id="cite_ref-101" class="reference"><a href="#cite_note-101"><span>[</span>101<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Management">Management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=19" title="Edit section: Management">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="hatnote relarticle mainarticle">Main article: <a href="/wiki/Management_of_prostate_cancer" title="Management of prostate cancer">Management of prostate cancer</a></div>
<p>The first decision to be made in managing prostate cancer is whether treatment is needed. Prostate cancer, especially low-grade forms found in elderly men, often grows so slowly that no treatment is required.<sup id="cite_ref-102" class="reference"><a href="#cite_note-102"><span>[</span>102<span>]</span></a></sup> Treatment may also be inappropriate if a person has other serious health problems or is not expected to live long enough for symptoms to appear.</p>
<p>Which option is best depends on the stage of the disease, the Gleason score, and the PSA level. Other important factors are age, general health, and a person's views about potential treatments and their possible side effects. Because most treatments can have significant <a href="/wiki/Adverse_effect_(medicine)" title="Adverse effect (medicine)" class="mw-redirect">side effects</a>, such as <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a> and <a href="/wiki/Urinary_incontinence" title="Urinary incontinence">urinary incontinence</a>, treatment discussions often focus on balancing the goals of therapy with the risks of lifestyle alterations. A combination of the treatment options is often recommended for managing prostate cancer.<sup id="cite_ref-103" class="reference"><a href="#cite_note-103"><span>[</span>103<span>]</span></a></sup><sup id="cite_ref-pmid19945664_104-0" class="reference"><a href="#cite_note-pmid19945664-104"><span>[</span>104<span>]</span></a></sup><sup id="cite_ref-pmid19945310_105-0" class="reference"><a href="#cite_note-pmid19945310-105"><span>[</span>105<span>]</span></a></sup></p>
<p>Guidelines for treatment for specific clinical situations requires a good estimation of a person's long-term life expectancy.<sup id="cite_ref-pmid21842788_106-0" class="reference"><a href="#cite_note-pmid21842788-106"><span>[</span>106<span>]</span></a></sup> People can also use an 18-item questionnaire to learn whether they have good knowledge and understanding about their treatment options before they choose. Most of those who are newly diagnosed and made a treatment choice can not correctly answer over half of the questions.<sup id="cite_ref-pmid21842788_106-1" class="reference"><a href="#cite_note-pmid21842788-106"><span>[</span>106<span>]</span></a></sup></p>
<p>If <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a> is done first, and fails, then <a href="/wiki/Radical_prostatectomy" title="Radical prostatectomy" class="mw-redirect">radical prostatectomy</a> becomes a very technically challenging surgery and may not be feasible. On the other hand, radiation therapy done after surgical failure may have many complications.<sup id="cite_ref-pmid16314889_107-0" class="reference"><a href="#cite_note-pmid16314889-107"><span>[</span>107<span>]</span></a></sup></p>
<p>In localized disease, it is unknown if radical prostatectomy is better or worse than watchful waiting.<sup id="cite_ref-108" class="reference"><a href="#cite_note-108"><span>[</span>108<span>]</span></a></sup></p>
<p>A <a href="/wiki/Meta-analysis" title="Meta-analysis">meta-analysis</a> on the effects of voiding position during urination in males with prostate enlargement showed that the sitting position was superior to the standing. Bladder emptying was significantly improved, while there was a trend towards a higher urinary flow and shorter voiding time.<sup id="cite_ref-109" class="reference"><a href="#cite_note-109"><span>[</span>109<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Surveillance">Surveillance</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=20" title="Edit section: Surveillance">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Many men diagnosed with low-risk prostate cancer are eligible for <i>active surveillance</i>. This term implies careful observation of the tumor over time, with the intention of treatment for cure if there are signs of cancer progression. Active surveillance is <i>not</i> synonymous with <a href="/wiki/Watchful_waiting" title="Watchful waiting">watchful waiting</a>, an older term which implies no treatment or specific program of monitoring, with the assumption that <i>palliative</i>, not curative, treatment would be used if advanced, symptomatic disease develops.</p>
<p>Active surveillance involves monitoring the tumor for signs of growth or the appearance of symptoms. The monitoring process may involve serial PSA, physical examination of the prostate, and/or repeated biopsies. The goal of surveillance is to avoid <a href="/wiki/Overtreatment" title="Overtreatment" class="mw-redirect">overtreatment</a> and the sometimes serious, permanent side effects of treatment for a slow-growing or self-limited tumor that would never cause any problems for the person. This approach is not used for aggressive cancers, but it may cause <a href="/wiki/Anxiety" title="Anxiety">anxiety</a> for people who wrongly believe that all cancer is deadly or themselves to have a life-threatening cancer. For 50% to 75% of people with prostate cancer it will cause no harm before a person dies.<sup id="cite_ref-110" class="reference"><a href="#cite_note-110"><span>[</span>110<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Aggressive_cancer">Aggressive cancer</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=21" title="Edit section: Aggressive cancer">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Treatment of aggressive prostate cancers may involve <a href="/wiki/Surgery" title="Surgery">surgery</a> (i.e. radical prostatectomy), <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a> including <a href="/wiki/Brachytherapy" title="Brachytherapy">brachytherapy</a> (<a href="/wiki/Prostate_brachytherapy" title="Prostate brachytherapy">prostate brachytherapy</a>) and external beam radiation therapy, <a href="/wiki/High-intensity_focused_ultrasound" title="High-intensity focused ultrasound">high-intensity focused ultrasound</a> (HIFU), <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a>, oral chemotherapeutic drugs (Temozolomide/TMZ), <a href="/wiki/Cryosurgery" title="Cryosurgery">cryosurgery</a>, <a href="/wiki/Hormonal_therapy_(oncology)" title="Hormonal therapy (oncology)">hormonal therapy</a>, or some combination.<sup id="cite_ref-pmid19946787_111-0" class="reference"><a href="#cite_note-pmid19946787-111"><span>[</span>111<span>]</span></a></sup><sup id="cite_ref-pmid19945663_112-0" class="reference"><a href="#cite_note-pmid19945663-112"><span>[</span>112<span>]</span></a></sup></p>
<p>Although the widespread use of prostate specific antigen (PSA) screening in the USA has resulted in diagnosis at earlier age and cancer stage, the vast majority of cases are still diagnosed in men older than 65 years, and approximately 25% of cases are diagnosed in men older than 75 years.<sup id="cite_ref-113" class="reference"><a href="#cite_note-113"><span>[</span>113<span>]</span></a></sup> Though US National Comprehensive Cancer Network guidelines recommend using life expectancy greater than or less than 10 years to help make treatment decisions, in practice, many elderly patients are not offered curative treatment options such as radical prostatectomy or radiation therapy and are instead treated with hormonal therapy or watchful waiting.<sup id="cite_ref-114" class="reference"><a href="#cite_note-114"><span>[</span>114<span>]</span></a></sup> This pattern can be attributed to factors such as medical co-morbidity and patient preferences is regard to quality of life in addition to prostate cancer specific risk factors such as pretreatment PSA, Gleason score and clinical stage. As the average life expectancy increases due to advances in treatment of cardiovascular, pulmonary and other chronic disease, it is likely that more elderly patients will be living long enough to suffer the consequences of their prostate cancer. Therefore, there is currently much interest in the role of aggressive prostate cancer treatment modalities such as with surgery or radiation in the elderly population who have localized disease.</p>
<p>If the cancer has spread beyond the prostate, treatment options significantly change, so most doctors that treat prostate cancer use a variety of <a href="/wiki/Nomogram" title="Nomogram">nomograms</a> to predict the probability of spread. Treatment by watchful waiting/active surveillance, external beam radiation therapy, brachytherapy, cryosurgery, HIFU, and surgery are, in general, offered to men whose cancer remains within the prostate. <a href="/wiki/Hormonal_therapy_(oncology)" title="Hormonal therapy (oncology)">Hormonal therapy</a> and chemotherapy are often reserved for disease that has spread beyond the prostate. However, there are exceptions: radiation therapy may be used for some advanced tumors, and <a href="/wiki/Hormonal_therapy_(oncology)" title="Hormonal therapy (oncology)">hormonal therapy</a> is used for some early stage tumors. <a href="/wiki/Cryotherapy" title="Cryotherapy">Cryotherapy</a> (the process of freezing the tumor), <a href="/wiki/Hormonal_therapy_(oncology)" title="Hormonal therapy (oncology)">hormonal therapy</a>, and chemotherapy may also be offered if initial treatment fails and the cancer progresses.</p>
<p><a href="/wiki/Sipuleucel-T" title="Sipuleucel-T">Sipuleucel-T</a>, a <a href="/wiki/Cancer_vaccine" title="Cancer vaccine">cancer vaccine</a> has been found to result in a benefit (a four-month increase in survival) for men with metastatic prostate cancer.<sup id="cite_ref-115" class="reference"><a href="#cite_note-115"><span>[</span>115<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Castration-resistant"><span id="Castration-resistant_prostate_cancer"></span> Castration-resistant</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=22" title="Edit section: Castration-resistant">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Most hormone dependent cancers become <a href="/wiki/Disease#Stages" title="Disease">resistant to treatment</a> after one to three years and resume growth despite hormone therapy. Previously considered "hormone-refractory prostate cancer" or "androgen-independent prostate cancer", the term castration-resistant has replaced "hormone refractory" because while they are no longer responsive to castration treatment (reduction of available <a href="/wiki/Androgen" title="Androgen">androgen</a>/<a href="/wiki/Testosterone" title="Testosterone">testosterone</a>/<a href="/wiki/Dihydrotestosterone" title="Dihydrotestosterone">DHT</a> by chemical or surgical means), these cancers still show reliance upon hormones for <a href="/wiki/Androgen_receptor" title="Androgen receptor">androgen receptor</a> activation.<sup id="cite_ref-pmid20859283_116-0" class="reference"><a href="#cite_note-pmid20859283-116"><span>[</span>116<span>]</span></a></sup> Before 2004, all treatments for castration-resistant prostate cancer (CRPC) were considered<sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Manual_of_Style/Words_to_watch#Unsupported_attributions" title="Wikipedia:Manual of Style/Words to watch"><span title="The material near this tag may use weasel words or too-vague attribution. (July 2011)">by whom?</span></a></i>]</sup> <a href="/wiki/Palliative_care" title="Palliative care">palliative</a> and not shown to prolong survival.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2011)">citation needed</span></a></i>]</sup> However, there are now several treatments available to treat CRPC that improve survival.</p>
<p>The <a href="/wiki/Chemotherapy" title="Chemotherapy">cancer chemotherapic</a> <a href="/wiki/Docetaxel" title="Docetaxel">docetaxel</a> has been used as treatment for CRPC with a median survival benefit of 2 to 3 months.<sup id="cite_ref-117" class="reference"><a href="#cite_note-117"><span>[</span>117<span>]</span></a></sup><sup id="cite_ref-urlProstate_cancer_.28hormone-refractory.29_-_docetaxel_118-0" class="reference"><a href="#cite_note-urlProstate_cancer_.28hormone-refractory.29_-_docetaxel-118"><span>[</span>118<span>]</span></a></sup> A second-line chemotherapy treatment is <a href="/wiki/Cabazitaxel" title="Cabazitaxel">cabazitaxel</a>.<sup id="cite_ref-pmid20888992_119-0" class="reference"><a href="#cite_note-pmid20888992-119"><span>[</span>119<span>]</span></a></sup> A combination of <a href="/wiki/Bevacizumab" title="Bevacizumab">bevacizumab</a>, <a href="/wiki/Docetaxel" title="Docetaxel">docetaxel</a>, <a href="/wiki/Thalidomide" title="Thalidomide">thalidomide</a> and <a href="/wiki/Prednisone" title="Prednisone">prednisone</a> appears effective in the treatment of CRPC.<sup id="cite_ref-120" class="reference"><a href="#cite_note-120"><span>[</span>120<span>]</span></a></sup></p>
<p>The immunotherapy treatment with <a href="/wiki/Sipuleucel-T" title="Sipuleucel-T">sipuleucel-T</a> in CRPC increases survival by 4 months.<sup id="cite_ref-pmid20818862_121-0" class="reference"><a href="#cite_note-pmid20818862-121"><span>[</span>121<span>]</span></a></sup> The second line hormonal therapy <a href="/wiki/Abiraterone" title="Abiraterone">abiraterone</a> increases survival by 4.6 months when compared to placebo.<sup id="cite_ref-122" class="reference"><a href="#cite_note-122"><span>[</span>122<span>]</span></a></sup> <a href="/wiki/Enzalutamide" title="Enzalutamide">Enzalutamide</a> is another second line hormonal agent with a 5-month survival advantage over placebo. Both abiraterone and enzalutamide are currently being tested in clinical trials in those with CRPC who have not previously received chemotherapy.<sup id="cite_ref-Xtandi-1_123-0" class="reference"><a href="#cite_note-Xtandi-1-123"><span>[</span>123<span>]</span></a></sup><sup id="cite_ref-Xtandi-2_124-0" class="reference"><a href="#cite_note-Xtandi-2-124"><span>[</span>124<span>]</span></a></sup></p>
<p>Only a subset of a people respond to androgen signaling blocking drugs and certain cells with characteristics resembling stem cells remain unaffected.<sup id="cite_ref-125" class="reference"><a href="#cite_note-125"><span>[</span>125<span>]</span></a></sup><sup id="cite_ref-126" class="reference"><a href="#cite_note-126"><span>[</span>126<span>]</span></a></sup> Therefore, the desire to improve outcome of people with CRPC has resulted into the claims of increasing doses further or combination therapy with synergistic androgen signaling blocking agents.<sup id="cite_ref-127" class="reference"><a href="#cite_note-127"><span>[</span>127<span>]</span></a></sup> But even these combination will not affect stem -like cells that do not exhibit androgen signaling. It is possible that for further advances, a combination of androgen signaling blocking agent with stem-like cell directed <a href="/wiki/Differentiation_therapy" title="Differentiation therapy">differentiation therapy</a> drug would prove ideal.<sup id="cite_ref-Rane2012_128-0" class="reference"><a href="#cite_note-Rane2012-128"><span>[</span>128<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Palliative_care">Palliative care</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=23" title="Edit section: Palliative care">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Palliative_care" title="Palliative care">Palliative care</a> is medical care which focuses on treatment of symptoms from serious illness, like cancer, and improving quality of life.<sup id="cite_ref-129" class="reference"><a href="#cite_note-129"><span>[</span>129<span>]</span></a></sup> One of the goals of treatment in palliative care is symptom control rather than a treatment of the underlying cancer. Pain is common in metastatic prostate cancer, and cancer pain related to bone metastases can be treated with <a href="/wiki/Bisphosphonate" title="Bisphosphonate">bisphosphonates</a>, medications such as <a href="/wiki/Opioid" title="Opioid">opioids</a>, and palliative <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a> to known metastases. Spinal cord compression can occur with metastases to the spine, and can be treated with <a href="/wiki/Steroid" title="Steroid">steroids</a>, surgery, or radiation therapy. Other symptoms that can be addressed through palliative care include fatigue, <a href="/wiki/Delirium" title="Delirium">delirium</a>, <a href="/wiki/Lymphedema" title="Lymphedema">lymphedema</a> in the scrotum or penis, nausea, vomiting, and weight loss.<sup id="cite_ref-130" class="reference"><a href="#cite_note-130"><span>[</span>130<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=24" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Prostate cancer rates are higher and prognoses are poorer in developed countries than in the rest of the world. Many of the risk factors for prostate cancer are more prevalent in the <a href="/wiki/Developed_world" title="Developed world" class="mw-redirect">developed world</a>, including longer life expectancy and diets high in red meat. (People who consume larger amounts of meat and dairy also tend to consume fewer portions of fruits and vegetables. It is not currently clear whether both of these factors, or just one of them, contribute to the occurrence of prostate cancer.<sup id="cite_ref-131" class="reference"><a href="#cite_note-131"><span>[</span>131<span>]</span></a></sup>) Also, where there is more access to screening programs, there is a higher detection rate. Prostate cancer is the ninth-most-common cancer in the world, but is the number-one non-skin cancer in men from the United States. Prostate cancer affected 18 percent of American men and caused death in three percent in 2005.<sup id="cite_ref-pmid15661684_19-1" class="reference"><a href="#cite_note-pmid15661684-19"><span>[</span>19<span>]</span></a></sup> In <a href="/wiki/Japan" title="Japan">Japan</a>, death from prostate cancer was one-fifth to one-half the rates in the United States and <a href="/wiki/Europe" title="Europe">Europe</a> in the 1990s.<sup id="cite_ref-pmid15714967_132-0" class="reference"><a href="#cite_note-pmid15714967-132"><span>[</span>132<span>]</span></a></sup> In <a href="/wiki/India" title="India">India</a> in the 1990s, half of the people with prostate cancer confined to the prostate died within ten years.<sup id="cite_ref-pmid1259345_133-0" class="reference"><a href="#cite_note-pmid1259345-133"><span>[</span>133<span>]</span></a></sup> African-American men have 50–60 times more prostate cancer and prostate cancer deaths than men in <a href="/wiki/Shanghai" title="Shanghai">Shanghai</a>, <a href="/wiki/China" title="China">China</a>.<sup id="cite_ref-pmid10585584_134-0" class="reference"><a href="#cite_note-pmid10585584-134"><span>[</span>134<span>]</span></a></sup> In <a href="/wiki/Nigeria" title="Nigeria">Nigeria</a>, two percent of men develop prostate cancer, and 64% of them are dead after two years.<sup id="cite_ref-pmid9120935_135-0" class="reference"><a href="#cite_note-pmid9120935-135"><span>[</span>135<span>]</span></a></sup></p>
<p>In patients who undergo treatment, the most important clinical prognostic indicators of disease outcome are stage, pre-therapy PSA level, and Gleason score. In general, the higher the grade and the stage, the poorer the prognosis. <a href="/wiki/Nomogram" title="Nomogram">Nomograms</a> can be used to calculate the estimated risk of the individual patient. The predictions are based on the experience of large groups of patients suffering from cancers at various stages.<sup id="cite_ref-pmid14571407_136-0" class="reference"><a href="#cite_note-pmid14571407-136"><span>[</span>136<span>]</span></a></sup></p>
<p>In 1941, <a href="/wiki/Charles_Huggins" title="Charles Huggins" class="mw-redirect">Charles Huggins</a> reported that androgen ablation therapy causes regression of primary and metastatic androgen-dependent prostate cancer.<sup id="cite_ref-137" class="reference"><a href="#cite_note-137"><span>[</span>137<span>]</span></a></sup> He was awarded the 1966 <a href="/wiki/Nobel_Prize_for_Physiology_or_Medicine" title="Nobel Prize for Physiology or Medicine" class="mw-redirect">Nobel Prize for Physiology or Medicine</a> for this discovery. Androgen ablation therapy causes remission in 80-90% of patients undergoing therapy, resulting in a median progression-free survival of 12 to 33 months. After remission, an androgen-independent phenotype typically emerges, wherein the median overall survival is 23–37 months from the time of initiation of androgen ablation therapy.<sup id="cite_ref-138" class="reference"><a href="#cite_note-138"><span>[</span>138<span>]</span></a></sup> It is not clear how the prostate cancer becomes androgen-independent or how it reestablishes progression, although a few possibilities (on how) have been proposed.<sup id="cite_ref-139" class="reference"><a href="#cite_note-139"><span>[</span>139<span>]</span></a></sup> And the way the cancer changes, to overcome the lack of androgen, may vary between individual patients.</p>
<h3><span class="mw-headline" id="Classification_systems">Classification systems</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=25" title="Edit section: Classification systems">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Prostate_cancer_with_Gleason_pattern_4_low_mag.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Prostate_cancer_with_Gleason_pattern_4_low_mag.jpg/220px-Prostate_cancer_with_Gleason_pattern_4_low_mag.jpg" width="220" height="145" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Prostate_cancer_with_Gleason_pattern_4_low_mag.jpg/330px-Prostate_cancer_with_Gleason_pattern_4_low_mag.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Prostate_cancer_with_Gleason_pattern_4_low_mag.jpg/440px-Prostate_cancer_with_Gleason_pattern_4_low_mag.jpg 2x" data-file-width="4132" data-file-height="2724" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Prostate_cancer_with_Gleason_pattern_4_low_mag.jpg" class="internal" title="Enlarge"></a></div>
<a href="/wiki/Micrograph" title="Micrograph">Micrograph</a> of prostate <a href="/wiki/Adenocarcinoma" title="Adenocarcinoma">adenocarcinoma</a>, acinar type, the most common type of prostate cancer. Needle <a href="/wiki/Biopsy" title="Biopsy">biopsy</a>, <a href="/wiki/H%26E_stain" title="H&amp;E stain">H&amp;E stain</a></div>
</div>
</div>
<p>Many prostate cancers are not destined to be lethal, and most men will ultimately not die as a result of the disease . Decisions about treatment type and timing may, therefore, be informed by an estimation of the risk that the tumor will ultimately recur after treatment and/or progress to metastases and mortality. Several tools are available to help predict outcomes, such as pathologic stage and recurrence after surgery or radiation therapy. Most combine stage, grade, and PSA level, and some also add the number or percent of biopsy cores positive, age, and/or other information.</p>
<ul>
<li>The <i>D'Amico classification</i> stratifies men by low, intermediate, or high risk based on stage, grade, and PSA. It is used widely in clinical practice and research settings. The major downside to the 3-level system is that it does not account for multiple adverse parameters (e.g., high Gleason score <i>and</i> high PSA) in stratifying patients.</li>
<li>The <a href="/w/index.php?title=Partin_tables&amp;action=edit&amp;redlink=1" class="new" title="Partin tables (page does not exist)">Partin tables</a><sup id="cite_ref-140" class="reference"><a href="#cite_note-140"><span>[</span>140<span>]</span></a></sup> predict pathologic outcomes (margin status, extraprostatic extension, and seminal vesicle invasion) based on the same three variables and are published as lookup tables.</li>
<li>The <i>Kattan nomograms</i> predict recurrence after surgery and/or radiation therapy, based on data available either at time of diagnosis or after surgery. The nomograms can be calculated using paper graphs or software available on a website or for handheld computers. The Kattan score represents the likelihood of remaining free of disease at a given time interval following treatment.</li>
<li>The UCSF <i>Cancer of the Prostate Risk Assessment (CAPRA) score</i> predicts both pathologic status and recurrence after surgery. It offers comparable accuracy as the Kattan preoperative nomogram, and can be calculated without paper tables or a calculator. Points are assigned based on PSA, Grade, stage, age, and percent of cores positive; the sum yields a 0–10 score, with every 2 points representing roughly a doubling of risk of recurrence. The CAPRA score was derived from community-based data in the <a rel="nofollow" class="external text" href="http://www.capsure.net">CaPSURE</a> database. It has been validated among over 10,000 prostatectomy patients, including patients from CaPSURE;<sup id="cite_ref-141" class="reference"><a href="#cite_note-141"><span>[</span>141<span>]</span></a></sup> the SEARCH registry, representing data from several Veterans Administration and active military medical centers;<sup id="cite_ref-142" class="reference"><a href="#cite_note-142"><span>[</span>142<span>]</span></a></sup> a multi-institutional cohort in Germany;<sup id="cite_ref-143" class="reference"><a href="#cite_note-143"><span>[</span>143<span>]</span></a></sup> and the prostatectomy cohort at Johns Hopkins University.<sup id="cite_ref-144" class="reference"><a href="#cite_note-144"><span>[</span>144<span>]</span></a></sup> More recently, it has been shown to predict metastasis and mortality following prostatectomy, radiation therapy, watchful waiting, or androgen deprivation therapy.<sup id="cite_ref-pmid19509351_145-0" class="reference"><a href="#cite_note-pmid19509351-145"><span>[</span>145<span>]</span></a></sup></li>
</ul>
<h3><span class="mw-headline" id="Life_expectancy">Life expectancy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=26" title="Edit section: Life expectancy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Life expectancy projections are averages for an entire male population, and many medical and lifestyle factors modify these numbers. For example, studies have shown that a 40-year-old man will lose 3.1 years of life if he is overweight (BMI 25-29) and 5.8 years of life if he is obese (BMI 30 or more), compared to men of normal weight. If he is both overweight and a smoker, he will lose 6.7 years, and if obese and a smoker, he will lose 13.7 years.<sup id="cite_ref-146" class="reference"><a href="#cite_note-146"><span>[</span>146<span>]</span></a></sup></p>
<p>At this time, there is no evidence that either surgery or beam radiation has an advantage over the other in this regard, the lower death rates reported with surgery appear to occur because surgery is more likely to be offered to younger men with less serious forms of cancer. Insufficient information is available to determine whether seed radiation extends life more readily than the other treatments, but data so far do not suggest that it does.<sup id="cite_ref-147" class="reference"><a href="#cite_note-147"><span>[</span>147<span>]</span></a></sup></p>
<p>People with low grade disease (Gleason 2-4) were unlikely to die of prostate cancer within 15 years of diagnosis. Older men (age 70-75) with low grade disease had an approximately 20% overall survival at 15 years due to deaths from competing causes. Men with high grade disease (Gleason 8-10) experienced high prostate cancer mortality within 15 years of diagnosis, regardless of their age at diagnosis, underscoring the very aggressive nature of poorly differentiated prostate cancer.<sup id="cite_ref-148" class="reference"><a href="#cite_note-148"><span>[</span>148<span>]</span></a></sup><sup id="cite_ref-149" class="reference"><a href="#cite_note-149"><span>[</span>149<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=27" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:262px;"><a href="/wiki/File:Prostate_cancer_world_map_-_Death_-_WHO2004.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a6/Prostate_cancer_world_map_-_Death_-_WHO2004.svg/260px-Prostate_cancer_world_map_-_Death_-_WHO2004.svg.png" width="260" height="115" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/a6/Prostate_cancer_world_map_-_Death_-_WHO2004.svg/390px-Prostate_cancer_world_map_-_Death_-_WHO2004.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a6/Prostate_cancer_world_map_-_Death_-_WHO2004.svg/520px-Prostate_cancer_world_map_-_Death_-_WHO2004.svg.png 2x" data-file-width="940" data-file-height="415" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Prostate_cancer_world_map_-_Death_-_WHO2004.svg" class="internal" title="Enlarge"></a></div>
<a href="/wiki/Age_adjustment" title="Age adjustment">Age-standardized</a> death from prostate cancer per 100,000&#160;inhabitants in 2004.<sup id="cite_ref-150" class="reference"><a href="#cite_note-150"><span>[</span>150<span>]</span></a></sup>
<div class="refbegin columns references-column-count references-column-count-3" style="-moz-column-count: 3; -webkit-column-count: 3; column-count: 3;">
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #b3b3b3; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;no data</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffff65; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;&lt;4</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #fff200; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;4-8</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffdc00; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;8-12</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffc600; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;12-16</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffb000; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;16-20</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff9a00; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;20-24</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff8400; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;24-28</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff6e00; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;28-32</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff5800; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;32-36</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff4200; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;36-40</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff2c00; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;40-44</div>
<div class="legend"><span class="legend-color" style="display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #cb0000; color:black; font-size:100%; text-align:center;">&#160;</span>&#160;&gt;44</div>
</div>
</div>
</div>
</div>
<p>As of 2012, prostate cancer is the second most frequently diagnosed cancer (at 15% of all male cancers)<sup id="cite_ref-151" class="reference"><a href="#cite_note-151"><span>[</span>151<span>]</span></a></sup> and the sixth leading cause of cancer death in males worldwide.<sup id="cite_ref-152" class="reference"><a href="#cite_note-152"><span>[</span>152<span>]</span></a></sup> In 2010 it resulted in 256,000 deaths up from 156,000 deaths in 1990.<sup id="cite_ref-Loz2012_153-0" class="reference"><a href="#cite_note-Loz2012-153"><span>[</span>153<span>]</span></a></sup> Rates of prostate cancer vary widely across the world. Although the rates vary widely between countries, it is least common in South and East Asia, and more common in Europe, North America, Australia and New Zealand.<sup id="cite_ref-prostates.com.au_154-0" class="reference"><a href="#cite_note-prostates.com.au-154"><span>[</span>154<span>]</span></a></sup> Prostate cancer is least common among Asian men and most common among black men, with figures for white men in between.<sup id="cite_ref-cancer.org_155-0" class="reference"><a href="#cite_note-cancer.org-155"><span>[</span>155<span>]</span></a></sup><sup id="cite_ref-Prostate_Cancer_FAQs_156-0" class="reference"><a href="#cite_note-Prostate_Cancer_FAQs-156"><span>[</span>156<span>]</span></a></sup> The average annual incidence rate of prostate cancer between 1988 and 1992 among Chinese men in the United States was 15 times higher than that of their counterparts living in Shanghai and Tianjin.<sup id="cite_ref-cancer.org_155-1" class="reference"><a href="#cite_note-cancer.org-155"><span>[</span>155<span>]</span></a></sup><sup id="cite_ref-Prostate_Cancer_FAQs_156-1" class="reference"><a href="#cite_note-Prostate_Cancer_FAQs-156"><span>[</span>156<span>]</span></a></sup><sup id="cite_ref-157" class="reference"><a href="#cite_note-157"><span>[</span>157<span>]</span></a></sup> However, these high rates may be affected by increasing rates of detection.<sup id="cite_ref-158" class="reference"><a href="#cite_note-158"><span>[</span>158<span>]</span></a></sup> Many suggest that prostate cancer may be under reported, yet <a href="/wiki/Benign_prostatic_hyperplasia" title="Benign prostatic hyperplasia">BPH</a> incidence in China and Japan is similar to rates in Western countries.<sup id="cite_ref-159" class="reference"><a href="#cite_note-159"><span>[</span>159<span>]</span></a></sup><sup id="cite_ref-160" class="reference"><a href="#cite_note-160"><span>[</span>160<span>]</span></a></sup> In Europe in 2012 it was the 3rd most diagnosed cancer after breast and colorectal at 417,000 cases.<sup id="cite_ref-161" class="reference"><a href="#cite_note-161"><span>[</span>161<span>]</span></a></sup></p>
<p>Prostate cancer develops primarily in men over fifty. It is the most common type of cancer in men in the United States, with 186,000 new cases in 2008 and 28,600 deaths.<sup id="cite_ref-162" class="reference"><a href="#cite_note-162"><span>[</span>162<span>]</span></a></sup> It is the second leading cause of cancer death in U.S. men after <a href="/wiki/Lung_cancer" title="Lung cancer">lung cancer</a>. In the United Kingdom it is also the second most common cause of cancer death after lung cancer, where around 35,000 cases are diagnosed every year and of which around 10,000 die of it.<sup id="cite_ref-163" class="reference"><a href="#cite_note-163"><span>[</span>163<span>]</span></a></sup></p>
<p>More than 80% of men will develop prostate cancer by the age of 80.<sup id="cite_ref-164" class="reference"><a href="#cite_note-164"><span>[</span>164<span>]</span></a></sup> However, in the majority of cases, it will be slow-growing and harmless. In such men, diagnosing prostate cancer is <a href="/wiki/Overdiagnosis" title="Overdiagnosis">overdiagnosis</a>—the needless identification of a technically aberrant condition that will never harm the patient—and treatment in such men exposes them to all of the adverse effects, with no possibility of extending their lives.<sup id="cite_ref-165" class="reference"><a href="#cite_note-165"><span>[</span>165<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=28" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Although the prostate was first described by <a href="/wiki/Venice" title="Venice">Venetian</a> anatomist <a href="/wiki/Niccol%C3%B2_Massa" title="Niccolò Massa">Niccolò Massa</a> in 1536, and illustrated by <a href="/wiki/Flanders" title="Flanders">Flemish</a> anatomist <a href="/wiki/Vesalius" title="Vesalius" class="mw-redirect">Andreas Vesalius</a> in 1538, prostate cancer was not identified until 1853.<sup id="cite_ref-166" class="reference"><a href="#cite_note-166"><span>[</span>166<span>]</span></a></sup> Prostate cancer was initially considered a rare disease, probably because of shorter <a href="/wiki/Life_expectancy" title="Life expectancy">life expectancies</a> and poorer detection methods in the 19th century. The first treatments of prostate cancer were surgeries to relieve urinary obstruction.<sup id="cite_ref-167" class="reference"><a href="#cite_note-167"><span>[</span>167<span>]</span></a></sup> Removal of the entire gland (radical perineal <a href="/wiki/Prostatectomy" title="Prostatectomy">prostatectomy</a>) was first performed in 1904 by <a href="/wiki/Hugh_H._Young" title="Hugh H. Young">Hugh H. Young</a> at <a href="/wiki/Johns_Hopkins_Hospital" title="Johns Hopkins Hospital">Johns Hopkins Hospital</a>.<sup id="cite_ref-168" class="reference"><a href="#cite_note-168"><span>[</span>168<span>]</span></a></sup> Surgical removal of the testes (<a href="/wiki/Orchiectomy" title="Orchiectomy">orchiectomy</a>) to treat prostate cancer was first performed in the 1890s, but with limited success. <a href="/wiki/Transurethral_resection_of_the_prostate" title="Transurethral resection of the prostate">Transurethral resection of the prostate</a> (TURP) replaced radical prostatectomy for symptomatic relief of obstruction in the middle of the 20th century because it could better preserve penile erectile function. Radical retropubic prostatectomy was developed in 1983 by Patrick Walsh.<sup id="cite_ref-169" class="reference"><a href="#cite_note-169"><span>[</span>169<span>]</span></a></sup> This surgical approach allowed for removal of the prostate and lymph nodes with maintenance of penile function.</p>
<p>In 1941, <a href="/wiki/Charles_B._Huggins" title="Charles B. Huggins" class="mw-redirect">Charles B. Huggins</a> published studies in which he used <a href="/wiki/Estrogen" title="Estrogen">estrogen</a> to oppose testosterone production in men with metastatic prostate cancer. This discovery of "chemical <a href="/wiki/Castration" title="Castration">castration</a>" won Huggins the 1966 <a href="/wiki/Nobel_Prize_in_Physiology_or_Medicine" title="Nobel Prize in Physiology or Medicine">Nobel Prize in Physiology or Medicine</a>.<sup id="cite_ref-170" class="reference"><a href="#cite_note-170"><span>[</span>170<span>]</span></a></sup> The role of the <a href="/wiki/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone">gonadotropin-releasing hormone</a> (GnRH) in reproduction was determined by <a href="/wiki/Andrzej_W._Schally" title="Andrzej W. Schally" class="mw-redirect">Andrzej W. Schally</a> and <a href="/wiki/Roger_Guillemin" title="Roger Guillemin">Roger Guillemin</a>, who both won the 1977 Nobel Prize in Physiology or Medicine for this work. GnRH receptor agonists, such as <a href="/wiki/Leuprolide" title="Leuprolide" class="mw-redirect">leuprolide</a> and <a href="/wiki/Goserelin" title="Goserelin">goserelin</a>, were subsequently developed and used to treat prostate cancer.<sup id="cite_ref-171" class="reference"><a href="#cite_note-171"><span>[</span>171<span>]</span></a></sup><sup id="cite_ref-172" class="reference"><a href="#cite_note-172"><span>[</span>172<span>]</span></a></sup></p>
<p><a href="/wiki/Radiation_therapy" title="Radiation therapy">Radiation therapy</a> for prostate cancer was first developed in the early 20th century and initially consisted of intraprostatic <a href="/wiki/Radium" title="Radium">radium</a> implants. <a href="/wiki/External_beam_radiotherapy" title="External beam radiotherapy">External beam radiotherapy</a> became more popular as stronger [X-ray] radiation sources became available in the middle of the 20th century. <a href="/wiki/Brachytherapy" title="Brachytherapy">Brachytherapy</a> with implanted seeds (for prostate cancer) was first described in 1983.<sup id="cite_ref-173" class="reference"><a href="#cite_note-173"><span>[</span>173<span>]</span></a></sup></p>
<p>Systemic <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a> for prostate cancer was first studied in the 1970s. The initial regimen of <a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">cyclophosphamide</a> and <a href="/wiki/5-fluorouracil" title="5-fluorouracil" class="mw-redirect">5-fluorouracil</a> was quickly joined by multiple regimens using a host of other systemic chemotherapy drugs.<sup id="cite_ref-174" class="reference"><a href="#cite_note-174"><span>[</span>174<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Cell-of-origin">Cell-of-origin</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=29" title="Edit section: Cell-of-origin">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>A series of studies published in <i><a href="/wiki/Science_(journal)" title="Science (journal)">Science</a></i> involved introduced viruses known to cause cancerous mutation in prostate cells: AKT, ERG, and AR into isolated samples of <a href="/wiki/Stratum_germinativum" title="Stratum germinativum" class="mw-redirect">basal</a> and luminal cells and grafted the treated tissue into mice. After 16 weeks, none of the luminal samples had undergone malignant mutation, while the basal samples had mutated into prostate-like tubules which had then developed malignancy and formed cancerous tumors, which appeared identical to human samples under magnification. This led to the conclusion that the prostate <a href="/wiki/Basal_cell" title="Basal cell" class="mw-redirect">basal cell</a> may be the most likely "site of origin" of prostate cancer.<sup id="cite_ref-pmid20671189_22-1" class="reference"><a href="#cite_note-pmid20671189-22"><span>[</span>22<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Society_and_culture">Society and culture</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=30" title="Edit section: Society and culture">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>People with prostate cancer generally encounter significant disparities in awareness, funding, media coverage, and research—and therefore, inferior treatment and poorer outcomes—compared to other cancers of equal prevalence.<sup id="cite_ref-Businessweek_2007-06-13_175-0" class="reference"><a href="#cite_note-Businessweek_2007-06-13-175"><span>[</span>175<span>]</span></a></sup> In 2001, <i><a href="/wiki/The_Guardian" title="The Guardian">The Guardian</a></i> noted that <a href="/wiki/United_Kingdom" title="United Kingdom">Britain</a> had 3,000 nurses specializing in <a href="/wiki/Breast_cancer" title="Breast cancer">breast cancer</a>, compared to only one for prostate cancer. It also discovered that the waiting time between referral and diagnosis was two weeks for breast cancer but three months for prostate cancer.<sup id="cite_ref-176" class="reference"><a href="#cite_note-176"><span>[</span>176<span>]</span></a></sup> A 2007 report by the U.S.-based <a href="/wiki/ZERO%E2%80%94The_Project_to_End_Prostate_Cancer" title="ZERO—The Project to End Prostate Cancer" class="mw-redirect">National Prostate Cancer Coalition</a> stated that for every prostate cancer drug on the market, there were seven used to treat breast cancer. <i><a href="/wiki/The_Times" title="The Times">The Times</a></i> also noted an "anti-male bias in cancer funding" with a four-to-one discrepancy in the <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a> by both the government and by cancer charities such as <a href="/wiki/Cancer_Research_UK" title="Cancer Research UK">Cancer Research UK</a>.<sup id="cite_ref-Businessweek_2007-06-13_175-1" class="reference"><a href="#cite_note-Businessweek_2007-06-13-175"><span>[</span>175<span>]</span></a></sup><sup id="cite_ref-177" class="reference"><a href="#cite_note-177"><span>[</span>177<span>]</span></a></sup> Equality campaigners such as author <a href="/wiki/Warren_Farrell" title="Warren Farrell">Warren Farrell</a> cite such stark spending inequalities as a clear example of governments unfairly favouring women's health over men's health.<sup id="cite_ref-178" class="reference"><a href="#cite_note-178"><span>[</span>178<span>]</span></a></sup></p>
<p>Disparities also extend into areas such as detection, with governments failing to fund or mandate prostate cancer screening while fully supporting breast cancer programs. For example, a 2007 report found 49 U.S. states mandate insurance coverage for routine breast cancer screening, compared to 28 for prostate cancer.<sup id="cite_ref-Businessweek_2007-06-13_175-2" class="reference"><a href="#cite_note-Businessweek_2007-06-13-175"><span>[</span>175<span>]</span></a></sup><sup id="cite_ref-179" class="reference"><a href="#cite_note-179"><span>[</span>179<span>]</span></a></sup> Prostate cancer also experiences significantly less media coverage than other, equally prevalent cancers, with a study by Prostate Coalition showing 2.6 breast cancer stories for each one covering cancer of the prostate.<sup id="cite_ref-Businessweek_2007-06-13_175-3" class="reference"><a href="#cite_note-Businessweek_2007-06-13-175"><span>[</span>175<span>]</span></a></sup></p>
<p>Prostate Cancer Awareness Month takes place in September in a number of countries. A light blue ribbon is used to promote the cause.<sup id="cite_ref-180" class="reference"><a href="#cite_note-180"><span>[</span>180<span>]</span></a></sup><sup id="cite_ref-181" class="reference"><a href="#cite_note-181"><span>[</span>181<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Research">Research</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=31" title="Edit section: Research">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Treatments">Treatments</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=32" title="Edit section: Treatments">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/MDV3100" title="MDV3100" class="mw-redirect">MDV3100</a> was in phase III trials for HRPC (chemo-naive and post-chemo patient populations)<sup id="cite_ref-CT.gov_182-0" class="reference"><a href="#cite_note-CT.gov-182"><span>[</span>182<span>]</span></a></sup> and gained FDA approval in 2012 as <a href="/wiki/Enzalutamide" title="Enzalutamide">enzalutamide</a> for the treatment of castration-resistant prostate cancer.<sup id="cite_ref-Xtandi-1_123-1" class="reference"><a href="#cite_note-Xtandi-1-123"><span>[</span>123<span>]</span></a></sup><sup id="cite_ref-Xtandi-2_124-1" class="reference"><a href="#cite_note-Xtandi-2-124"><span>[</span>124<span>]</span></a></sup></p>
<p><a href="/wiki/Alpharadin" title="Alpharadin" class="mw-redirect">Alpharadin</a> completed a phase 3 trial for CRPC patients with bone metastasis. A pre-planned interim analysis showed improved survival and quality of life. The study was stopped for ethical reasons to give the placebo group the same treatment. Alpharadin uses bone targeted Radium-223 isotopes to kill cancer cells by alpha radiation.<sup id="cite_ref-urlAlgeta.com_183-0" class="reference"><a href="#cite_note-urlAlgeta.com-183"><span>[</span>183<span>]</span></a></sup> It was approved by the U.S. Food and Drug Administration (FDA) on May, 15th 2013 ahead of schedule under the priority review program.<sup id="cite_ref-184" class="reference"><a href="#cite_note-184"><span>[</span>184<span>]</span></a></sup> Alpharadin still waits for approval by the European Medicines Agency (EMA).</p>
<p><a href="/wiki/Arachidonate_5-lipoxygenase" title="Arachidonate 5-lipoxygenase">Arachidonate 5-lipoxygenase</a> has been identified as playing a significant role in the survival of prostate cancer cells.<sup id="cite_ref-Primary_source_cited_in_1st_review_185-0" class="reference"><a href="#cite_note-Primary_source_cited_in_1st_review-185"><span>[</span>185<span>]</span></a></sup><sup id="cite_ref-MEDRS_review_1_186-0" class="reference"><a href="#cite_note-MEDRS_review_1-186"><span>[</span>186<span>]</span></a></sup><sup id="cite_ref-MEDRS_review_2_187-0" class="reference"><a href="#cite_note-MEDRS_review_2-187"><span>[</span>187<span>]</span></a></sup> Medications which target this enzyme may be an effective therapy for limiting tumor growth and <a href="/wiki/Cancer_metastasis" title="Cancer metastasis" class="mw-redirect">cancer metastasis</a> as well as inducing <a href="/wiki/Apoptosis" title="Apoptosis">programmed cell death</a> in cancer cells.<sup id="cite_ref-Primary_source_cited_in_1st_review_185-1" class="reference"><a href="#cite_note-Primary_source_cited_in_1st_review-185"><span>[</span>185<span>]</span></a></sup><sup id="cite_ref-MEDRS_review_1_186-1" class="reference"><a href="#cite_note-MEDRS_review_1-186"><span>[</span>186<span>]</span></a></sup><sup id="cite_ref-MEDRS_review_2_187-1" class="reference"><a href="#cite_note-MEDRS_review_2-187"><span>[</span>187<span>]</span></a></sup> In particular, <a href="/wiki/Arachidonate_5-lipoxygenase_inhibitors" title="Arachidonate 5-lipoxygenase inhibitors" class="mw-redirect">arachidonate 5-lipoxygenase inhibitors</a> produce massive, rapid programmed cell death in prostate cancer cells.<sup id="cite_ref-Primary_source_cited_in_1st_review_185-2" class="reference"><a href="#cite_note-Primary_source_cited_in_1st_review-185"><span>[</span>185<span>]</span></a></sup><sup id="cite_ref-MEDRS_review_1_186-2" class="reference"><a href="#cite_note-MEDRS_review_1-186"><span>[</span>186<span>]</span></a></sup><sup id="cite_ref-MEDRS_review_2_187-2" class="reference"><a href="#cite_note-MEDRS_review_2-187"><span>[</span>187<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Cancer_models">Cancer models</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=33" title="Edit section: Cancer models">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Scientists have established a few prostate cancer <a href="/wiki/Cell_lines" title="Cell lines" class="mw-redirect">cell lines</a> to investigate the mechanism involved in the progression of prostate cancer. <a href="/wiki/LNCaP" title="LNCaP">LNCaP</a>, PC-3 (<a href="/wiki/PC3" title="PC3">PC3</a>), and DU-145 (<a href="/wiki/DU145" title="DU145">DU145</a>) are commonly used prostate cancer cell lines. The LNCaP cancer cell line was established from a human lymph node metastatic lesion of prostatic adenocarcinoma. PC-3 and DU-145 cells were established from human prostatic adenocarcinoma metastatic to bone and to brain, respectively. LNCaP cells express <a href="/wiki/Androgen_receptor" title="Androgen receptor">androgen receptor</a> (AR); however, PC-3 and DU-145 cells express very little or no AR. AR, an androgen-activated <a href="/wiki/Transcription_factor" title="Transcription factor">transcription factor</a>, belongs to the steroid <a href="/wiki/Nuclear_receptor" title="Nuclear receptor">nuclear receptor</a> family. Development of the prostate is dependent on androgen signaling mediated through AR, and AR is also important during the development of prostate cancer. The proliferation of LNCaP cells is <a href="/wiki/Androgen" title="Androgen">androgen</a>-dependent but the proliferation of PC-3 and DU-145 cells is <a href="/wiki/Androgen" title="Androgen">androgen</a>-insensitive. Elevation of AR expression is often observed in advanced prostate <a href="/wiki/Tumor" title="Tumor" class="mw-redirect">tumors</a> in patients.<sup id="cite_ref-188" class="reference"><a href="#cite_note-188"><span>[</span>188<span>]</span></a></sup><sup id="cite_ref-189" class="reference"><a href="#cite_note-189"><span>[</span>189<span>]</span></a></sup> Some androgen-independent LNCaP sublines have been developed from the ATCC androgen-dependent LNCaP cells after androgen deprivation for study of prostate cancer progression. These <a href="/wiki/Androgen" title="Androgen">androgen</a>-independent LNCaP cells have elevated <a href="/wiki/Androgen_receptor" title="Androgen receptor">AR</a> expression and express <a href="/wiki/Prostate_specific_antigen" title="Prostate specific antigen" class="mw-redirect">prostate specific antigen</a> upon <a href="/wiki/Androgen" title="Androgen">androgen</a> treatment. The paradox is that <a href="/wiki/Androgen" title="Androgen">androgens</a> inhibit the proliferation of these <a href="/wiki/Androgen" title="Androgen">androgen</a>-independent prostate <a href="/wiki/Cancer" title="Cancer">cancer</a> cells.<sup id="cite_ref-190" class="reference"><a href="#cite_note-190"><span>[</span>190<span>]</span></a></sup><sup id="cite_ref-191" class="reference"><a href="#cite_note-191"><span>[</span>191<span>]</span></a></sup><sup id="cite_ref-192" class="reference"><a href="#cite_note-192"><span>[</span>192<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Diagnosis_2">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=34" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>At present, an active area of research and non-clinically applied investigations involve non-invasive methods of prostate tumor detection. Adenoviruses modified to transfect tumor cells with harmless yet distinct genes (such as <a href="/wiki/Luciferase" title="Luciferase">luciferase</a>) have proven capable of early detection. So far, however, this area of research has been tested only in animal and <a href="/wiki/LNCaP" title="LNCaP">LNCaP</a> cell models.<sup id="cite_ref-pmid15865048_193-0" class="reference"><a href="#cite_note-pmid15865048-193"><span>[</span>193<span>]</span></a></sup></p>
<dl>
<dt>EN2</dt>
</dl>
<p>Presence of the <a href="/wiki/EN2_(gene)" title="EN2 (gene)">EN2 (gene)</a> in urine has been correlated to a high probability of prostate cancer.<sup id="cite_ref-pmid21364037_194-0" class="reference"><a href="#cite_note-pmid21364037-194"><span>[</span>194<span>]</span></a></sup></p>
<dl>
<dt>PCA3</dt>
</dl>
<p>Another potential non-invasive method of early prostate tumor detection is through a molecular test that detects the presence of cell-associated <a href="/wiki/PCA3" title="PCA3">PCA3</a> mRNA in fluid massaged from the prostate by the doctor and first-void urinated out within a limited amount of urine into the specimen container. PCA3 mRNA is expressed almost exclusively by prostate cells and has been shown to be highly over-expressed in prostate cancer cells. The test result is currently reported as a specimen ratio of PCA3 mRNA to PSA mRNA. Although not a replacement for serum PSA level, the PCA3 test is an additional tool to help decide whether, in men suspected of having prostate cancer (especially if an initial biopsy fails to explain the elevated serum PSA), a biopsy/rebiopsy is really needed. The higher the expression of PCA3 in the sample, the greater the likelihood of a positive biopsy; i.e., the presence of cancer cells in the prostate.<sup id="cite_ref-pmid21176272_195-0" class="reference"><a href="#cite_note-pmid21176272-195"><span>[</span>195<span>]</span></a></sup></p>
<dl>
<dt>Early prostate cancer antigen-2</dt>
</dl>
<p>A new blood test for <a href="/wiki/Early_prostate_cancer_antigen-2" title="Early prostate cancer antigen-2">early prostate cancer antigen-2</a> (EPCA-2) may alert men if they have prostate cancer and how aggressive it will be.<sup id="cite_ref-pmid17437801_196-0" class="reference"><a href="#cite_note-pmid17437801-196"><span>[</span>196<span>]</span></a></sup></p>
<p><a href="/wiki/Thrombophlebitis" title="Thrombophlebitis">Thrombophlebitis</a> is associated with an increased risk of prostate cancer and may be a good way for physicians to remind themselves to screen patients with thrombophlebitis for prostate cancer as well since these two are closely linked.<sup id="cite_ref-pmid19946524_197-0" class="reference"><a href="#cite_note-pmid19946524-197"><span>[</span>197<span>]</span></a></sup></p>
<dl>
<dt>Prostasomes</dt>
</dl>
<p>Epithelial cells of the prostate secrete <a href="/wiki/Prostasomes" title="Prostasomes">prostasomes</a> as well as <a href="/wiki/Prostate-specific_antigen" title="Prostate-specific antigen">PSA</a>. Prostasomes are membrane–surrounded, prostate-derived organelles that appear extracellularly, and one of their physiological functions is to protect the sperm from attacks by the female immune system. Cancerous prostate cells continue to synthesize and secrete prostasomes, and may be shielded against immunological attacks by these prostasomes. Research of several aspects of prostasomal involvement in prostate cancer has been performed.<sup id="cite_ref-198" class="reference"><a href="#cite_note-198"><span>[</span>198<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=35" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-1">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/types/prostate">"Prostate Cancer"</a>. <i>National Cancer Institute</i><span class="reference-accessdate">. Retrieved <span class="nowrap">12 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Prostate+Cancer&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Ftypes%2Fprostate&amp;rft.jtitle=National+Cancer+Institute&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-WCR2014-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-WCR2014_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WCR2014_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-WCR2014_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-WCR2014_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-WCR2014_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-WCR2014_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-WCR2014_2-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><span class="citation book"><i>World Cancer Report 2014</i>. World Health Organization. 2014. pp.&#160;Chapter 5.11. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9283204298" title="Special:BookSources/9283204298">9283204298</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.btitle=World+Cancer+Report+2014&amp;rft.date=2014&amp;rft.genre=book&amp;rft.isbn=9283204298&amp;rft.pages=Chapter+5.11&amp;rft.pub=World+Health+Organization&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-NCI2014TxPro-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-NCI2014TxPro_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NCI2014TxPro_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NCI2014TxPro_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NCI2014TxPro_3-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-NCI2014TxPro_3-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-NCI2014TxPro_3-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/pdq/treatment/prostate/HealthProfessional/page1/AllPages">"Prostate Cancer Treatment (PDQ®)"</a>. <i>NCI</i>. 2014-04-11<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Prostate+Cancer+Treatment+%28PDQ%C2%AE%29&amp;rft.date=2014-04-11&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Fpdq%2Ftreatment%2Fprostate%2FHealthProfessional%2Fpage1%2FAllPages&amp;rft.jtitle=NCI&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><span class="citation book">Ruddon, Raymond W. (2007). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=PymZ1ORk0TcC&amp;pg=PA223"><i>Cancer biology</i></a> (4th ed. ed.). Oxford: Oxford University Press. p.&#160;223. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780195175431" title="Special:BookSources/9780195175431">9780195175431</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.aufirst=Raymond+W.&amp;rft.aulast=Ruddon&amp;rft.au=Ruddon%2C+Raymond+W.&amp;rft.btitle=Cancer+biology&amp;rft.date=2007&amp;rft.edition=4th+ed.&amp;rft.genre=book&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DPymZ1ORk0TcC%26pg%3DPA223&amp;rft.isbn=9780195175431&amp;rft.pages=223&amp;rft.place=Oxford&amp;rft.pub=Oxford+University+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-NCI2013TxPt-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-NCI2013TxPt_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NCI2013TxPt_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NCI2013TxPt_5-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NCI2013TxPt_5-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/pdq/treatment/prostate/Patient/page1/AllPages">"Prostate Cancer Treatment (PDQ®)"</a>. <i>National Cancer Institute</i>. 2014-04-08<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Prostate+Cancer+Treatment+%28PDQ%C2%AE%29&amp;rft.date=2014-04-08&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Fpdq%2Ftreatment%2Fprostate%2FPatient%2Fpage1%2FAllPages&amp;rft.jtitle=National+Cancer+Institute&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-CainiGandini2014-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-CainiGandini2014_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-CainiGandini2014_6-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Caini, Saverio; Gandini, Sara; Dudas, Maria; Bremer, Viviane; Severi, Ettore; Gherasim, Alin (2014). "Sexually transmitted infections and prostate cancer risk: A systematic review and meta-analysis". <i>Cancer Epidemiology</i> <b>38</b> (4): 329–338. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24986642">24986642</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Sexually+transmitted+infections+and+prostate+cancer+risk%3A+A+systematic+review+and+meta-analysis&amp;rft.au=Bremer%2C+Viviane&amp;rft.au=Caini%2C+Saverio&amp;rft.au=Dudas%2C+Maria&amp;rft.aufirst=Saverio&amp;rft.au=Gandini%2C+Sara&amp;rft.au=Gherasim%2C+Alin&amp;rft.aulast=Caini&amp;rft.au=Severi%2C+Ettore&amp;rft.date=2014&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F24986642&amp;rft.issue=4&amp;rft.jtitle=Cancer+Epidemiology&amp;rft.pages=329-338&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=38" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-BMJ2010-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-BMJ2010_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-BMJ2010_7-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Djulbegovic M, Beyth RJ, Neuberger MM, Stoffs TL, Vieweg J, Djulbegovic B, Dahm P (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2939952">"Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials"</a>. <i>BMJ</i> <b>341</b>: c4543. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fbmj.c4543">10.1136/bmj.c4543</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2939952">2939952</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20843937">20843937</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Screening+for+prostate+cancer%3A+systematic+review+and+meta-analysis+of+randomised+controlled+trials&amp;rft.au=Djulbegovic+M%2C+Beyth+RJ%2C+Neuberger+MM%2C+Stoffs+TL%2C+Vieweg+J%2C+Djulbegovic+B%2C+Dahm+P&amp;rft.aulast=Djulbegovic+M%2C+Beyth+RJ%2C+Neuberger+MM%2C+Stoffs+TL%2C+Vieweg+J%2C+Djulbegovic+B%2C+Dahm+P&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2939952&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.c4543&amp;rft_id=info%3Apmc%2F2939952&amp;rft_id=info%3Apmid%2F20843937&amp;rft.jtitle=BMJ&amp;rft.pages=c4543&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=341" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-USPTF2012-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-USPTF2012_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-USPTF2012_8-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.uspreventiveservicestaskforce.org/prostatecancerscreening/prostatecancerscript.pdf">"Talking With Your Patients About Screening for Prostate Cancer"</a> <span style="font-size:85%;">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">2012-07-02</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.btitle=Talking+With+Your+Patients+About+Screening+for+Prostate+Cancer&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.uspreventiveservicestaskforce.org%2Fprostatecancerscreening%2Fprostatecancerscript.pdf&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Strat2011-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-Strat2011_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Strat2011_9-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Stratton J, Godwin M (2011). "The effect of supplemental vitamins and minerals on the development of prostate cancer: A systematic review and meta-analysis". <i>Family practice</i> <b>28</b> (3): 243–52. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Ffampra%2Fcmq115">10.1093/fampra/cmq115</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21273283">21273283</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=The+effect+of+supplemental+vitamins+and+minerals+on+the+development+of+prostate+cancer%3A+A+systematic+review+and+meta-analysis&amp;rft.aulast=Stratton+J%2C+Godwin+M&amp;rft.au=Stratton+J%2C+Godwin+M&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Ffampra%2Fcmq115&amp;rft_id=info%3Apmid%2F21273283&amp;rft.issue=3&amp;rft.jtitle=Family+practice&amp;rft.pages=243-52&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=28" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://seer.cancer.gov/statfacts/html/prost.html">"SEER Stat Fact Sheets: Prostate Cancer"</a>. <i>NCI</i><span class="reference-accessdate">. Retrieved <span class="nowrap">18 June</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=SEER+Stat+Fact+Sheets%3A+Prostate+Cancer&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fseer.cancer.gov%2Fstatfacts%2Fhtml%2Fprost.html&amp;rft.jtitle=NCI&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-WCR2014Epi-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-WCR2014Epi_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WCR2014Epi_11-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book"><i>World Cancer Report 2014</i>. World Health Organization. 2014. pp.&#160;Chapter 1.1. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9283204298" title="Special:BookSources/9283204298">9283204298</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.btitle=World+Cancer+Report+2014&amp;rft.date=2014&amp;rft.genre=book&amp;rft.isbn=9283204298&amp;rft.pages=Chapter+1.1&amp;rft.pub=World+Health+Organization&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Baade2009-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-Baade2009_12-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Baade PD, Youlden DR, Krnjacki LJ (February 2009). "International epidemiology of prostate cancer: geographical distribution and secular trends". <i>Molecular nutrition &amp; food research</i> <b>53</b> (2): 171–84. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fmnfr.200700511">10.1002/mnfr.200700511</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19101947">19101947</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=International+epidemiology+of+prostate+cancer%3A+geographical+distribution+and+secular+trends&amp;rft.au=Baade+PD%2C+Youlden+DR%2C+Krnjacki+LJ&amp;rft.aulast=Baade+PD%2C+Youlden+DR%2C+Krnjacki+LJ&amp;rft.date=February+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fmnfr.200700511&amp;rft_id=info%3Apmid%2F19101947&amp;rft.issue=2&amp;rft.jtitle=Molecular+nutrition+%26+food+research&amp;rft.pages=171-84&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=53" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-prostateCApresentation-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-prostateCApresentation_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-prostateCApresentation_13-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Miller DC, Hafez KS, Stewart A, Montie JE, Wei JT (September 2003). "Prostate carcinoma presentation, diagnosis, and staging: an update form the National Cancer Data Base". <i>Cancer</i> <b>98</b> (6): 1169–78. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fcncr.11635">10.1002/cncr.11635</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12973840">12973840</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Prostate+carcinoma+presentation%2C+diagnosis%2C+and+staging%3A+an+update+form+the+National+Cancer+Data+Base&amp;rft.aulast=Miller+DC%2C+Hafez+KS%2C+Stewart+A%2C+Montie+JE%2C+Wei+JT&amp;rft.au=Miller+DC%2C+Hafez+KS%2C+Stewart+A%2C+Montie+JE%2C+Wei+JT&amp;rft.date=September+2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fcncr.11635&amp;rft_id=info%3Apmid%2F12973840&amp;rft.issue=6&amp;rft.jtitle=Cancer&amp;rft.pages=1169-78&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=98" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><span class="citation journal">van der Cruijsen-Koeter IW, Vis AN, Roobol MJ, Wildhagen MF, de Koning HJ, van der Kwast TH, Schröder FH (July 2005). "Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam". <i>Urol</i> <b>174</b> (1): 121–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F01.ju.0000162061.40533.0f">10.1097/01.ju.0000162061.40533.0f</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15947595">15947595</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Comparison+of+screen+detected+and+clinically+diagnosed+prostate+cancer+in+the+European+randomized+study+of+screening+for+prostate+cancer%2C+section+rotterdam&amp;rft.aulast=van+der+Cruijsen-Koeter+IW%2C+Vis+AN%2C+Roobol+MJ%2C+Wildhagen+MF%2C+de+Koning+HJ%2C+van+der+Kwast+TH%2C+Schr%C3%B6der+FH&amp;rft.au=van+der+Cruijsen-Koeter+IW%2C+Vis+AN%2C+Roobol+MJ%2C+Wildhagen+MF%2C+de+Koning+HJ%2C+van+der+Kwast+TH%2C+Schr%C3%B6der+FH&amp;rft.date=July+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F01.ju.0000162061.40533.0f&amp;rft_id=info%3Apmid%2F15947595&amp;rft.issue=1&amp;rft.jtitle=Urol&amp;rft.pages=121-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=174" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation journal">Hsing AW, Chokkalingam AP (2006). "Prostate cancer epidemiology". <i>Frontiers in Bioscience</i> <b>11</b>: 1388–413. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2741%2F1891">10.2741/1891</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16368524">16368524</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Prostate+cancer+epidemiology&amp;rft.au=Hsing+AW%2C+Chokkalingam+AP&amp;rft.aulast=Hsing+AW%2C+Chokkalingam+AP&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2741%2F1891&amp;rft_id=info%3Apmid%2F16368524&amp;rft.jtitle=Frontiers+in+Bioscience&amp;rft.pages=1388-413&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><span class="citation journal">Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, Ries LA, Merrill RM, Kaplan RS (June 16, 1999). "Cancer surveillance series: interpreting trends in prostate cancer—part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates". <i>J Natl Cancer Inst</i> <b>91</b> (12): 1017–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fjnci%2F91.12.1017">10.1093/jnci/91.12.1017</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10379964">10379964</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Cancer+surveillance+series%3A+interpreting+trends+in+prostate+cancer%E2%80%94part+I%3A+Evidence+of+the+effects+of+screening+in+recent+prostate+cancer+incidence%2C+mortality%2C+and+survival+rates&amp;rft.au=Hankey+BF%2C+Feuer+EJ%2C+Clegg+LX%2C+Hayes+RB%2C+Legler+JM%2C+Prorok+PC%2C+Ries+LA%2C+Merrill+RM%2C+Kaplan+RS&amp;rft.aulast=Hankey+BF%2C+Feuer+EJ%2C+Clegg+LX%2C+Hayes+RB%2C+Legler+JM%2C+Prorok+PC%2C+Ries+LA%2C+Merrill+RM%2C+Kaplan+RS&amp;rft.date=June+16%2C+1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2F91.12.1017&amp;rft_id=info%3Apmid%2F10379964&amp;rft.issue=12&amp;rft.jtitle=J+Natl+Cancer+Inst&amp;rft.pages=1017-24&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=91" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><span class="citation journal">Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH, Tulinius H (November 15, 1977). "Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France". <i>Int J Cancer</i> <b>20</b> (5): 680–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fijc.2910200506">10.1002/ijc.2910200506</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/924691">924691</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Latent+carcinoma+of+prostate+at+autopsy+in+seven+areas.+The+International+Agency+for+Research+on+Cancer%2C+Lyons%2C+France&amp;rft.au=Breslow+N%2C+Chan+CW%2C+Dhom+G%2C+Drury+RA%2C+Franks+LM%2C+Gellei+B%2C+Lee+YS%2C+Lundberg+S%2C+Sparke+B%2C+Sternby+NH%2C+Tulinius+H&amp;rft.aulast=Breslow+N%2C+Chan+CW%2C+Dhom+G%2C+Drury+RA%2C+Franks+LM%2C+Gellei+B%2C+Lee+YS%2C+Lundberg+S%2C+Sparke+B%2C+Sternby+NH%2C+Tulinius+H&amp;rft.date=November+15%2C+1977&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fijc.2910200506&amp;rft_id=info%3Apmid%2F924691&amp;rft.issue=5&amp;rft.jtitle=Int+J+Cancer&amp;rft.pages=680-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation journal">Zeegers MP, Jellema A, Ostrer H (2003). "Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis". <i>Cancer</i> <b>97</b> (8): 1894–903. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fcncr.11262">10.1002/cncr.11262</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12673715">12673715</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Empiric+risk+of+prostate+carcinoma+for+relatives+of+patients+with+prostate+carcinoma%3A+a+meta-analysis&amp;rft.aulast=Zeegers+MP%2C+Jellema+A%2C+Ostrer+H&amp;rft.au=Zeegers+MP%2C+Jellema+A%2C+Ostrer+H&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fcncr.11262&amp;rft_id=info%3Apmid%2F12673715&amp;rft.issue=8&amp;rft.jtitle=Cancer&amp;rft.pages=1894-903&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=97" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15661684-19"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid15661684_19-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15661684_19-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ (2005). "Cancer statistics, 2005". <i>CA Cancer J Clin</i> <b>55</b> (1): 10–30. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3322%2Fcanjclin.55.1.10">10.3322/canjclin.55.1.10</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15661684">15661684</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Cancer+statistics%2C+2005&amp;rft.au=Jemal+A%2C+Murray+T%2C+Ward+E%2C+Samuels+A%2C+Tiwari+RC%2C+Ghafoor+A%2C+Feuer+EJ%2C+Thun+MJ&amp;rft.aulast=Jemal+A%2C+Murray+T%2C+Ward+E%2C+Samuels+A%2C+Tiwari+RC%2C+Ghafoor+A%2C+Feuer+EJ%2C+Thun+MJ&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3322%2Fcanjclin.55.1.10&amp;rft_id=info%3Apmid%2F15661684&amp;rft.issue=1&amp;rft.jtitle=CA+Cancer+J+Clin&amp;rft.pages=10-30&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=55" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19949849-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19949849_20-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Martin RM, Vatten L, Gunnell D, Romundstad P (March 2010). "Blood pressure and risk of prostate cancer: cohort Norway (CONOR)". <i>Cancer Causes Control</i> <b>21</b> (3): 463–72. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs10552-009-9477-x">10.1007/s10552-009-9477-x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19949849">19949849</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Blood+pressure+and+risk+of+prostate+cancer%3A+cohort+Norway+%28CONOR%29&amp;rft.aulast=Martin+RM%2C+Vatten+L%2C+Gunnell+D%2C+Romundstad+P&amp;rft.au=Martin+RM%2C+Vatten+L%2C+Gunnell+D%2C+Romundstad+P&amp;rft.date=March+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs10552-009-9477-x&amp;rft_id=info%3Apmid%2F19949849&amp;rft.issue=3&amp;rft.jtitle=Cancer+Causes+Control&amp;rft.pages=463-72&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><span class="citation journal">Friedenreich CM, Neilson HK, Lynch BM (Sep 2010). "State of the epidemiological evidence on physical activity and cancer prevention". <i>European journal of cancer (Oxford, England&#160;: 1990)</i> <b>46</b> (14): 2593–604. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.ejca.2010.07.028">10.1016/j.ejca.2010.07.028</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20843488">20843488</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=State+of+the+epidemiological+evidence+on+physical+activity+and+cancer+prevention&amp;rft.au=Friedenreich+CM%2C+Neilson+HK%2C+Lynch+BM&amp;rft.aulast=Friedenreich+CM%2C+Neilson+HK%2C+Lynch+BM&amp;rft.date=Sep+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ejca.2010.07.028&amp;rft_id=info%3Apmid%2F20843488&amp;rft.issue=14&amp;rft.jtitle=European+journal+of+cancer+%28Oxford%2C+England+%3A+1990%29&amp;rft.pages=2593-604&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=46" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20671189-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20671189_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20671189_22-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON (July 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2917982">"Identification of a cell of origin for human prostate cancer"</a>. <i>Science</i> <b>329</b> (5991): 568–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1126%2Fscience.1189992">10.1126/science.1189992</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2917982">2917982</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20671189">20671189</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Identification+of+a+cell+of+origin+for+human+prostate+cancer&amp;rft.au=Goldstein+AS%2C+Huang+J%2C+Guo+C%2C+Garraway+IP%2C+Witte+ON&amp;rft.aulast=Goldstein+AS%2C+Huang+J%2C+Guo+C%2C+Garraway+IP%2C+Witte+ON&amp;rft.date=July+2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2917982&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1189992&amp;rft_id=info%3Apmc%2F2917982&amp;rft_id=info%3Apmid%2F20671189&amp;rft.issue=5991&amp;rft.jtitle=Science&amp;rft.pages=568-71&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=329" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid2251225-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid2251225_23-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC (1990). "Family history and the risk of prostate cancer". <i>Prostate</i> <b>17</b> (4): 337–47. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fpros.2990170409">10.1002/pros.2990170409</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2251225">2251225</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Family+history+and+the+risk+of+prostate+cancer&amp;rft.aulast=Steinberg+GD%2C+Carter+BS%2C+Beaty+TH%2C+Childs+B%2C+Walsh+PC&amp;rft.au=Steinberg+GD%2C+Carter+BS%2C+Beaty+TH%2C+Childs+B%2C+Walsh+PC&amp;rft.date=1990&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fpros.2990170409&amp;rft_id=info%3Apmid%2F2251225&amp;rft.issue=4&amp;rft.jtitle=Prostate&amp;rft.pages=337-47&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9805030-24"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid9805030_24-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid9805030_24-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Gallagher RP, Fleshner N (October 1998). <a rel="nofollow" class="external text" href="http://www.cmaj.ca/cgi/reprint/159/7/807.pdf">"Prostate cancer: 3. Individual risk factors"</a> <span style="font-size:85%;">(PDF)</span>. <i>CMAJ</i> <b>159</b> (7): 807–13. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1232741">1232741</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9805030">9805030</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Prostate+cancer%3A+3.+Individual+risk+factors&amp;rft.au=Gallagher+RP%2C+Fleshner+N&amp;rft.aulast=Gallagher+RP%2C+Fleshner+N&amp;rft.date=October+1998&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cmaj.ca%2Fcgi%2Freprint%2F159%2F7%2F807.pdf&amp;rft_id=info%3Apmc%2F1232741&amp;rft_id=info%3Apmid%2F9805030&amp;rft.issue=7&amp;rft.jtitle=CMAJ&amp;rft.pages=807-13&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=159" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11238701-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11238701_25-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hoffman RM, Gilliland FD, Eley JW, Harlan LC, Stephenson RA, Stanford JL, Albertson PC, Hamilton AS, Hunt WC, Potosky AL (March 2001). "Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study". <i>J. Natl. Cancer Inst.</i> <b>93</b> (5): 388–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fjnci%2F93.5.388">10.1093/jnci/93.5.388</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11238701">11238701</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Racial+and+ethnic+differences+in+advanced-stage+prostate+cancer%3A+the+Prostate+Cancer+Outcomes+Study&amp;rft.au=Hoffman+RM%2C+Gilliland+FD%2C+Eley+JW%2C+Harlan+LC%2C+Stephenson+RA%2C+Stanford+JL%2C+Albertson+PC%2C+Hamilton+AS%2C+Hunt+WC%2C+Potosky+AL&amp;rft.aulast=Hoffman+RM%2C+Gilliland+FD%2C+Eley+JW%2C+Harlan+LC%2C+Stephenson+RA%2C+Stanford+JL%2C+Albertson+PC%2C+Hamilton+AS%2C+Hunt+WC%2C+Potosky+AL&amp;rft.date=March+2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2F93.5.388&amp;rft_id=info%3Apmid%2F11238701&amp;rft.issue=5&amp;rft.jtitle=J.+Natl.+Cancer+Inst.&amp;rft.pages=388-95&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=93" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid10891514-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10891514_26-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (July 2000). "Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland". <i>N. Engl. J. Med.</i> <b>343</b> (2): 78–85. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM200007133430201">10.1056/NEJM200007133430201</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10891514">10891514</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Environmental+and+heritable+factors+in+the+causation+of+cancer--analyses+of+cohorts+of+twins+from+Sweden%2C+Denmark%2C+and+Finland&amp;rft.aulast=Lichtenstein+P%2C+Holm+NV%2C+Verkasalo+PK%2C+Iliadou+A%2C+Kaprio+J%2C+Koskenvuo+M%2C+Pukkala+E%2C+Skytthe+A%2C+Hemminki+K&amp;rft.au=Lichtenstein+P%2C+Holm+NV%2C+Verkasalo+PK%2C+Iliadou+A%2C+Kaprio+J%2C+Koskenvuo+M%2C+Pukkala+E%2C+Skytthe+A%2C+Hemminki+K&amp;rft.date=July+2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM200007133430201&amp;rft_id=info%3Apmid%2F10891514&amp;rft.issue=2&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=78-85&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=343" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9145676-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9145676_27-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA (May 1997). "The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews". <i>N. Engl. J. Med.</i> <b>336</b> (20): 1401–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM199705153362001">10.1056/NEJM199705153362001</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9145676">9145676</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=The+risk+of+cancer+associated+with+specific+mutations+of+BRCA1+and+BRCA2+among+Ashkenazi+Jews&amp;rft.aulast=Struewing+JP%2C+Hartge+P%2C+Wacholder+S%2C+Baker+SM%2C+Berlin+M%2C+McAdams+M%2C+Timmerman+MM%2C+Brody+LC%2C+Tucker+MA&amp;rft.au=Struewing+JP%2C+Hartge+P%2C+Wacholder+S%2C+Baker+SM%2C+Berlin+M%2C+McAdams+M%2C+Timmerman+MM%2C+Brody+LC%2C+Tucker+MA&amp;rft.date=May+1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199705153362001&amp;rft_id=info%3Apmid%2F9145676&amp;rft.issue=20&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1401-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=336" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19945666-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19945666_28-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Beuzeboc P, Soulié M, Richaud P, Salomon L, Staerman F, Peyromaure M, Mongiat-Artus P, Cornud F, Paparel P, Davin JL, Molinié V (December 2009). "[Fusion genes and prostate cancer. From discovery to prognosis and therapeutic perspectives]". <i>Prog. Urol.</i> (in French) <b>19</b> (11): 819–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.purol.2009.06.002">10.1016/j.purol.2009.06.002</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19945666">19945666</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=%5BFusion+genes+and+prostate+cancer.+From+discovery+to+prognosis+and+therapeutic+perspectives%5D&amp;rft.au=Beuzeboc+P%2C+Souli%C3%A9+M%2C+Richaud+P%2C+Salomon+L%2C+Staerman+F%2C+Peyromaure+M%2C+Mongiat-Artus+P%2C+Cornud+F%2C+Paparel+P%2C+Davin+JL%2C+Molini%C3%A9+V&amp;rft.aulast=Beuzeboc+P%2C+Souli%C3%A9+M%2C+Richaud+P%2C+Salomon+L%2C+Staerman+F%2C+Peyromaure+M%2C+Mongiat-Artus+P%2C+Cornud+F%2C+Paparel+P%2C+Davin+JL%2C+Molini%C3%A9+V&amp;rft.date=December+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.purol.2009.06.002&amp;rft_id=info%3Apmid%2F19945666&amp;rft.issue=11&amp;rft.jtitle=Prog.+Urol.&amp;rft.pages=819-24&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><span class="citation journal">Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J, Field HI, Southey MC, Severi G, Donovan JL, Hamdy FC, Dearnaley DP, Muir KR, Smith C, Bagnato M, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Cox A, Lewis S, Brown PM, Jhavar SG, Tymrakiewicz M, Lophatananon A, Bryant SL, Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Fisher C, Jamieson C, Cooper CS, English DR, Hopper JL, Neal DE, Easton DF (March 2008). "Multiple newly identified loci associated with prostate cancer susceptibility". <i>Nature Genetics</i> <b>40</b> (3): 316–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fng.90">10.1038/ng.90</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18264097">18264097</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Multiple+newly+identified+loci+associated+with+prostate+cancer+susceptibility&amp;rft.au=Eeles+RA%2C+Kote-Jarai+Z%2C+Giles+GG%2C+Olama+AA%2C+Guy+M%2C+Jugurnauth+SK%2C+Mulholland+S%2C+Leongamornlert+DA%2C+Edwards+SM%2C+Morrison+J%2C+Field+HI%2C+Southey+MC%2C+Severi+G%2C+Donovan+JL%2C+Hamdy+FC%2C+Dearnaley+DP%2C+Muir+KR%2C+Smith+C%2C+Bagnato+M%2C+Ardern-Jones+AT%2C+Hall+AL%2C+O%27Brien+LT%2C+Gehr-Swain+BN%2C+Wilkinson+RA%2C+Cox+A%2C+Lewis+S%2C+Brown+PM%2C+Jhavar+SG%2C+Tymrakiewicz+M%2C+Lophatananon+A%2C+Bryant+SL%2C+Horwich+A%2C+Huddart+RA%2C+Khoo+VS%2C+Parker+CC%2C+Woodhouse+CJ%2C+Thompson+A%2C+Christmas+T%2C+Ogden+C%2C+Fisher+C%2C+Jamieson+C%2C+Cooper+CS%2C+English+DR%2C+Hopper+JL%2C+Neal+DE%2C+Easton+DF&amp;rft.aulast=Eeles+RA%2C+Kote-Jarai+Z%2C+Giles+GG%2C+Olama+AA%2C+Guy+M%2C+Jugurnauth+SK%2C+Mulholland+S%2C+Leongamornlert+DA%2C+Edwards+SM%2C+Morrison+J%2C+Field+HI%2C+Southey+MC%2C+Severi+G%2C+Donovan+JL%2C+Hamdy+FC%2C+Dearnaley+DP%2C+Muir+KR%2C+Smith+C%2C+Bagnato+M%2C+Ardern-Jones+AT%2C+Hall+AL%2C+O%27Brien+LT%2C+Gehr-Swain+BN%2C+Wilkinson+RA%2C+Cox+A%2C+Lewis+S%2C+Brown+PM%2C+Jhavar+SG%2C+Tymrakiewicz+M%2C+Lophatananon+A%2C+Bryant+SL%2C+Horwich+A%2C+Huddart+RA%2C+Khoo+VS%2C+Parker+CC%2C+Woodhouse+CJ%2C+Thompson+A%2C+Christmas+T%2C+Ogden+C%2C+Fisher+C%2C+Jamieson+C%2C+Cooper+CS%2C+English+DR%2C+Hopper+JL%2C+Neal+DE%2C+Easton+DF&amp;rft.date=March+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fng.90&amp;rft_id=info%3Apmid%2F18264097&amp;rft.issue=3&amp;rft.jtitle=Nature+Genetics&amp;rft.pages=316-21&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=40" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><span class="citation journal">Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, Crenshaw A, Cancel-Tassin G, Staats BJ, Wang Z, Gonzalez-Bosquet J, Fang J, Deng X, Berndt SI, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cussenot O, Valeri A, Andriole GL, Crawford ED, Tucker M, Gerhard DS, Fraumeni JF, Hoover R, Hayes RB, Hunter DJ, Chanock SJ (March 2008). "Multiple loci identified in a genome-wide association study of prostate cancer". <i>Nature Genetics</i> <b>40</b> (3): 310–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fng.91">10.1038/ng.91</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18264096">18264096</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Multiple+loci+identified+in+a+genome-wide+association+study+of+prostate+cancer&amp;rft.aulast=Thomas+G%2C+Jacobs+KB%2C+Yeager+M%2C+Kraft+P%2C+Wacholder+S%2C+Orr+N%2C+Yu+K%2C+Chatterjee+N%2C+Welch+R%2C+Hutchinson+A%2C+Crenshaw+A%2C+Cancel-Tassin+G%2C+Staats+BJ%2C+Wang+Z%2C+Gonzalez-Bosquet+J%2C+Fang+J%2C+Deng+X%2C+Berndt+SI%2C+Calle+EE%2C+Feigelson+HS%2C+Thun+MJ%2C+Rodriguez+C%2C+Albanes+D%2C+Virtamo+J%2C+Weinstein+S%2C+Schumacher+FR%2C+Giovannucci+E%2C+Willett+WC%2C+Cussenot+O%2C+Valeri+A%2C+Andriole+GL%2C+Crawford+ED%2C+Tucker+M%2C+Gerhard+DS%2C+Fraumeni+JF%2C+Hoover+R%2C+Hayes+RB%2C+Hunter+DJ%2C+Chanock+SJ&amp;rft.au=Thomas+G%2C+Jacobs+KB%2C+Yeager+M%2C+Kraft+P%2C+Wacholder+S%2C+Orr+N%2C+Yu+K%2C+Chatterjee+N%2C+Welch+R%2C+Hutchinson+A%2C+Crenshaw+A%2C+Cancel-Tassin+G%2C+Staats+BJ%2C+Wang+Z%2C+Gonzalez-Bosquet+J%2C+Fang+J%2C+Deng+X%2C+Berndt+SI%2C+Calle+EE%2C+Feigelson+HS%2C+Thun+MJ%2C+Rodriguez+C%2C+Albanes+D%2C+Virtamo+J%2C+Weinstein+S%2C+Schumacher+FR%2C+Giovannucci+E%2C+Willett+WC%2C+Cussenot+O%2C+Valeri+A%2C+Andriole+GL%2C+Crawford+ED%2C+Tucker+M%2C+Gerhard+DS%2C+Fraumeni+JF%2C+Hoover+R%2C+Hayes+RB%2C+Hunter+DJ%2C+Chanock+SJ&amp;rft.date=March+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fng.91&amp;rft_id=info%3Apmid%2F18264096&amp;rft.issue=3&amp;rft.jtitle=Nature+Genetics&amp;rft.pages=310-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=40" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><span class="citation journal">Whitaker HC, Kote-Jarai Z, Ross-Adams H, Warren AY, Burge J, George A, Bancroft E, Jhavar S, Leongamornlert D, Tymrakiewicz M, Saunders E, Page E, Mitra A, Mitchell G, Lindeman GJ, Evans DG, Blanco I, Mercer C, Rubinstein WS, Clowes V, Douglas F, Hodgson S, Walker L, Donaldson A, Izatt L, Dorkins H, Male A, Tucker K, Stapleton A, Lam J, Kirk J, Lilja H, Easton D, Cooper C, Eeles R, Neal DE (Oct 13, 2010). Vickers, Andrew, ed. <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2954177">"The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine"</a>. <i>PLoS ONE</i> <b>5</b> (10): e13363. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1371%2Fjournal.pone.0013363">10.1371/journal.pone.0013363</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2954177">2954177</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20967219">20967219</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=The+rs10993994+risk+allele+for+prostate+cancer+results+in+clinically+relevant+changes+in+microseminoprotein-beta+expression+in+tissue+and+urine&amp;rft.aulast=Whitaker+HC%2C+Kote-Jarai+Z%2C+Ross-Adams+H%2C+Warren+AY%2C+Burge+J%2C+George+A%2C+Bancroft+E%2C+Jhavar+S%2C+Leongamornlert+D%2C+Tymrakiewicz+M%2C+Saunders+E%2C+Page+E%2C+Mitra+A%2C+Mitchell+G%2C+Lindeman+GJ%2C+Evans+DG%2C+Blanco+I%2C+Mercer+C%2C+Rubinstein+WS%2C+Clowes+V%2C+Douglas+F%2C+Hodgson+S%2C+Walker+L%2C+Donaldson+A%2C+Izatt+L%2C+Dorkins+H%2C+Male+A%2C+Tucker+K%2C+Stapleton+A%2C+Lam+J%2C+Kirk+J%2C+Lilja+H%2C+Easton+D%2C+Cooper+C%2C+Eeles+R%2C+Neal+DE&amp;rft.au=Whitaker+HC%2C+Kote-Jarai+Z%2C+Ross-Adams+H%2C+Warren+AY%2C+Burge+J%2C+George+A%2C+Bancroft+E%2C+Jhavar+S%2C+Leongamornlert+D%2C+Tymrakiewicz+M%2C+Saunders+E%2C+Page+E%2C+Mitra+A%2C+Mitchell+G%2C+Lindeman+GJ%2C+Evans+DG%2C+Blanco+I%2C+Mercer+C%2C+Rubinstein+WS%2C+Clowes+V%2C+Douglas+F%2C+Hodgson+S%2C+Walker+L%2C+Donaldson+A%2C+Izatt+L%2C+Dorkins+H%2C+Male+A%2C+Tucker+K%2C+Stapleton+A%2C+Lam+J%2C+Kirk+J%2C+Lilja+H%2C+Easton+D%2C+Cooper+C%2C+Eeles+R%2C+Neal+DE&amp;rft.date=Oct+13%2C+2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2954177&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0013363&amp;rft_id=info%3Apmc%2F2954177&amp;rft_id=info%3Apmid%2F20967219&amp;rft.issue=10&amp;rft.jtitle=PLoS+ONE&amp;rft.pages=e13363&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span> <a href="/wiki/Open_access" title="open access publication - free to read"><img alt="open access publication - free to read" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/8px-Open_Access_logo_PLoS_transparent.svg.png" width="8" height="13" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/12px-Open_Access_logo_PLoS_transparent.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/16px-Open_Access_logo_PLoS_transparent.svg.png 2x" data-file-width="640" data-file-height="1000" /></a></span></li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><span class="citation journal">Venkateswaran V, Klotz LH (Aug 2010). "Diet and prostate cancer: mechanisms of action and implications for chemoprevention". <i>Nature Reviews Urology</i> <b>7</b> (8): 442–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fnrurol.2010.102">10.1038/nrurol.2010.102</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20647991">20647991</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Diet+and+prostate+cancer%3A+mechanisms+of+action+and+implications+for+chemoprevention&amp;rft.aulast=Venkateswaran+V%2C+Klotz+LH&amp;rft.au=Venkateswaran+V%2C+Klotz+LH&amp;rft.date=Aug+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fnrurol.2010.102&amp;rft_id=info%3Apmid%2F20647991&amp;rft.issue=8&amp;rft.jtitle=Nature+Reviews+Urology&amp;rft.pages=442-53&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><span class="citation journal">Key TJ (2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3039795">"Fruit and vegetables and cancer risk"</a>. <i>British journal of cancer</i> <b>104</b> (1): 6–11. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fsj.bjc.6606032">10.1038/sj.bjc.6606032</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3039795">3039795</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21119663">21119663</a>. <q>For other common cancers, including colorectal, breast and prostate cancer, epidemiological studies suggest little or no association between total fruit and vegetable consumption and risk.</q></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Fruit+and+vegetables+and+cancer+risk&amp;rft.au=Key+TJ&amp;rft.aulast=Key+TJ&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3039795&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.bjc.6606032&amp;rft_id=info%3Apmc%2F3039795&amp;rft_id=info%3Apmid%2F21119663&amp;rft.issue=1&amp;rft.jtitle=British+journal+of+cancer&amp;rft.pages=6-11&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=104" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><span class="citation journal">Alexander DD, Mink PJ, Cushing CA, Sceurman B (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2987772">"A review and meta-analysis of prospective studies of red and processed meat intake and prostate cancer"</a>. <i>Nutrition journal</i> <b>9</b>: 50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1186%2F1475-2891-9-50">10.1186/1475-2891-9-50</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2987772">2987772</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21044319">21044319</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=A+review+and+meta-analysis+of+prospective+studies+of+red+and+processed+meat+intake+and+prostate+cancer&amp;rft.au=Alexander+DD%2C+Mink+PJ%2C+Cushing+CA%2C+Sceurman+B&amp;rft.aulast=Alexander+DD%2C+Mink+PJ%2C+Cushing+CA%2C+Sceurman+B&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2987772&amp;rft_id=info%3Adoi%2F10.1186%2F1475-2891-9-50&amp;rft_id=info%3Apmc%2F2987772&amp;rft_id=info%3Apmid%2F21044319&amp;rft.jtitle=Nutrition+journal&amp;rft.pages=50&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/factsheet/Risk/cooked-meats">"Chemicals in Meat Cooked at High Temperatures and Cancer Risk"</a>. <i>National Cancer Institute</i>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Chemicals+in+Meat+Cooked+at+High+Temperatures+and+Cancer+Risk&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Ffactsheet%2FRisk%2Fcooked-meats&amp;rft.jtitle=National+Cancer+Institute&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><span class="citation journal">Wigle DT, Turner MC, Gomes J, Parent ME (March 2008). "Role of hormonal and other factors in human prostate cancer". <i>Journal of Toxicology and Environmental Health. Part B, Critical Reviews</i> <b>11</b> (3–4): 242–59. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1080%2F10937400701873548">10.1080/10937400701873548</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18368555">18368555</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Role+of+hormonal+and+other+factors+in+human+prostate+cancer&amp;rft.aulast=Wigle+DT%2C+Turner+MC%2C+Gomes+J%2C+Parent+ME&amp;rft.au=Wigle+DT%2C+Turner+MC%2C+Gomes+J%2C+Parent+ME&amp;rft.date=March+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1080%2F10937400701873548&amp;rft_id=info%3Apmid%2F18368555&amp;rft.issue=3%E2%80%934&amp;rft.jtitle=Journal+of+Toxicology+and+Environmental+Health.+Part+B%2C+Critical+Reviews&amp;rft.pages=242-59&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><span class="citation journal">Qin X, Cui Y, Shen L, Sun N, Zhang Y, Li J, Xu X, Wang B, Xu X, Huo Y, Wang X (Jan 22, 2013). "Folic acid supplementation and cancer risk: A meta-analysis of randomized controlled trials". <i>International Journal of Cancer. Journal International Du Cancer</i> <b>133</b> (5): 1033–41. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fijc.28038">10.1002/ijc.28038</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23338728">23338728</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Folic+acid+supplementation+and+cancer+risk%3A+A+meta-analysis+of+randomized+controlled+trials&amp;rft.aulast=Qin+X%2C+Cui+Y%2C+Shen+L%2C+Sun+N%2C+Zhang+Y%2C+Li+J%2C+Xu+X%2C+Wang+B%2C+Xu+X%2C+Huo+Y%2C+Wang+X&amp;rft.au=Qin+X%2C+Cui+Y%2C+Shen+L%2C+Sun+N%2C+Zhang+Y%2C+Li+J%2C+Xu+X%2C+Wang+B%2C+Xu+X%2C+Huo+Y%2C+Wang+X&amp;rft.date=Jan+22%2C+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fijc.28038&amp;rft_id=info%3Apmid%2F23338728&amp;rft.issue=5&amp;rft.jtitle=International+Journal+of+Cancer.+Journal+International+Du+Cancer&amp;rft.pages=1033-41&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=133" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15998950-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15998950_38-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Jacobs EJ, Rodriguez C, Mondul AM, Connell CJ, Henley SJ, Calle EE, Thun MJ (July 2005). "A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence". <i>J. Natl. Cancer Inst.</i> <b>97</b> (13): 975–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fjnci%2Fdji173">10.1093/jnci/dji173</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15998950">15998950</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=A+large+cohort+study+of+aspirin+and+other+nonsteroidal+anti-inflammatory+drugs+and+prostate+cancer+incidence&amp;rft.au=Jacobs+EJ%2C+Rodriguez+C%2C+Mondul+AM%2C+Connell+CJ%2C+Henley+SJ%2C+Calle+EE%2C+Thun+MJ&amp;rft.aulast=Jacobs+EJ%2C+Rodriguez+C%2C+Mondul+AM%2C+Connell+CJ%2C+Henley+SJ%2C+Calle+EE%2C+Thun+MJ&amp;rft.date=July+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2Fdji173&amp;rft_id=info%3Apmid%2F15998950&amp;rft.issue=13&amp;rft.jtitle=J.+Natl.+Cancer+Inst.&amp;rft.pages=975-80&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=97" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16014776-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16014776_39-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Shannon J, Tewoderos S, Garzotto M, Beer TM, Derenick R, Palma A, Farris PE (August 2005). "Statins and prostate cancer risk: a case-control study". <i>Am. J. Epidemiol.</i> <b>162</b> (4): 318–25. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Faje%2Fkwi203">10.1093/aje/kwi203</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16014776">16014776</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Statins+and+prostate+cancer+risk%3A+a+case-control+study&amp;rft.aulast=Shannon+J%2C+Tewoderos+S%2C+Garzotto+M%2C+Beer+TM%2C+Derenick+R%2C+Palma+A%2C+Farris+PE&amp;rft.au=Shannon+J%2C+Tewoderos+S%2C+Garzotto+M%2C+Beer+TM%2C+Derenick+R%2C+Palma+A%2C+Farris+PE&amp;rft.date=August+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Faje%2Fkwi203&amp;rft_id=info%3Apmid%2F16014776&amp;rft.issue=4&amp;rft.jtitle=Am.+J.+Epidemiol.&amp;rft.pages=318-25&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=162" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12100928-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12100928_40-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Dennis LK, Lynch CF, Torner JC (July 2002). "Epidemiologic association between prostatitis and prostate cancer". <i>Urology</i> <b>60</b> (1): 78–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0090-4295%2802%2901637-0">10.1016/S0090-4295(02)01637-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12100928">12100928</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Epidemiologic+association+between+prostatitis+and+prostate+cancer&amp;rft.au=Dennis+LK%2C+Lynch+CF%2C+Torner+JC&amp;rft.aulast=Dennis+LK%2C+Lynch+CF%2C+Torner+JC&amp;rft.date=July+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0090-4295%2802%2901637-0&amp;rft_id=info%3Apmid%2F12100928&amp;rft.issue=1&amp;rft.jtitle=Urology&amp;rft.pages=78-83&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=60" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12711737-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12711737_41-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (April 2003). "Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults". <i>N. Engl. J. Med.</i> <b>348</b> (17): 1625–38. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa021423">10.1056/NEJMoa021423</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12711737">12711737</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Overweight%2C+obesity%2C+and+mortality+from+cancer+in+a+prospectively+studied+cohort+of+U.S.+adults&amp;rft.au=Calle+EE%2C+Rodriguez+C%2C+Walker-Thurmond+K%2C+Thun+MJ&amp;rft.aulast=Calle+EE%2C+Rodriguez+C%2C+Walker-Thurmond+K%2C+Thun+MJ&amp;rft.date=April+2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa021423&amp;rft_id=info%3Apmid%2F12711737&amp;rft.issue=17&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1625-38&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=348" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid8757191-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8757191_42-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ (August 1996). "Prospective study of sex hormone levels and risk of prostate cancer". <i>J. Natl. Cancer Inst.</i> <b>88</b> (16): 1118–26. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fjnci%2F88.16.1118">10.1093/jnci/88.16.1118</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8757191">8757191</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Prospective+study+of+sex+hormone+levels+and+risk+of+prostate+cancer&amp;rft.au=Gann+PH%2C+Hennekens+CH%2C+Ma+J%2C+Longcope+C%2C+Stampfer+MJ&amp;rft.aulast=Gann+PH%2C+Hennekens+CH%2C+Ma+J%2C+Longcope+C%2C+Stampfer+MJ&amp;rft.date=August+1996&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2F88.16.1118&amp;rft_id=info%3Apmid%2F8757191&amp;rft.issue=16&amp;rft.jtitle=J.+Natl.+Cancer+Inst.&amp;rft.pages=1118-26&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=88" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-bccancer.bc.ca-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-bccancer.bc.ca_43-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.bccancer.bc.ca">"?"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">9 August</span> 2010</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.btitle=%3F&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.bccancer.bc.ca&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-aorange-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-aorange_44-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="https://my.mcg.edu/portal/page/portal/News/archive/2007/Veterans%20exposed%20to%20Agent%20%20Orange%20have%20higher%20rates%20of%20prost">"Veterans exposed to Agent Orange have higher rates of prostate cancer recurrence"</a>. <i>Medical College of Georgia News</i>. May 20, 2007.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Veterans+exposed+to+Agent+Orange+have+higher+rates+of+prostate+cancer+recurrence&amp;rft.date=May+20%2C+2007&amp;rft.genre=article&amp;rft_id=https%3A%2F%2Fmy.mcg.edu%2Fportal%2Fpage%2Fportal%2FNews%2Farchive%2F2007%2FVeterans%2520exposed%2520to%2520Agent%2520%2520Orange%2520have%2520higher%2520rates%2520of%2520prost&amp;rft.jtitle=Medical+College+of+Georgia+News&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16609730-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16609730_45-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D, Silverman RH, DeRisi JL (March 2006). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1434790">"Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant"</a>. <i>PLoS Pathog.</i> <b>2</b> (3): e25. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1371%2Fjournal.ppat.0020025">10.1371/journal.ppat.0020025</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1434790">1434790</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16609730">16609730</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Identification+of+a+Novel+Gammaretrovirus+in+Prostate+Tumors+of+Patients+Homozygous+for+R462Q+RNASEL+Variant&amp;rft.aulast=Urisman+A%2C+Molinaro+RJ%2C+Fischer+N%2C+Plummer+SJ%2C+Casey+G%2C+Klein+EA%2C+Malathi+K%2C+Magi-Galluzzi+C%2C+Tubbs+RR%2C+Ganem+D%2C+Silverman+RH%2C+DeRisi+JL&amp;rft.au=Urisman+A%2C+Molinaro+RJ%2C+Fischer+N%2C+Plummer+SJ%2C+Casey+G%2C+Klein+EA%2C+Malathi+K%2C+Magi-Galluzzi+C%2C+Tubbs+RR%2C+Ganem+D%2C+Silverman+RH%2C+DeRisi+JL&amp;rft.date=March+2006&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1434790&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.ppat.0020025&amp;rft_id=info%3Apmc%2F1434790&amp;rft_id=info%3Apmid%2F16609730&amp;rft.issue=3&amp;rft.jtitle=PLoS+Pathog.&amp;rft.pages=e25&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span> <a href="/wiki/Open_access" title="open access publication - free to read"><img alt="open access publication - free to read" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/8px-Open_Access_logo_PLoS_transparent.svg.png" width="8" height="13" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/12px-Open_Access_logo_PLoS_transparent.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/16px-Open_Access_logo_PLoS_transparent.svg.png 2x" data-file-width="640" data-file-height="1000" /></a></span></li>
<li id="cite_note-pmid19805305-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19805305_46-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR (September 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2739868">"XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors"</a>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <b>106</b> (38): 16351–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1073%2Fpnas.0906922106">10.1073/pnas.0906922106</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2739868">2739868</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19805305">19805305</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=XMRV+is+present+in+malignant+prostatic+epithelium+and+is+associated+with+prostate+cancer%2C+especially+high-grade+tumors&amp;rft.aulast=Schlaberg+R%2C+Choe+DJ%2C+Brown+KR%2C+Thaker+HM%2C+Singh+IR&amp;rft.au=Schlaberg+R%2C+Choe+DJ%2C+Brown+KR%2C+Thaker+HM%2C+Singh+IR&amp;rft.date=September+2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2739868&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.0906922106&amp;rft_id=info%3Apmc%2F2739868&amp;rft_id=info%3Apmid%2F19805305&amp;rft.issue=38&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.pages=16351-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=106" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19835577-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19835577_47-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, Denner J, Miller K, Kurth R, Bannert N (2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2770519">"Lack of evidence for xenotropic murine leukemia virus-related virus (XMRV) in German prostate cancer patients"</a>. <i>Retrovirology</i> <b>6</b>: 92. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1186%2F1742-4690-6-92">10.1186/1742-4690-6-92</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2770519">2770519</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19835577">19835577</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Lack+of+evidence+for+xenotropic+murine+leukemia+virus-related+virus+%28XMRV%29+in+German+prostate+cancer+patients&amp;rft.au=Hohn+O%2C+Krause+H%2C+Barbarotto+P%2C+Niederstadt+L%2C+Beimforde+N%2C+Denner+J%2C+Miller+K%2C+Kurth+R%2C+Bannert+N&amp;rft.aulast=Hohn+O%2C+Krause+H%2C+Barbarotto+P%2C+Niederstadt+L%2C+Beimforde+N%2C+Denner+J%2C+Miller+K%2C+Kurth+R%2C+Bannert+N&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2770519&amp;rft_id=info%3Adoi%2F10.1186%2F1742-4690-6-92&amp;rft_id=info%3Apmc%2F2770519&amp;rft_id=info%3Apmid%2F19835577&amp;rft.jtitle=Retrovirology&amp;rft.pages=92&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><span class="citation journal">Lee D, Das Gupta J, Gaughan C, Steffen I, Tang N, Luk KC, Qiu X, Urisman A, Fischer N, Molinaro R, Broz M, Schochetman G, Klein EA, Ganem D, Derisi JL, Simmons G, Hackett J, Silverman RH, Chiu CY (2012). Tachedjian, Gilda, ed. <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3445615">"In-Depth Investigation of Archival and Prospectively Collected Samples Reveals No Evidence for XMRV Infection in Prostate Cancer"</a>. <i>PLoS ONE</i> <b>7</b> (9): e44954. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1371%2Fjournal.pone.0044954">10.1371/journal.pone.0044954</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3445615">3445615</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23028701">23028701</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=In-Depth+Investigation+of+Archival+and+Prospectively+Collected+Samples+Reveals+No+Evidence+for+XMRV+Infection+in+Prostate+Cancer&amp;rft.aulast=Lee+D%2C+Das+Gupta+J%2C+Gaughan+C%2C+Steffen+I%2C+Tang+N%2C+Luk+KC%2C+Qiu+X%2C+Urisman+A%2C+Fischer+N%2C+Molinaro+R%2C+Broz+M%2C+Schochetman+G%2C+Klein+EA%2C+Ganem+D%2C+Derisi+JL%2C+Simmons+G%2C+Hackett+J%2C+Silverman+RH%2C+Chiu+CY&amp;rft.au=Lee+D%2C+Das+Gupta+J%2C+Gaughan+C%2C+Steffen+I%2C+Tang+N%2C+Luk+KC%2C+Qiu+X%2C+Urisman+A%2C+Fischer+N%2C+Molinaro+R%2C+Broz+M%2C+Schochetman+G%2C+Klein+EA%2C+Ganem+D%2C+Derisi+JL%2C+Simmons+G%2C+Hackett+J%2C+Silverman+RH%2C+Chiu+CY&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3445615&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0044954&amp;rft_id=info%3Apmc%2F3445615&amp;rft_id=info%3Apmid%2F23028701&amp;rft.issue=9&amp;rft.jtitle=PLoS+ONE&amp;rft.pages=e44954&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span> <a href="/wiki/Open_access" title="open access publication - free to read"><img alt="open access publication - free to read" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/8px-Open_Access_logo_PLoS_transparent.svg.png" width="8" height="13" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/12px-Open_Access_logo_PLoS_transparent.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/16px-Open_Access_logo_PLoS_transparent.svg.png 2x" data-file-width="640" data-file-height="1000" /></a></span></li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><span class="citation journal">Alberts B (Dec 23, 2011). "Retraction". <i>Science</i> <b>334</b> (6063): 1636. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1126%2Fscience.334.6063.1636-a">10.1126/science.334.6063.1636-a</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22194552">22194552</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Retraction&amp;rft.au=Alberts+B&amp;rft.aulast=Alberts+B&amp;rft.date=Dec+23%2C+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.334.6063.1636-a&amp;rft_id=info%3Apmid%2F22194552&amp;rft.issue=6063&amp;rft.jtitle=Science&amp;rft.pages=1636&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=334" class="Z3988"><span style="display:none;">&#160;</span></span> <a href="/wiki/Open_access" title="open access publication - free to read"><img alt="open access publication - free to read" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/8px-Open_Access_logo_PLoS_transparent.svg.png" width="8" height="13" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/12px-Open_Access_logo_PLoS_transparent.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/16px-Open_Access_logo_PLoS_transparent.svg.png 2x" data-file-width="640" data-file-height="1000" /></a></span></li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><span class="citation journal">Ross, Susan, ed. (September 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3445601">"Retraction. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant"</a>. <i>PLoS Pathogens</i> <b>8</b> (9): 10.1371/annotation/7e2efc01–2e9b–4e9b–aef0–87ab0e4e4732. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1371%2Fannotation%2F7e2efc01-2e9b-4e9b-aef0-87ab0e4e4732">10.1371/annotation/7e2efc01-2e9b-4e9b-aef0-87ab0e4e4732</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3445601">3445601</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23028303">23028303</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Retraction.+Identification+of+a+novel+gammaretrovirus+in+prostate+tumors+of+patients+homozygous+for+R462Q+RNASEL+variant&amp;rft.date=September+2012&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3445601&amp;rft_id=info%3Adoi%2F10.1371%2Fannotation%2F7e2efc01-2e9b-4e9b-aef0-87ab0e4e4732&amp;rft_id=info%3Apmc%2F3445601&amp;rft_id=info%3Apmid%2F23028303&amp;rft.issue=9&amp;rft.jtitle=PLoS+Pathogens&amp;rft.pages=10.1371%2Fannotation%2F7e2efc01-2e9b-4e9b-aef0-87ab0e4e4732&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span> <a href="/wiki/Open_access" title="open access publication - free to read"><img alt="open access publication - free to read" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/8px-Open_Access_logo_PLoS_transparent.svg.png" width="8" height="13" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/12px-Open_Access_logo_PLoS_transparent.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/16px-Open_Access_logo_PLoS_transparent.svg.png 2x" data-file-width="640" data-file-height="1000" /></a></span></li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><span class="citation journal">Dennis LK, Dawson DV (January 2002). "Meta-analysis of measures of sexual activity and prostate cancer". <i>Epidemiology (Cambridge, Mass.)</i> <b>13</b> (1): 72–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F00001648-200201000-00012">10.1097/00001648-200201000-00012</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11805589">11805589</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Meta-analysis+of+measures+of+sexual+activity+and+prostate+cancer&amp;rft.au=Dennis+LK%2C+Dawson+DV&amp;rft.aulast=Dennis+LK%2C+Dawson+DV&amp;rft.date=January+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F00001648-200201000-00012&amp;rft_id=info%3Apmid%2F11805589&amp;rft.issue=1&amp;rft.jtitle=Epidemiology+%28Cambridge%2C+Mass.%29&amp;rft.pages=72-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=13" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Rosenblatt_1152.E2.80.938-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-Rosenblatt_1152.E2.80.938_52-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rosenblatt KA, Wicklund KG, Stanford JL (Jun 15, 2001). "Sexual factors and the risk of prostate cancer". <i>American Journal of Epidemiology</i> <b>153</b> (12): 1152–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Faje%2F153.12.1152">10.1093/aje/153.12.1152</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11415949">11415949</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Sexual+factors+and+the+risk+of+prostate+cancer&amp;rft.aulast=Rosenblatt+KA%2C+Wicklund+KG%2C+Stanford+JL&amp;rft.au=Rosenblatt+KA%2C+Wicklund+KG%2C+Stanford+JL&amp;rft.date=Jun+15%2C+2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Faje%2F153.12.1152&amp;rft_id=info%3Apmid%2F11415949&amp;rft.issue=12&amp;rft.jtitle=American+Journal+of+Epidemiology&amp;rft.pages=1152-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=153" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text"><span class="citation journal">Sarma AV, McLaughlin JC, Wallner LP, Dunn RL, Cooney KA, Schottenfeld D, Montie JE, Wei JT (September 2006). "Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men". <i>The Journal of Urology</i> <b>176</b> (3): 1108–13. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.juro.2006.04.075">10.1016/j.juro.2006.04.075</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16890703">16890703</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Sexual+behavior%2C+sexually+transmitted+diseases+and+prostatitis%3A+the+risk+of+prostate+cancer+in+black+men&amp;rft.aulast=Sarma+AV%2C+McLaughlin+JC%2C+Wallner+LP%2C+Dunn+RL%2C+Cooney+KA%2C+Schottenfeld+D%2C+Montie+JE%2C+Wei+JT&amp;rft.au=Sarma+AV%2C+McLaughlin+JC%2C+Wallner+LP%2C+Dunn+RL%2C+Cooney+KA%2C+Schottenfeld+D%2C+Montie+JE%2C+Wei+JT&amp;rft.date=September+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.juro.2006.04.075&amp;rft_id=info%3Apmid%2F16890703&amp;rft.issue=3&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.pages=1108-13&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=176" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text"><span class="citation book"><a rel="nofollow" class="external text" href="https://books.google.com/books?id=mAYPxgOoBK4C&amp;pg=PA27"><i>Male Reproductive Cancers</i></a>. Springer New York. 2010. p.&#160;27. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9781441904508" title="Special:BookSources/9781441904508">9781441904508</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.btitle=Male+Reproductive+Cancers&amp;rft.date=2010&amp;rft.genre=book&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DmAYPxgOoBK4C%26pg%3DPA27&amp;rft.isbn=9781441904508&amp;rft.pages=27&amp;rft.pub=Springer+New+York&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><span class="citation book">Scardino, Peter (2005). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=jaLRxFFEwNsC&amp;pg=PA16"><i>Comprehensive textbook of genitourinary oncology</i></a> (3rd ed.). Philadelphia: Lippincott Williams &amp; Wilkins. p.&#160;16. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780781749848" title="Special:BookSources/9780781749848">9780781749848</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.aufirst=Peter&amp;rft.aulast=Scardino&amp;rft.au=Scardino%2C+Peter&amp;rft.btitle=Comprehensive+textbook+of+genitourinary+oncology&amp;rft.date=2005&amp;rft.edition=3rd&amp;rft.genre=book&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DjaLRxFFEwNsC%26pg%3DPA16&amp;rft.isbn=9780781749848&amp;rft.pages=16&amp;rft.place=Philadelphia&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><span class="citation journal">Leitzmann, MF; Platz, EA; Stampfer, MJ; Willett, WC; Giovannucci, E (7 April 2004). "Ejaculation frequency and subsequent risk of prostate cancer.". <i>JAMA</i> <b>291</b> (13): 1578–86. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Fjama.291.13.1578">10.1001/jama.291.13.1578</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15069045">15069045</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Ejaculation+frequency+and+subsequent+risk+of+prostate+cancer.&amp;rft.aufirst=MF&amp;rft.au=Giovannucci%2C+E&amp;rft.aulast=Leitzmann&amp;rft.au=Leitzmann%2C+MF&amp;rft.au=Platz%2C+EA&amp;rft.au=Stampfer%2C+MJ&amp;rft.au=Willett%2C+WC&amp;rft.date=7+April+2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.291.13.1578&amp;rft_id=info%3Apmid%2F15069045&amp;rft.issue=13&amp;rft.jtitle=JAMA&amp;rft.pages=1578-86&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=291" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><span class="citation journal">Giles, GG; Severi, G; English, DR; McCredie, MR; Borland, R; Boyle, P; Hopper, JL (August 2003). "Sexual factors and prostate cancer.". <i>BJU international</i> <b>92</b> (3): 211–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1046%2Fj.1464-410x.2003.04319.x">10.1046/j.1464-410x.2003.04319.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12887469">12887469</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Sexual+factors+and+prostate+cancer.&amp;rft.au=Borland%2C+R&amp;rft.au=Boyle%2C+P&amp;rft.au=English%2C+DR&amp;rft.aufirst=GG&amp;rft.au=Giles%2C+GG&amp;rft.au=Hopper%2C+JL&amp;rft.aulast=Giles&amp;rft.au=McCredie%2C+MR&amp;rft.au=Severi%2C+G&amp;rft.date=August+2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1464-410x.2003.04319.x&amp;rft_id=info%3Apmid%2F12887469&amp;rft.issue=3&amp;rft.jtitle=BJU+international&amp;rft.pages=211-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=92" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-58">^</a></b></span> <span class="reference-text"><span class="citation book">Aumüller, G. (1979). <i>Prostate Gland and Seminal Vesicles</i>. Berlin-Heidelberg: Springer-Verlag.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.au=Aum%C3%BCller%2C+G.&amp;rft.aufirst=G.&amp;rft.aulast=Aum%C3%BCller&amp;rft.btitle=Prostate+Gland+and+Seminal+Vesicles&amp;rft.date=1979&amp;rft.genre=book&amp;rft.place=Berlin-Heidelberg&amp;rft.pub=Springer-Verlag&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><span class="citation book">Moore, K.; Dalley, A. (1999). <i>Clinically Oriented Anatomy</i>. Baltimore, Maryland: Lippincott Williams &amp; Wilkins. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-683-06132-1" title="Special:BookSources/0-683-06132-1">0-683-06132-1</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.au=Dalley%2C+A.&amp;rft.aufirst=K.&amp;rft.aulast=Moore&amp;rft.au=Moore%2C+K.&amp;rft.btitle=Clinically+Oriented+Anatomy&amp;rft.date=1999&amp;rft.genre=book&amp;rft.isbn=0-683-06132-1&amp;rft.place=Baltimore%2C+Maryland&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><span class="citation book">Steive, H. (1930). "<i>Männliche Genitalorgane</i>". Handbuch der mikroskopischen Anatomie des Menschen. <i>Vol. VII Part 2</i>. Berlin: Springer. pp.&#160;1–399.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=M%C3%A4nnliche+Genitalorgane&amp;rft.aufirst=H.&amp;rft.aulast=Steive&amp;rft.au=Steive%2C+H.&amp;rft.btitle=Handbuch+der+mikroskopischen+Anatomie+des+Menschen.+Vol.+VII+Part+2&amp;rft.date=1930&amp;rft.genre=bookitem&amp;rft.pages=1-399&amp;rft.place=Berlin&amp;rft.pub=Springer&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-metastasis-route-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-metastasis-route_61-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.webcitation.org/5yHQ19Rrp">"Male Genitals - Prostate Neoplasms"</a>. <i>Pathology study images</i>. University of Virginia School of Medicine. Archived from <a rel="nofollow" class="external text" href="http://www.med-ed.virginia.edu/courses/path/gu/prostate3.cfm">the original</a> on 2011-04-28<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-04-28</span></span>. <q>There are many connections between the prostatic venous plexus and the vertebral veins. The veins forming the prostatic plexus do not contain valves and it is thought that straining to urinate causes prostatic venous blood to flow in a reverse direction and enter the vertebral veins carrying malignant cells to the vertebral column.</q></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Male+Genitals+-+Prostate+Neoplasms&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.med-ed.virginia.edu%2Fcourses%2Fpath%2Fgu%2Fprostate3.cfm&amp;rft.jtitle=Pathology+study+images&amp;rft.pub=University+of+Virginia+School+of+Medicine&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text">Journal-molecular cancer, review, 2006 5:17, <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1186%2F1476-4598-5-17">10.1186/1476-4598-5-17</a></span></li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.mskcc.org/mskcc/html/59384.cfm">"Scientists Discover Anti-Cancer Mechanism that Arrests Early Prostate Cancer"</a>. August 4, 2005.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.btitle=Scientists+Discover+Anti-Cancer+Mechanism+that+Arrests+Early+Prostate+Cancer&amp;rft.date=August+4%2C+2005&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.mskcc.org%2Fmskcc%2Fhtml%2F59384.cfm&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19948822-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19948822_64-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Leav I, Plescia J, Goel HL, Li J, Jiang Z, Cohen RJ, Languino LR, Altieri DC (January 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2797899">"Cytoprotective Mitochondrial Chaperone TRAP-1 As a Novel Molecular Target in Localized and Metastatic Prostate Cancer"</a>. <i>Am. J. Pathol.</i> <b>176</b> (1): 393–401. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2353%2Fajpath.2010.090521">10.2353/ajpath.2010.090521</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2797899">2797899</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19948822">19948822</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Cytoprotective+Mitochondrial+Chaperone+TRAP-1+As+a+Novel+Molecular+Target+in+Localized+and+Metastatic+Prostate+Cancer&amp;rft.aulast=Leav+I%2C+Plescia+J%2C+Goel+HL%2C+Li+J%2C+Jiang+Z%2C+Cohen+RJ%2C+Languino+LR%2C+Altieri+DC&amp;rft.au=Leav+I%2C+Plescia+J%2C+Goel+HL%2C+Li+J%2C+Jiang+Z%2C+Cohen+RJ%2C+Languino+LR%2C+Altieri+DC&amp;rft.date=January+2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2797899&amp;rft_id=info%3Adoi%2F10.2353%2Fajpath.2010.090521&amp;rft_id=info%3Apmc%2F2797899&amp;rft_id=info%3Apmid%2F19948822&amp;rft.issue=1&amp;rft.jtitle=Am.+J.+Pathol.&amp;rft.pages=393-401&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=176" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19947572-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19947572_65-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Zha J, Huang YF (September 2009). "[TGF-beta/Smad in prostate cancer: an update]". <i>Zhonghua Nan Ke Xue</i> (in Chinese) <b>15</b> (9): 840–3. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19947572">19947572</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=%5BTGF-beta%2FSmad+in+prostate+cancer%3A+an+update%5D&amp;rft.aulast=Zha+J%2C+Huang+YF&amp;rft.au=Zha+J%2C+Huang+YF&amp;rft.date=September+2009&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F19947572&amp;rft.issue=9&amp;rft.jtitle=Zhonghua+Nan+Ke+Xue&amp;rft.pages=840-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19946707-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19946707_66-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Watanabe SI, Miyata Y, Kanda S, Iwata T, Hayashi T, Kanetake H, Sakai H (November 2009). "Expression of X-linked inhibitor of apoptosis protein in human prostate cancer specimens with and without neo-adjuvant hormonal therapy". <i>J Cancer Res Clin Oncol</i> <b>136</b> (5): 787–93. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs00432-009-0718-x">10.1007/s00432-009-0718-x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19946707">19946707</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Expression+of+X-linked+inhibitor+of+apoptosis+protein+in+human+prostate+cancer+specimens+with+and+without+neo-adjuvant+hormonal+therapy&amp;rft.aulast=Watanabe+SI%2C+Miyata+Y%2C+Kanda+S%2C+Iwata+T%2C+Hayashi+T%2C+Kanetake+H%2C+Sakai+H&amp;rft.au=Watanabe+SI%2C+Miyata+Y%2C+Kanda+S%2C+Iwata+T%2C+Hayashi+T%2C+Kanetake+H%2C+Sakai+H&amp;rft.date=November+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00432-009-0718-x&amp;rft_id=info%3Apmid%2F19946707&amp;rft.issue=5&amp;rft.jtitle=J+Cancer+Res+Clin+Oncol&amp;rft.pages=787-93&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=136" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19946339-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19946339_67-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Senapati S, Rachagani S, Chaudhary K, Johansson SL, Singh RK, Batra SK (March 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2896817">"Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK–RhoA signaling pathway"</a>. <i>Oncogene</i> <b>29</b> (9): 1293–302. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fonc.2009.420">10.1038/onc.2009.420</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2896817">2896817</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19946339">19946339</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Overexpression+of+macrophage+inhibitory+cytokine-1+induces+metastasis+of+human+prostate+cancer+cells+through+the+FAK%E2%80%93RhoA+signaling+pathway&amp;rft.aulast=Senapati+S%2C+Rachagani+S%2C+Chaudhary+K%2C+Johansson+SL%2C+Singh+RK%2C+Batra+SK&amp;rft.au=Senapati+S%2C+Rachagani+S%2C+Chaudhary+K%2C+Johansson+SL%2C+Singh+RK%2C+Batra+SK&amp;rft.date=March+2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2896817&amp;rft_id=info%3Adoi%2F10.1038%2Fonc.2009.420&amp;rft_id=info%3Apmc%2F2896817&amp;rft_id=info%3Apmid%2F19946339&amp;rft.issue=9&amp;rft.jtitle=Oncogene&amp;rft.pages=1293-302&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=29" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19946220-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19946220_68-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Narizhneva NV, Tararova ND, Ryabokon P, Shyshynova I, Prokvolit A, Komarov PG, Purmal AA, Gudkov AV, Gurova KV (December 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2896895">"Small molecule screening reveals a transcription-independent pro-survival function of androgen receptor in castration-resistant prostate cancer"</a>. <i>Cell Cycle</i> <b>8</b> (24): 4155–67. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.4161%2Fcc.8.24.10316">10.4161/cc.8.24.10316</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2896895">2896895</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19946220">19946220</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Small+molecule+screening+reveals+a+transcription-independent+pro-survival+function+of+androgen+receptor+in+castration-resistant+prostate+cancer&amp;rft.aulast=Narizhneva+NV%2C+Tararova+ND%2C+Ryabokon+P%2C+Shyshynova+I%2C+Prokvolit+A%2C+Komarov+PG%2C+Purmal+AA%2C+Gudkov+AV%2C+Gurova+KV&amp;rft.au=Narizhneva+NV%2C+Tararova+ND%2C+Ryabokon+P%2C+Shyshynova+I%2C+Prokvolit+A%2C+Komarov+PG%2C+Purmal+AA%2C+Gudkov+AV%2C+Gurova+KV&amp;rft.date=December+2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2896895&amp;rft_id=info%3Adoi%2F10.4161%2Fcc.8.24.10316&amp;rft_id=info%3Apmc%2F2896895&amp;rft_id=info%3Apmid%2F19946220&amp;rft.issue=24&amp;rft.jtitle=Cell+Cycle&amp;rft.pages=4155-67&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19830782-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19830782_69-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Yao V, Berkman CE, Choi JK, O'Keefe DS, Bacich DJ (February 2010). "Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid". <i>Prostate</i> <b>70</b> (3): 305–16. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fpros.21065">10.1002/pros.21065</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19830782">19830782</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Expression+of+prostate-specific+membrane+antigen+%28PSMA%29%2C+increases+cell+folate+uptake+and+proliferation+and+suggests+a+novel+role+for+PSMA+in+the+uptake+of+the+non-polyglutamated+folate%2C+folic+acid&amp;rft.aulast=Yao+V%2C+Berkman+CE%2C+Choi+JK%2C+O%27Keefe+DS%2C+Bacich+DJ&amp;rft.au=Yao+V%2C+Berkman+CE%2C+Choi+JK%2C+O%27Keefe+DS%2C+Bacich+DJ&amp;rft.date=February+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fpros.21065&amp;rft_id=info%3Apmid%2F19830782&amp;rft.issue=3&amp;rft.jtitle=Prostate&amp;rft.pages=305-16&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=70" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.cancer.org/Healthy/FindCancerEarly/CancerScreeningGuidelines/american-cancer-society-guidelines-for-the-early-detection-of-cancer">http://www.cancer.org/Healthy/FindCancerEarly/CancerScreeningGuidelines/american-cancer-society-guidelines-for-the-early-detection-of-cancer</a> American Cancer Society American Cancer Society Guidelines for the early detection of cancer Cited: September 2011</span></li>
<li id="cite_note-pmid21571651-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21571651_71-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Bonekamp D, Jacobs MA, El-Khouli R, Stoianovici D, Macura KJ (May–June 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3093638">"Advancements in MR Imaging of the Prostate: From Diagnosis to Interventions"</a>. <i>Radiographics</i> <b>31</b> (3 Suppl): 677–703. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1148%2Frg.313105139">10.1148/rg.313105139</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3093638">3093638</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21571651">21571651</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Advancements+in+MR+Imaging+of+the+Prostate%3A+From+Diagnosis+to+Interventions&amp;rft.au=Bonekamp+D%2C+Jacobs+MA%2C+El-Khouli+R%2C+Stoianovici+D%2C+Macura+KJ&amp;rft.aulast=Bonekamp+D%2C+Jacobs+MA%2C+El-Khouli+R%2C+Stoianovici+D%2C+Macura+KJ&amp;rft.date=May-June+2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3093638&amp;rft_id=info%3Adoi%2F10.1148%2Frg.313105139&amp;rft_id=info%3Apmc%2F3093638&amp;rft_id=info%3Apmid%2F21571651&amp;rft.issue=3+Suppl&amp;rft.jtitle=Radiographics&amp;rft.pages=677-703&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid22322308-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22322308_72-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, Rouviere O, Logager V, Fütterer JJ (2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3297750">"ESUR prostate MR guidelines 2012"</a>. <i>European Radiology</i> <b>22</b> (4): 746–57. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs00330-011-2377-y">10.1007/s00330-011-2377-y</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3297750">3297750</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22322308">22322308</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=ESUR+prostate+MR+guidelines+2012&amp;rft.au=Barentsz+JO%2C+Richenberg+J%2C+Clements+R%2C+Choyke+P%2C+Verma+S%2C+Villeirs+G%2C+Rouviere+O%2C+Logager+V%2C+F%C3%BCtterer+JJ&amp;rft.aulast=Barentsz+JO%2C+Richenberg+J%2C+Clements+R%2C+Choyke+P%2C+Verma+S%2C+Villeirs+G%2C+Rouviere+O%2C+Logager+V%2C+F%C3%BCtterer+JJ&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3297750&amp;rft_id=info%3Adoi%2F10.1007%2Fs00330-011-2377-y&amp;rft_id=info%3Apmc%2F3297750&amp;rft_id=info%3Apmid%2F22322308&amp;rft.issue=4&amp;rft.jtitle=European+Radiology&amp;rft.pages=746-57&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid21555104-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21555104_73-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Natarajan S, Marks LS, Margolis DJ, Huang J, Macairan ML, Lieu P, Fenster A (May 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3432280">"Clinical application of a 3D ultrasound-guided prostate biopsy system"</a>. <i>Urol Oncol</i> <b>29</b> (3 Suppl): 334–42. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.urolonc.2011.02.014">10.1016/j.urolonc.2011.02.014</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3432280">3432280</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21555104">21555104</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Clinical+application+of+a+3D+ultrasound-guided+prostate+biopsy+system&amp;rft.aulast=Natarajan+S%2C+Marks+LS%2C+Margolis+DJ%2C+Huang+J%2C+Macairan+ML%2C+Lieu+P%2C+Fenster+A&amp;rft.au=Natarajan+S%2C+Marks+LS%2C+Margolis+DJ%2C+Huang+J%2C+Macairan+ML%2C+Lieu+P%2C+Fenster+A&amp;rft.date=May+2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3432280&amp;rft_id=info%3Adoi%2F10.1016%2Fj.urolonc.2011.02.014&amp;rft_id=info%3Apmc%2F3432280&amp;rft_id=info%3Apmid%2F21555104&amp;rft.issue=3+Suppl&amp;rft.jtitle=Urol+Oncol&amp;rft.pages=334-42&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=29" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid21993567-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21993567_74-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Tan N, Margolis DJ, McClure TD, Thomas A, Finley DS, Reiter RE, Huang J, Raman SS (October 2011). "Radical prostatectomy: value of prostate MRI in surgical planning". <i>Abdominal Imaging</i> <b>37</b> (4): 664–74. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs00261-011-9805-y">10.1007/s00261-011-9805-y</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21993567">21993567</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Radical+prostatectomy%3A+value+of+prostate+MRI+in+surgical+planning&amp;rft.aulast=Tan+N%2C+Margolis+DJ%2C+McClure+TD%2C+Thomas+A%2C+Finley+DS%2C+Reiter+RE%2C+Huang+J%2C+Raman+SS&amp;rft.au=Tan+N%2C+Margolis+DJ%2C+McClure+TD%2C+Thomas+A%2C+Finley+DS%2C+Reiter+RE%2C+Huang+J%2C+Raman+SS&amp;rft.date=October+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00261-011-9805-y&amp;rft_id=info%3Apmid%2F21993567&amp;rft.issue=4&amp;rft.jtitle=Abdominal+Imaging&amp;rft.pages=664-74&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=37" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9637143-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9637143_75-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Essink-Bot ML, de Koning HJ, Nijs HG, Kirkels WJ, van der Maas PJ, Schröder FH (June 1998). "Short-term effects of population-based screening for prostate cancer on health-related quality of life". <i>J. Natl. Cancer Inst.</i> <b>90</b> (12): 925–31. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fjnci%2F90.12.925">10.1093/jnci/90.12.925</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9637143">9637143</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Short-term+effects+of+population-based+screening+for+prostate+cancer+on+health-related+quality+of+life&amp;rft.au=Essink-Bot+ML%2C+de+Koning+HJ%2C+Nijs+HG%2C+Kirkels+WJ%2C+van+der+Maas+PJ%2C+Schr%C3%B6der+FH&amp;rft.aulast=Essink-Bot+ML%2C+de+Koning+HJ%2C+Nijs+HG%2C+Kirkels+WJ%2C+van+der+Maas+PJ%2C+Schr%C3%B6der+FH&amp;rft.date=June+1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2F90.12.925&amp;rft_id=info%3Apmid%2F9637143&amp;rft.issue=12&amp;rft.jtitle=J.+Natl.+Cancer+Inst.&amp;rft.pages=925-31&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=90" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19276452-76"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid19276452_76-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19276452_76-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS, Burke CA, McKeown-Eyssen GE, Baron JA (March 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2657096">"Folic Acid and Risk of Prostate Cancer: Results From a Randomized Clinical Trial"</a>. <i>J. Natl. Cancer Inst.</i> <b>101</b> (6): 432–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fjnci%2Fdjp019">10.1093/jnci/djp019</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2657096">2657096</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19276452">19276452</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Folic+Acid+and+Risk+of+Prostate+Cancer%3A+Results+From+a+Randomized+Clinical+Trial&amp;rft.au=Figueiredo+JC%2C+Grau+MV%2C+Haile+RW%2C+Sandler+RS%2C+Summers+RW%2C+Bresalier+RS%2C+Burke+CA%2C+McKeown-Eyssen+GE%2C+Baron+JA&amp;rft.aulast=Figueiredo+JC%2C+Grau+MV%2C+Haile+RW%2C+Sandler+RS%2C+Summers+RW%2C+Bresalier+RS%2C+Burke+CA%2C+McKeown-Eyssen+GE%2C+Baron+JA&amp;rft.date=March+2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2657096&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2Fdjp019&amp;rft_id=info%3Apmc%2F2657096&amp;rft_id=info%3Apmid%2F19276452&amp;rft.issue=6&amp;rft.jtitle=J.+Natl.+Cancer+Inst.&amp;rft.pages=432-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=101" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17667550-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17667550_77-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI (August 2007). "Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma". <i>Am. J. Surg. Pathol.</i> <b>31</b> (8): 1246–55. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2FPAS.0b013e31802f5d33">10.1097/PAS.0b013e31802f5d33</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17667550">17667550</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Immunohistochemical+differentiation+of+high-grade+prostate+carcinoma+from+urothelial+carcinoma&amp;rft.au=Chuang+AY%2C+DeMarzo+AM%2C+Veltri+RW%2C+Sharma+RB%2C+Bieberich+CJ%2C+Epstein+JI&amp;rft.aulast=Chuang+AY%2C+DeMarzo+AM%2C+Veltri+RW%2C+Sharma+RB%2C+Bieberich+CJ%2C+Epstein+JI&amp;rft.date=August+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FPAS.0b013e31802f5d33&amp;rft_id=info%3Apmid%2F17667550&amp;rft.issue=8&amp;rft.jtitle=Am.+J.+Surg.+Pathol.&amp;rft.pages=1246-55&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9227387-78"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid9227387_78-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid9227387_78-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Nutting C, Horwich A, Fisher C, Parsons C, Dearnaley DP (June 1997). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1296316">"Small-cell carcinoma of the prostate"</a>. <i>Journal of the Royal Society of Medicine</i> <b>90</b> (6): 340–1. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1296316">1296316</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9227387">9227387</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Small-cell+carcinoma+of+the+prostate&amp;rft.aulast=Nutting+C%2C+Horwich+A%2C+Fisher+C%2C+Parsons+C%2C+Dearnaley+DP&amp;rft.au=Nutting+C%2C+Horwich+A%2C+Fisher+C%2C+Parsons+C%2C+Dearnaley+DP&amp;rft.date=June+1997&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1296316&amp;rft_id=info%3Apmc%2F1296316&amp;rft_id=info%3Apmid%2F9227387&amp;rft.issue=6&amp;rft.jtitle=Journal+of+the+Royal+Society+of+Medicine&amp;rft.pages=340-1&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=90" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19947569-79"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid19947569_79-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19947569_79-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Wei ZF, Xu H, Wang H, Wei W, Cheng W, Zhou WQ, Ge JP, Zhang ZY, Gao JP, Yin HL (September 2009). "[Clinicopathological characterization of prostatic small cell carcinoma: a case report and review of the literature]". <i>Zhonghua Nan Ke Xue</i> (in Chinese) <b>15</b> (9): 829–32. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19947569">19947569</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=%5BClinicopathological+characterization+of+prostatic+small+cell+carcinoma%3A+a+case+report+and+review+of+the+literature%5D&amp;rft.aulast=Wei+ZF%2C+Xu+H%2C+Wang+H%2C+Wei+W%2C+Cheng+W%2C+Zhou+WQ%2C+Ge+JP%2C+Zhang+ZY%2C+Gao+JP%2C+Yin+HL&amp;rft.au=Wei+ZF%2C+Xu+H%2C+Wang+H%2C+Wei+W%2C+Cheng+W%2C+Zhou+WQ%2C+Ge+JP%2C+Zhang+ZY%2C+Gao+JP%2C+Yin+HL&amp;rft.date=September+2009&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F19947569&amp;rft.issue=9&amp;rft.jtitle=Zhonghua+Nan+Ke+Xue&amp;rft.pages=829-32&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-80">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.freepatentsonline.com/20090221672.pdf">"Biomarker for Prostate Cancer"</a> <span style="font-size:85%;">(PDF)</span>. Freepatentsonline.com<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-08-29</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.btitle=Biomarker+for+Prostate+Cancer&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.freepatentsonline.com%2F20090221672.pdf&amp;rft.pub=Freepatentsonline.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12510149-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12510149_81-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Catz SD, Johnson JL (January 2003). "BCL-2 in prostate cancer: a minireview". <i>Apoptosis</i> <b>8</b> (1): 29–37. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1023%2FA%3A1021692801278">10.1023/A:1021692801278</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12510149">12510149</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=BCL-2+in+prostate+cancer%3A+a+minireview&amp;rft.au=Catz+SD%2C+Johnson+JL&amp;rft.aulast=Catz+SD%2C+Johnson+JL&amp;rft.date=January+2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1023%2FA%3A1021692801278&amp;rft_id=info%3Apmid%2F12510149&amp;rft.issue=1&amp;rft.jtitle=Apoptosis&amp;rft.pages=29-37&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-82">^</a></b></span> <span class="reference-text"><span class="citation journal">Srikumar Chakravarthi, David Low Wee Yang, Thanikachalam P, Nagaraja HS, Nadeem Irfan Bukhari (2009). "Assessment of proliferative index and its association with Ki-67 antigen molecule expression in nodular hyperplasia of prostate". <i>Indian Journal of Science &amp; Technology</i> <b>2</b> (8): 1–4.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Assessment+of+proliferative+index+and+its+association+with+Ki-67+antigen+molecule+expression+in+nodular+hyperplasia+of+prostate&amp;rft.aulast=Srikumar+Chakravarthi%2C+David+Low+Wee+Yang%2C++Thanikachalam+P%2C+Nagaraja+HS%2C+Nadeem+Irfan+Bukhari&amp;rft.au=Srikumar+Chakravarthi%2C+David+Low+Wee+Yang%2C++Thanikachalam+P%2C+Nagaraja+HS%2C+Nadeem+Irfan+Bukhari&amp;rft.date=2009&amp;rft.genre=article&amp;rft.issue=8&amp;rft.jtitle=Indian+Journal+of+Science+%26+Technology&amp;rft.pages=1-4&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-83">^</a></b></span> <span class="reference-text">British Journal of Cancer - 15 Feb 2011</span></li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><span class="citation news">BMJ Group (8 December 2009). <a rel="nofollow" class="external text" href="http://www.guardian.co.uk/lifeandstyle/besttreatments/prostate-cancer-how-far-has-your-cancer-spread-the-tnm-system">"Prostate cancer: How far has your cancer spread? The TNM system"</a>. London: <a href="/wiki/Guardian.co.uk" title="Guardian.co.uk" class="mw-redirect">Guardian.co.uk</a><span class="reference-accessdate">. Retrieved <span class="nowrap">9 August</span> 2010</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.au=BMJ+Group&amp;rft.aulast=BMJ+Group&amp;rft.btitle=Prostate+cancer%3A+How+far+has+your+cancer+spread%3F+The+TNM+system&amp;rft.date=8+December+2009&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.guardian.co.uk%2Flifeandstyle%2Fbesttreatments%2Fprostate-cancer-how-far-has-your-cancer-spread-the-tnm-system&amp;rft.place=London&amp;rft.pub=Guardian.co.uk&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-ASCOfive-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-ASCOfive_85-0">^</a></b></span> <span class="reference-text"><span class="citation journal"><a href="/wiki/American_Society_of_Clinical_Oncology" title="American Society of Clinical Oncology">American Society of Clinical Oncology</a> (2013). <a rel="nofollow" class="external text" href="http://choosingwisely.org/wp-content/uploads/2012/04/5things_12_factsheet_Amer_Soc_Clin_Onc.pdf">"Five things physicians and patients should question"</a> <span style="font-size:85%;">(PDF)</span>. <i>The Journal of the Oklahoma State Medical Association</i> <b>106</b> (4): 150–1. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23795527">23795527</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Five+things+physicians+and+patients+should+question&amp;rft.au=American+Society+of+Clinical+Oncology&amp;rft.aulast=American+Society+of+Clinical+Oncology&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fchoosingwisely.org%2Fwp-content%2Fuploads%2F2012%2F04%2F5things_12_factsheet_Amer_Soc_Clin_Onc.pdf&amp;rft_id=info%3Apmid%2F23795527&amp;rft.issue=4&amp;rft.jtitle=The+Journal+of+the+Oklahoma+State+Medical+Association&amp;rft.pages=150-1&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=106" class="Z3988"><span style="display:none;">&#160;</span></span></span>
<ul>
<li><span class="citation journal">Makarov DV, Desai RA, Yu JB, Sharma R, Abraham N, Albertsen PC, Penson DF, Gross CP (2012). "The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population". <i>The Journal of Urology</i> <b>187</b> (1): 97–102. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.juro.2011.09.042">10.1016/j.juro.2011.09.042</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22088337">22088337</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=The+population+level+prevalence+and+correlates+of+appropriate+and+inappropriate+imaging+to+stage+incident+prostate+cancer+in+the+medicare+population&amp;rft.aulast=Makarov+DV%2C+Desai+RA%2C+Yu+JB%2C+Sharma+R%2C+Abraham+N%2C+Albertsen+PC%2C+Penson+DF%2C+Gross+CP&amp;rft.au=Makarov+DV%2C+Desai+RA%2C+Yu+JB%2C+Sharma+R%2C+Abraham+N%2C+Albertsen+PC%2C+Penson+DF%2C+Gross+CP&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.juro.2011.09.042&amp;rft_id=info%3Apmid%2F22088337&amp;rft.issue=1&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.pages=97-102&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=187" class="Z3988"><span style="display:none;">&#160;</span></span></li>
<li><span class="citation web"><a href="/wiki/National_Comprehensive_Cancer_Network" title="National Comprehensive Cancer Network">National Comprehensive Cancer Network - Prostate</a> (2012). <a rel="nofollow" class="external text" href="http://www.nccn.org/professionals/physician_gls/f_guidelines.asp">"NCCN Clinical Practice Guidelines in Oncology"</a>. <i>nccn.org</i><span class="reference-accessdate">. Retrieved <span class="nowrap">15 November</span> 2012</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=NCCN+Clinical+Practice+Guidelines+in+Oncology&amp;rft.aulast=National+Comprehensive+Cancer+Network+-+Prostate&amp;rft.au=National+Comprehensive+Cancer+Network+-+Prostate&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fphysician_gls%2Ff_guidelines.asp&amp;rft.jtitle=nccn.org&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></li>
<li><span class="citation journal">Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen CM (2007). "Guideline for the management of clinically localized prostate cancer: 2007 update". <i>The Journal of Urology</i> <b>177</b> (6): 2106–31. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.juro.2007.03.003">10.1016/j.juro.2007.03.003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17509297">17509297</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Guideline+for+the+management+of+clinically+localized+prostate+cancer%3A+2007+update&amp;rft.aulast=Thompson+I%2C+Thrasher+JB%2C+Aus+G%2C+Burnett+AL%2C+Canby-Hagino+ED%2C+Cookson+MS%2C+D%27Amico+AV%2C+Dmochowski+RR%2C+Eton+DT%2C+Forman+JD%2C+Goldenberg+SL%2C+Hernandez+J%2C+Higano+CS%2C+Kraus+SR%2C+Moul+JW%2C+Tangen+CM&amp;rft.au=Thompson+I%2C+Thrasher+JB%2C+Aus+G%2C+Burnett+AL%2C+Canby-Hagino+ED%2C+Cookson+MS%2C+D%27Amico+AV%2C+Dmochowski+RR%2C+Eton+DT%2C+Forman+JD%2C+Goldenberg+SL%2C+Hernandez+J%2C+Higano+CS%2C+Kraus+SR%2C+Moul+JW%2C+Tangen+CM&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.juro.2007.03.003&amp;rft_id=info%3Apmid%2F17509297&amp;rft.issue=6&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.pages=2106-31&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=177" class="Z3988"><span style="display:none;">&#160;</span></span></li>
</ul>
</li>
<li id="cite_note-Masko2012-86"><span class="mw-cite-backlink">^ <a href="#cite_ref-Masko2012_86-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Masko2012_86-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Masko2012_86-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Masko2012_86-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Masko2012_86-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Masko EM, Allott EH, Freedland SJ (Nov 15, 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3597758">"The Relationship Between Nutrition and Prostate Cancer: Is More Always Better?"</a>. <i>European Urology</i> <b>63</b> (5): 810–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.eururo.2012.11.012">10.1016/j.eururo.2012.11.012</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3597758">3597758</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23219353">23219353</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=The+Relationship+Between+Nutrition+and+Prostate+Cancer%3A+Is+More+Always+Better%3F&amp;rft.aulast=Masko+EM%2C+Allott+EH%2C+Freedland+SJ&amp;rft.au=Masko+EM%2C+Allott+EH%2C+Freedland+SJ&amp;rft.date=Nov+15%2C+2012&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3597758&amp;rft_id=info%3Adoi%2F10.1016%2Fj.eururo.2012.11.012&amp;rft_id=info%3Apmc%2F3597758&amp;rft_id=info%3Apmid%2F23219353&amp;rft.issue=5&amp;rft.jtitle=European+Urology&amp;rft.pages=810-20&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=63" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><span class="citation journal">Thompson AK, Shaw DI, Minihane AM, Williams CM (Dec 2008). "Trans-fatty acids and cancer: the evidence reviewed". <i>Nutrition research reviews</i> <b>21</b> (2): 174–88. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1017%2FS0954422408110964">10.1017/S0954422408110964</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19087370">19087370</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Trans-fatty+acids+and+cancer%3A+the+evidence+reviewed&amp;rft.aulast=Thompson+AK%2C+Shaw+DI%2C+Minihane+AM%2C+Williams+CM&amp;rft.au=Thompson+AK%2C+Shaw+DI%2C+Minihane+AM%2C+Williams+CM&amp;rft.date=Dec+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1017%2FS0954422408110964&amp;rft_id=info%3Apmid%2F19087370&amp;rft.issue=2&amp;rft.jtitle=Nutrition+research+reviews&amp;rft.pages=174-88&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-88">^</a></b></span> <span class="reference-text"><span class="citation journal">Heinze VM, Actis AB (February 2012). "Dietary conjugated linoleic acid and long-chain n-3 fatty acids in mammary and prostate cancer protection: a review". <i>International journal of food sciences and nutrition</i> <b>63</b> (1): 66–78. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3109%2F09637486.2011.598849">10.3109/09637486.2011.598849</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21762028">21762028</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Dietary+conjugated+linoleic+acid+and+long-chain+n-3+fatty+acids+in+mammary+and+prostate+cancer+protection%3A+a+review&amp;rft.au=Heinze+VM%2C+Actis+AB&amp;rft.aulast=Heinze+VM%2C+Actis+AB&amp;rft.date=February+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3109%2F09637486.2011.598849&amp;rft_id=info%3Apmid%2F21762028&amp;rft.issue=1&amp;rft.jtitle=International+journal+of+food+sciences+and+nutrition&amp;rft.pages=66-78&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=63" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-89">^</a></b></span> <span class="reference-text"><span class="citation journal">Datta M, Schwartz GG (2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3448410">"Calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical review"</a>. <i>The oncologist</i> <b>17</b> (9): 1171–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1634%2Ftheoncologist.2012-0051">10.1634/theoncologist.2012-0051</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3448410">3448410</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22836449">22836449</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Calcium+and+vitamin+D+supplementation+during+androgen+deprivation+therapy+for+prostate+cancer%3A+a+critical+review&amp;rft.au=Datta+M%2C+Schwartz+GG&amp;rft.aulast=Datta+M%2C+Schwartz+GG&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3448410&amp;rft_id=info%3Adoi%2F10.1634%2Ftheoncologist.2012-0051&amp;rft_id=info%3Apmc%2F3448410&amp;rft_id=info%3Apmid%2F22836449&amp;rft.issue=9&amp;rft.jtitle=The+oncologist&amp;rft.pages=1171-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-90">^</a></b></span> <span class="reference-text"><span class="citation journal">Szymanski KM, Wheeler DC, Mucci LA (Nov 2010). "Fish consumption and prostate cancer risk: a review and meta-analysis". <i>The American journal of clinical nutrition</i> <b>92</b> (5): 1223–33. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3945%2Fajcn.2010.29530">10.3945/ajcn.2010.29530</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20844069">20844069</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Fish+consumption+and+prostate+cancer+risk%3A+a+review+and+meta-analysis&amp;rft.aulast=Szymanski+KM%2C+Wheeler+DC%2C+Mucci+LA&amp;rft.au=Szymanski+KM%2C+Wheeler+DC%2C+Mucci+LA&amp;rft.date=Nov+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3945%2Fajcn.2010.29530&amp;rft_id=info%3Apmid%2F20844069&amp;rft.issue=5&amp;rft.jtitle=The+American+journal+of+clinical+nutrition&amp;rft.pages=1223-33&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=92" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-91">^</a></b></span> <span class="reference-text"><span class="citation journal">American Dietetic Association and Dieticians of Canada (June 2003). "Position of the American Dietetic Association and Dietitians of Canada: Vegetarian diets". <i>Journal of the American Dietetic Association</i> <b>103</b> (6): 748–65. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fjada.2003.50142">10.1053/jada.2003.50142</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12778049">12778049</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Position+of+the+American+Dietetic+Association+and+Dietitians+of+Canada%3A+Vegetarian+diets&amp;rft.au=American+Dietetic+Association+and+Dieticians+of+Canada&amp;rft.aulast=American+Dietetic+Association+and+Dieticians+of+Canada&amp;rft.date=June+2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1053%2Fjada.2003.50142&amp;rft_id=info%3Apmid%2F12778049&amp;rft.issue=6&amp;rft.jtitle=Journal+of+the+American+Dietetic+Association&amp;rft.pages=748-65&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=103" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-WCR2007-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-WCR2007_92-0">^</a></b></span> <span class="reference-text"><span class="citation book">Research, World Cancer Research Fund&#160;; American Institute for Cancer (2007). <a rel="nofollow" class="external text" href="http://eprints.ucl.ac.uk/4841/1/4841.pdf"><i>Food, nutrition, physical activity, and the prevention of cancer a global perspective</i></a> <span style="font-size:85%;">(PDF)</span>. Washington, D.C.: American Institute for Cancer Research. p.&#160;76. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-9722522-2-5" title="Special:BookSources/978-0-9722522-2-5">978-0-9722522-2-5</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.aufirst=World+Cancer+Research+Fund+%3B+American+Institute+for+Cancer&amp;rft.aulast=Research&amp;rft.au=Research%2C+World+Cancer+Research+Fund+%3B+American+Institute+for+Cancer&amp;rft.btitle=Food%2C+nutrition%2C+physical+activity%2C+and+the+prevention+of+cancer+a+global+perspective&amp;rft.date=2007&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Feprints.ucl.ac.uk%2F4841%2F1%2F4841.pdf&amp;rft.isbn=978-0-9722522-2-5&amp;rft.pages=76&amp;rft.place=Washington%2C+D.C.&amp;rft.pub=American+Institute+for+Cancer+Research&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Cancer.org-93"><span class="mw-cite-backlink">^ <a href="#cite_ref-Cancer.org_93-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Cancer.org_93-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.org/acs/groups/cid/documents/webcontent/002577-pdf.pdf">"American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention"</a> <span style="font-size:85%;">(PDF)</span>. <i>Last Revised: 1/11/2012</i>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=American+Cancer+Society+Guidelines+on+Nutrition+and+Physical+Activity+for+Cancer+Prevention&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cancer.org%2Facs%2Fgroups%2Fcid%2Fdocuments%2Fwebcontent%2F002577-pdf.pdf&amp;rft.jtitle=Last+Revised%3A+1%2F11%2F2012&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18425978-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18425978_94-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Wilt TJ, MacDonald R, Hagerty K, Schellhammer P, Kramer BS (2008). Wilt, Timothy J, ed. "Five-alpha-reductase Inhibitors for prostate cancer prevention". <i>Cochrane Database Syst Rev</i> (2): CD007091. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD007091">10.1002/14651858.CD007091</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18425978">18425978</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Five-alpha-reductase+Inhibitors+for+prostate+cancer+prevention&amp;rft.aulast=Wilt+TJ%2C+MacDonald+R%2C+Hagerty+K%2C+Schellhammer+P%2C+Kramer+BS&amp;rft.au=Wilt+TJ%2C+MacDonald+R%2C+Hagerty+K%2C+Schellhammer+P%2C+Kramer+BS&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD007091&amp;rft_id=info%3Apmid%2F18425978&amp;rft.issue=2&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.pages=CD007091&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-PSA-20111012-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-PSA-20111012_95-0">^</a></b></span> <span class="reference-text"><span class="citation news">Marcione, Marilyn (12 October 2011). <a rel="nofollow" class="external text" href="http://apnews.excite.com/article/20111012/D9QAUS2O0.html">"Prostate testing's dark side: Men who were harmed"</a>. <a href="/wiki/Associated_Press" title="Associated Press">Associated Press</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2011-10-13</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.aufirst=Marilyn&amp;rft.aulast=Marcione&amp;rft.au=Marcione%2C+Marilyn&amp;rft.btitle=Prostate+testing%27s+dark+side%3A+Men+who+were+harmed&amp;rft.date=12+October+2011&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fapnews.excite.com%2Farticle%2F20111012%2FD9QAUS2O0.html&amp;rft.pub=Associated+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-96">^</a></b></span> <span class="reference-text"><span class="citation journal">Moyer VA, on behalf of the U.S. Preventive Services Task, Force (May 2012). "Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement". <i>Annals of Internal Medicine</i>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1059%2F0003-4819-157-2-201207170-00459">10.1059/0003-4819-157-2-201207170-00459</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22615453">22615453</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Screening+for+Prostate+Cancer%3A+U.S.+Preventive+Services+Task+Force+Recommendation+Statement&amp;rft.aulast=Moyer+VA%2C+on+behalf+of+the+U.S.+Preventive+Services+Task%2C+Force&amp;rft.au=Moyer+VA%2C+on+behalf+of+the+U.S.+Preventive+Services+Task%2C+Force&amp;rft.date=May+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1059%2F0003-4819-157-2-201207170-00459&amp;rft_id=info%3Apmid%2F22615453&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-USPSTF-20111007-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-USPSTF-20111007_97-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Chou R, Croswell JM, Dana T, Bougatsos C, Blazina I, Fu R, Gleitsmann K, Koenig HC, Lam C, Maltz A, Rugge JB, Lin K (December 2011). <a rel="nofollow" class="external text" href="http://www.uspreventiveservicestaskforce.org/uspstf12/prostate/prostateart.htm">"Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force"</a>. <i>Annals of Internal Medicine</i> <b>155</b> (11): 762–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1059%2F0003-4819-155-11-201112060-00375">10.1059/0003-4819-155-11-201112060-00375</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21984740">21984740</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Screening+for+prostate+cancer%3A+a+review+of+the+evidence+for+the+U.S.+Preventive+Services+Task+Force&amp;rft.au=Chou+R%2C+Croswell+JM%2C+Dana+T%2C+Bougatsos+C%2C+Blazina+I%2C+Fu+R%2C+Gleitsmann+K%2C+Koenig+HC%2C+Lam+C%2C+Maltz+A%2C+Rugge+JB%2C+Lin+K&amp;rft.aulast=Chou+R%2C+Croswell+JM%2C+Dana+T%2C+Bougatsos+C%2C+Blazina+I%2C+Fu+R%2C+Gleitsmann+K%2C+Koenig+HC%2C+Lam+C%2C+Maltz+A%2C+Rugge+JB%2C+Lin+K&amp;rft.date=December+2011&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.uspreventiveservicestaskforce.org%2Fuspstf12%2Fprostate%2Fprostateart.htm&amp;rft_id=info%3Adoi%2F10.1059%2F0003-4819-155-11-201112060-00375&amp;rft_id=info%3Apmid%2F21984740&amp;rft.issue=11&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.pages=762-71&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=155" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-CDC-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-CDC_98-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.cdc.gov/cancer/Prostate/basic_info/screening.htm">Prostate Cancer Screening</a> CDC, updated April 6, 2010</span></li>
<li id="cite_note-Qa2013-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-Qa2013_99-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Qaseem A, Barry MJ, Denberg TD, Owens DK, Shekelle P (April 2013). "Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians". <i>Annals of Internal Medicine</i> <b>158</b> (10): 761–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.7326%2F0003-4819-158-10-201305210-00633">10.7326/0003-4819-158-10-201305210-00633</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23567643">23567643</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Screening+for+Prostate+Cancer%3A+A+Guidance+Statement+From+the+Clinical+Guidelines+Committee+of+the+American+College+of+Physicians&amp;rft.aulast=Qaseem+A%2C+Barry+MJ%2C+Denberg+TD%2C+Owens+DK%2C+Shekelle+P&amp;rft.au=Qaseem+A%2C+Barry+MJ%2C+Denberg+TD%2C+Owens+DK%2C+Shekelle+P&amp;rft.date=April+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-158-10-201305210-00633&amp;rft_id=info%3Apmid%2F23567643&amp;rft.issue=10&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.pages=761-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=158" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-100">^</a></b></span> <span class="reference-text"><span class="citation journal">Basch E, Oliver TK, Vickers A, Thompson I, Kantoff P, Parnes H, Loblaw DA, Roth B, Williams J, Nam RK (Jul 16, 2012). <a rel="nofollow" class="external text" href="http://jco.ascopubs.org/content/early/2012/07/16/JCO.2012.43.3441.full.pdf">"Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion"</a> <span style="font-size:85%;">(PDF)</span>. <i>Journal of clinical oncology&#160;: official journal of the American Society of Clinical Oncology</i> <b>30</b> (24): 3020–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1200%2FJCO.2012.43.3441">10.1200/JCO.2012.43.3441</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3776923">3776923</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22802323">22802323</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Screening+for+Prostate+Cancer+With+Prostate-Specific+Antigen+Testing%3A+American+Society+of+Clinical+Oncology+Provisional+Clinical+Opinion&amp;rft.au=Basch+E%2C+Oliver+TK%2C+Vickers+A%2C+Thompson+I%2C+Kantoff+P%2C+Parnes+H%2C+Loblaw+DA%2C+Roth+B%2C+Williams+J%2C+Nam+RK&amp;rft.aulast=Basch+E%2C+Oliver+TK%2C+Vickers+A%2C+Thompson+I%2C+Kantoff+P%2C+Parnes+H%2C+Loblaw+DA%2C+Roth+B%2C+Williams+J%2C+Nam+RK&amp;rft.date=Jul+16%2C+2012&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjco.ascopubs.org%2Fcontent%2Fearly%2F2012%2F07%2F16%2FJCO.2012.43.3441.full.pdf&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2012.43.3441&amp;rft_id=info%3Apmc%2F3776923&amp;rft_id=info%3Apmid%2F22802323&amp;rft.issue=24&amp;rft.jtitle=Journal+of+clinical+oncology+%3A+official+journal+of+the+American+Society+of+Clinical+Oncology&amp;rft.pages=3020-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-101">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.auanet.org/education/guidelines/prostate-cancer-detection.cfm">"EARLY DETECTION OF PROSTATE CANCER: AUA GUIDELINE"</a>. <i>American Urological Association</i>. 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">10 May</span> 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=EARLY+DETECTION+OF+PROSTATE+CANCER%3A+AUA+GUIDELINE&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.auanet.org%2Feducation%2Fguidelines%2Fprostate-cancer-detection.cfm&amp;rft.jtitle=American+Urological+Association&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-102">^</a></b></span> <span class="reference-text"><span class="citation news">Kolata, Gina (21 November 2011). <a rel="nofollow" class="external text" href="http://www.nytimes.com/2011/11/22/health/cancer-by-any-other-name-would-not-be-as-terrifying.html">"‘Cancer’ or ‘Weird Cells’: Which Sounds Deadlier?"</a>. <i>The New York Times</i>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=%E2%80%98Cancer%E2%80%99+or+%E2%80%98Weird+Cells%E2%80%99%3A+Which+Sounds+Deadlier%3F&amp;rft.au=Kolata%2C+Gina&amp;rft.aulast=Kolata%2C+Gina&amp;rft.date=21+November+2011&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2011%2F11%2F22%2Fhealth%2Fcancer-by-any-other-name-would-not-be-as-terrifying.html&amp;rft.jtitle=The+New+York+Times&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-103">^</a></b></span> <span class="reference-text"><span class="citation journal">Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Barry MJ, Zietman A, O'Leary M, Walker-Corkery E, Yao SL (September 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2822438">"Outcomes of Localized Prostate Cancer Following Conservative Management"</a>. <i>The Journal of the American Medical Association</i> <b>302</b> (11): 1202–09. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Fjama.2009.1348">10.1001/jama.2009.1348</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2822438">2822438</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19755699">19755699</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Outcomes+of+Localized+Prostate+Cancer+Following+Conservative+Management&amp;rft.aulast=Lu-Yao+GL%2C+Albertsen+PC%2C+Moore+DF%2C+Shih+W%2C+Lin+Y%2C+DiPaola+RS%2C+Barry+MJ%2C+Zietman+A%2C+O%27Leary+M%2C+Walker-Corkery+E%2C+Yao+SL&amp;rft.au=Lu-Yao+GL%2C+Albertsen+PC%2C+Moore+DF%2C+Shih+W%2C+Lin+Y%2C+DiPaola+RS%2C+Barry+MJ%2C+Zietman+A%2C+O%27Leary+M%2C+Walker-Corkery+E%2C+Yao+SL&amp;rft.date=September+2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2822438&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2009.1348&amp;rft_id=info%3Apmc%2F2822438&amp;rft_id=info%3Apmid%2F19755699&amp;rft.issue=11&amp;rft.jtitle=The+Journal+of+the+American+Medical+Association&amp;rft.pages=1202-09&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=302" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19945664-104"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19945664_104-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Mongiat-Artus P, Peyromaure M, Richaud P, Droz JP, Rainfray M, Jeandel C, Rebillard X, Moreau JL, Davin JL, Salomon L, Soulié M (December 2009). "[Recommendations for the treatment of prostate cancer in the elderly man: A study by the oncology committee of the French association of urology]". <i>Prog. Urol.</i> (in French) <b>19</b> (11): 810–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.purol.2009.02.008">10.1016/j.purol.2009.02.008</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19945664">19945664</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=%5BRecommendations+for+the+treatment+of+prostate+cancer+in+the+elderly+man%3A+A+study+by+the+oncology+committee+of+the+French+association+of+urology%5D&amp;rft.aulast=Mongiat-Artus+P%2C+Peyromaure+M%2C+Richaud+P%2C+Droz+JP%2C+Rainfray+M%2C+Jeandel+C%2C+Rebillard+X%2C+Moreau+JL%2C+Davin+JL%2C+Salomon+L%2C+Souli%C3%A9+M&amp;rft.au=Mongiat-Artus+P%2C+Peyromaure+M%2C+Richaud+P%2C+Droz+JP%2C+Rainfray+M%2C+Jeandel+C%2C+Rebillard+X%2C+Moreau+JL%2C+Davin+JL%2C+Salomon+L%2C+Souli%C3%A9+M&amp;rft.date=December+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.purol.2009.02.008&amp;rft_id=info%3Apmid%2F19945664&amp;rft.issue=11&amp;rft.jtitle=Prog.+Urol.&amp;rft.pages=810-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19945310-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19945310_105-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Picard JC, Golshayan AR, Marshall DT, Opfermann KJ, Keane TE (November 2009). "The multi-disciplinary management of high-risk prostate cancer". <i>Urol. Oncol.</i> <b>30</b> (1): 3–15. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.urolonc.2009.09.002">10.1016/j.urolonc.2009.09.002</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19945310">19945310</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=The+multi-disciplinary+management+of+high-risk+prostate+cancer&amp;rft.aulast=Picard+JC%2C+Golshayan+AR%2C+Marshall+DT%2C+Opfermann+KJ%2C+Keane+TE&amp;rft.au=Picard+JC%2C+Golshayan+AR%2C+Marshall+DT%2C+Opfermann+KJ%2C+Keane+TE&amp;rft.date=November+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.urolonc.2009.09.002&amp;rft_id=info%3Apmid%2F19945310&amp;rft.issue=1&amp;rft.jtitle=Urol.+Oncol.&amp;rft.pages=3-15&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid21842788-106"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid21842788_106-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid21842788_106-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Mohan R, Schellhammer PF (August 2011). "Treatment options for localized prostate cancer". <i>Am Fam Physician</i> <b>84</b> (4): 413–20. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21842788">21842788</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Treatment+options+for+localized+prostate+cancer&amp;rft.aulast=Mohan+R%2C+Schellhammer+PF&amp;rft.au=Mohan+R%2C+Schellhammer+PF&amp;rft.date=August+2011&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F21842788&amp;rft.issue=4&amp;rft.jtitle=Am+Fam+Physician&amp;rft.pages=413-20&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=84" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16314889-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16314889_107-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Mouraviev V, Evans B, Polascik TJ (2006). "Salvage prostate cryoablation after primary interstitial brachytherapy failure: a feasible approach". <i>Prostate Cancer Prostatic Dis.</i> <b>9</b> (1): 99–101. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fsj.pcan.4500853">10.1038/sj.pcan.4500853</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16314889">16314889</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Salvage+prostate+cryoablation+after+primary+interstitial+brachytherapy+failure%3A+a+feasible+approach&amp;rft.aulast=Mouraviev+V%2C+Evans+B%2C+Polascik+TJ&amp;rft.au=Mouraviev+V%2C+Evans+B%2C+Polascik+TJ&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.pcan.4500853&amp;rft_id=info%3Apmid%2F16314889&amp;rft.issue=1&amp;rft.jtitle=Prostate+Cancer+Prostatic+Dis.&amp;rft.pages=99-101&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-108">^</a></b></span> <span class="reference-text"><span class="citation journal">Hegarty J, Beirne PV, Walsh E, Comber H, Fitzgerald T, Wallace Kazer M (Nov 10, 2010). Hegarty, Josephine, ed. "Radical prostatectomy versus watchful waiting for prostate cancer". <i>Cochrane database of systematic reviews (Online)</i> (11): CD006590. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD006590.pub2">10.1002/14651858.CD006590.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21069689">21069689</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Radical+prostatectomy+versus+watchful+waiting+for+prostate+cancer&amp;rft.au=Hegarty+J%2C+Beirne+PV%2C+Walsh+E%2C+Comber+H%2C+Fitzgerald+T%2C+Wallace+Kazer+M&amp;rft.aulast=Hegarty+J%2C+Beirne+PV%2C+Walsh+E%2C+Comber+H%2C+Fitzgerald+T%2C+Wallace+Kazer+M&amp;rft.date=Nov+10%2C+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD006590.pub2&amp;rft_id=info%3Apmid%2F21069689&amp;rft.issue=11&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.pages=CD006590&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-109"><span class="mw-cite-backlink"><b><a href="#cite_ref-109">^</a></b></span> <span class="reference-text"><span class="citation journal">de Jong, Y; Pinckaers, JH; Ten Brinck, RM; Lycklama À Nijeholt, AA; Dekkers, OM (2014). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4106761">"Urinating Standing versus Sitting: Position Is of Influence in Men with Prostate Enlargement. A Systematic Review and Meta-Analysis."</a>. <i>PLoS ONE</i> <b>9</b> (7): e101320. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1371%2Fjournal.pone.0101320">10.1371/journal.pone.0101320</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4106761">4106761</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25051345">25051345</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Urinating+Standing+versus+Sitting%3A+Position+Is+of+Influence+in+Men+with+Prostate+Enlargement.+A+Systematic+Review+and+Meta-Analysis.&amp;rft.au=de+Jong%2C+Y&amp;rft.au=Dekkers%2C+OM&amp;rft.aufirst=Y&amp;rft.aulast=de+Jong&amp;rft.au=Lycklama+%C3%80+Nijeholt%2C+AA&amp;rft.au=Pinckaers%2C+JH&amp;rft.au=Ten+Brinck%2C+RM&amp;rft.date=2014&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4106761&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0101320&amp;rft_id=info%3Apmc%2F4106761&amp;rft_id=info%3Apmid%2F25051345&amp;rft.issue=7&amp;rft.jtitle=PLoS+ONE&amp;rft.pages=e101320&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span> <a href="/wiki/Open_access" title="open access publication - free to read"><img alt="open access publication - free to read" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/8px-Open_Access_logo_PLoS_transparent.svg.png" width="8" height="13" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/12px-Open_Access_logo_PLoS_transparent.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/16px-Open_Access_logo_PLoS_transparent.svg.png 2x" data-file-width="640" data-file-height="1000" /></a></span></li>
<li id="cite_note-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-110">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.gov/ncicancerbulletin/041911/page2">"Active Surveillance May Be Preferred Option in Some Men with Prostate Cancer"</a>. Cancer.gov. 2011-04-19<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-08-29</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.btitle=Active+Surveillance+May+Be+Preferred+Option+in+Some+Men+with+Prostate+Cancer&amp;rft.date=2011-04-19&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fncicancerbulletin%2F041911%2Fpage2&amp;rft.pub=Cancer.gov&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19946787-111"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19946787_111-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hong H, Zhang Y, Sun J, Cai W (November 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2883014">"Positron emission tomography imaging of prostate cancer"</a>. <i>Amino Acids</i> <b>39</b> (1): 11–27. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs00726-009-0394-9">10.1007/s00726-009-0394-9</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2883014">2883014</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19946787">19946787</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Positron+emission+tomography+imaging+of+prostate+cancer&amp;rft.au=Hong+H%2C+Zhang+Y%2C+Sun+J%2C+Cai+W&amp;rft.aulast=Hong+H%2C+Zhang+Y%2C+Sun+J%2C+Cai+W&amp;rft.date=November+2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2883014&amp;rft_id=info%3Adoi%2F10.1007%2Fs00726-009-0394-9&amp;rft_id=info%3Apmc%2F2883014&amp;rft_id=info%3Apmid%2F19946787&amp;rft.issue=1&amp;rft.jtitle=Amino+Acids&amp;rft.pages=11-27&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=39" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19945663-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19945663_112-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Peyromaure M, Valéri A, Rebillard X, Beuzeboc P, Richaud P, Soulié M, Salomon L (December 2009). "[Characteristics of prostate cancer in men less than 50-year-old]". <i>Prog. Urol.</i> (in French) <b>19</b> (11): 803–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.purol.2009.04.010">10.1016/j.purol.2009.04.010</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19945663">19945663</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=%5BCharacteristics+of+prostate+cancer+in+men+less+than+50-year-old%5D&amp;rft.aulast=Peyromaure+M%2C+Val%C3%A9ri+A%2C+Rebillard+X%2C+Beuzeboc+P%2C+Richaud+P%2C+Souli%C3%A9+M%2C+Salomon+L&amp;rft.au=Peyromaure+M%2C+Val%C3%A9ri+A%2C+Rebillard+X%2C+Beuzeboc+P%2C+Richaud+P%2C+Souli%C3%A9+M%2C+Salomon+L&amp;rft.date=December+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.purol.2009.04.010&amp;rft_id=info%3Apmid%2F19945663&amp;rft.issue=11&amp;rft.jtitle=Prog.+Urol.&amp;rft.pages=803-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-113"><span class="mw-cite-backlink"><b><a href="#cite_ref-113">^</a></b></span> <span class="reference-text"><span class="citation journal">Fitzpatrick JM (2008). "Management of localized prostate cancer in senior adults: the crucial role of comorbidity". <i>BJU international</i>. 101 Suppl 2: 16–22. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1464-410X.2007.07487.x">10.1111/j.1464-410X.2007.07487.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18307688">18307688</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Management+of+localized+prostate+cancer+in+senior+adults%3A+the+crucial+role+of+comorbidity&amp;rft.au=Fitzpatrick+JM&amp;rft.aulast=Fitzpatrick+JM&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1464-410X.2007.07487.x&amp;rft_id=info%3Apmid%2F18307688&amp;rft.jtitle=BJU+international&amp;rft.pages=16-22&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=101+Suppl+2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-114">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.nccn.org/index.asp">"Evidence-Based Cancer Guidelines, Oncology Drug Compendium, Oncology Continuing Medical Education"</a>. NCCN<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-08-29</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.btitle=Evidence-Based+Cancer+Guidelines%2C+Oncology+Drug+Compendium%2C+Oncology+Continuing+Medical+Education&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.nccn.org%2Findex.asp&amp;rft.pub=NCCN&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-115">^</a></b></span> <span class="reference-text"><span class="citation journal">Hammerstrom AE, Cauley DH, Atkinson BJ, Sharma P (August 2011). "Cancer immunotherapy: sipuleucel-T and beyond". <i>Pharmacotherapy</i> <b>31</b> (8): 813–28. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1592%2Fphco.31.8.813">10.1592/phco.31.8.813</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21923608">21923608</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Cancer+immunotherapy%3A+sipuleucel-T+and+beyond&amp;rft.au=Hammerstrom+AE%2C+Cauley+DH%2C+Atkinson+BJ%2C+Sharma+P&amp;rft.aulast=Hammerstrom+AE%2C+Cauley+DH%2C+Atkinson+BJ%2C+Sharma+P&amp;rft.date=August+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1592%2Fphco.31.8.813&amp;rft_id=info%3Apmid%2F21923608&amp;rft.issue=8&amp;rft.jtitle=Pharmacotherapy&amp;rft.pages=813-28&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20859283-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20859283_116-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Seruga B, Ocana A, Tannock IF (January 2011). "Drug resistance in metastatic castration-resistant prostate cancer". <i>Nature Reviews Clinical Oncology</i> <b>8</b> (1): 12–23. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fnrclinonc.2010.136">10.1038/nrclinonc.2010.136</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20859283">20859283</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Drug+resistance+in+metastatic+castration-resistant+prostate+cancer&amp;rft.aulast=Seruga+B%2C+Ocana+A%2C+Tannock+IF&amp;rft.au=Seruga+B%2C+Ocana+A%2C+Tannock+IF&amp;rft.date=January+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fnrclinonc.2010.136&amp;rft_id=info%3Apmid%2F20859283&amp;rft.issue=1&amp;rft.jtitle=Nature+Reviews+Clinical+Oncology&amp;rft.pages=12-23&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-117">^</a></b></span> <span class="reference-text"><span class="citation web">Clarke NW (c. 2005). <a rel="nofollow" class="external text" href="http://www.nice.org.uk/nicemedia/live/11577/33321/33321.pdf">"Docetaxel for the Treatment of Hormone Refractory Prostate Cancer"</a> <span style="font-size:85%;">(PDF)</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.au=Clarke+NW&amp;rft.aulast=Clarke+NW&amp;rft.btitle=Docetaxel+for+the+Treatment+of+Hormone+Refractory+Prostate+Cancer&amp;rft.date=c.+2005&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.nice.org.uk%2Fnicemedia%2Flive%2F11577%2F33321%2F33321.pdf&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlProstate_cancer_.28hormone-refractory.29_-_docetaxel-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlProstate_cancer_.28hormone-refractory.29_-_docetaxel_118-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.nice.org.uk/TA101">"Prostate cancer (hormone-refractory) - docetaxel"</a>. National Institute for Health and Clinical Excellence. 2010-12-10<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-07-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.btitle=Prostate+cancer+%28hormone-refractory%29+-+docetaxel&amp;rft.date=2010-12-10&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.nice.org.uk%2FTA101&amp;rft.pub=National+Institute+for+Health+and+Clinical+Excellence&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20888992-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20888992_119-0">^</a></b></span> <span class="reference-text"><span class="citation journal">de Bono JS, Oudard S, Ozguroglu M, Hansen S, Machiels JP, Kocak I, Gravis G, Bodrogi I, Mackenzie MJ, Shen L, Roessner M, Gupta S, Sartor AO (October 2010). "Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial". <i>Lancet</i> <b>376</b> (9747): 1147–54. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2810%2961389-X">10.1016/S0140-6736(10)61389-X</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20888992">20888992</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Prednisone+plus+cabazitaxel+or+mitoxantrone+for+metastatic+castration-resistant+prostate+cancer+progressing+after+docetaxel+treatment%3A+a+randomised+open-label+trial&amp;rft.au=de+Bono+JS%2C+Oudard+S%2C+Ozguroglu+M%2C+Hansen+S%2C+Machiels+JP%2C+Kocak+I%2C+Gravis+G%2C+Bodrogi+I%2C+Mackenzie+MJ%2C+Shen+L%2C+Roessner+M%2C+Gupta+S%2C+Sartor+AO&amp;rft.aulast=de+Bono+JS%2C+Oudard+S%2C+Ozguroglu+M%2C+Hansen+S%2C+Machiels+JP%2C+Kocak+I%2C+Gravis+G%2C+Bodrogi+I%2C+Mackenzie+MJ%2C+Shen+L%2C+Roessner+M%2C+Gupta+S%2C+Sartor+AO&amp;rft.date=October+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2810%2961389-X&amp;rft_id=info%3Apmid%2F20888992&amp;rft.issue=9747&amp;rft.jtitle=Lancet&amp;rft.pages=1147-54&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=376" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-120">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://professional.cancerconsultants.com/oncology_main_news.aspx?id=44815">"Avastin, Thalomid, Taxotere, and Prednisone Effective for Men with Hormone Refractory Prostate Cancer"</a>. March 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">10 May</span> 2010</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.btitle=Avastin%2C+Thalomid%2C+Taxotere%2C+and+Prednisone+Effective+for+Men+with+Hormone+Refractory+Prostate+Cancer&amp;rft.date=March+2010&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fprofessional.cancerconsultants.com%2Foncology_main_news.aspx%3Fid%3D44815&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20818862-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20818862_121-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF (July 2010). "Sipuleucel-T immunotherapy for castration-resistant prostate cancer". <i>N. Engl. J. Med.</i> <b>363</b> (5): 411–22. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa1001294">10.1056/NEJMoa1001294</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20818862">20818862</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Sipuleucel-T+immunotherapy+for+castration-resistant+prostate+cancer&amp;rft.au=Kantoff+PW%2C+Higano+CS%2C+Shore+ND%2C+Berger+ER%2C+Small+EJ%2C+Penson+DF%2C+Redfern+CH%2C+Ferrari+AC%2C+Dreicer+R%2C+Sims+RB%2C+Xu+Y%2C+Frohlich+MW%2C+Schellhammer+PF&amp;rft.aulast=Kantoff+PW%2C+Higano+CS%2C+Shore+ND%2C+Berger+ER%2C+Small+EJ%2C+Penson+DF%2C+Redfern+CH%2C+Ferrari+AC%2C+Dreicer+R%2C+Sims+RB%2C+Xu+Y%2C+Frohlich+MW%2C+Schellhammer+PF&amp;rft.date=July+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1001294&amp;rft_id=info%3Apmid%2F20818862&amp;rft.issue=5&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=411-22&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=363" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-122">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm253055.htm">"FDA approves Zytiga for late-stage prostate cancer"</a>. U.S. Food and Drug Administration. 2011-04-28.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.btitle=FDA+approves+Zytiga+for+late-stage+prostate+cancer&amp;rft.date=2011-04-28&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm253055.htm&amp;rft.pub=U.S.+Food+and+Drug+Administration&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Xtandi-1-123"><span class="mw-cite-backlink">^ <a href="#cite_ref-Xtandi-1_123-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Xtandi-1_123-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm317838.htm">"FDA approves new treatment for a type of late stage prostate cancer"</a>. <i>press release</i>. United States Food and Drug Administration. 2012-08-31.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=FDA+approves+new+treatment+for+a+type+of+late+stage+prostate+cancer&amp;rft.date=2012-08-31&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm317838.htm&amp;rft.jtitle=press+release&amp;rft.pub=United+States+Food+and+Drug+Administration&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Xtandi-2-124"><span class="mw-cite-backlink">^ <a href="#cite_ref-Xtandi-2_124-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Xtandi-2_124-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation web">Anna Azvolinsky (September 4, 2012). <a rel="nofollow" class="external text" href="http://www.cancernetwork.com/prostate-cancer/content/article/10165/2099887">"FDA Approves Enzalutamide (Xtandi) for Late-Stage Prostate Cancer"</a>. CancerNetwork.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.au=Anna+Azvolinsky&amp;rft.aulast=Anna+Azvolinsky&amp;rft.btitle=FDA+Approves+Enzalutamide+%28Xtandi%29+for+Late-Stage+Prostate+Cancer&amp;rft.date=September+4%2C+2012&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancernetwork.com%2Fprostate-cancer%2Fcontent%2Farticle%2F10165%2F2099887&amp;rft.pub=CancerNetwork&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-125"><span class="mw-cite-backlink"><b><a href="#cite_ref-125">^</a></b></span> <span class="reference-text"><span class="citation journal">Qin J, Liu X, Laffin B, Chen X, Choy G, Jeter CR, Calhoun-Davis T, Li H, Palapattu GS, Pang S, Lin K, Huang J, Ivanov I, Li W, Suraneni MV, Tang DG (2012). <a rel="nofollow" class="external text" href="http://www.cell.com/cell-stem-cell/abstract/S1934-5909(12)00126-9?script=true">"The PSA−/lo Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist Castration"</a>. <i>Cell Stem Cell</i> <b>10</b> (5): 556–69. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.stem.2012.03.009">10.1016/j.stem.2012.03.009</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3348510">3348510</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22560078">22560078</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=The+PSA%E2%88%92%2Flo+Prostate+Cancer+Cell+Population+Harbors+Self-Renewing+Long-Term+Tumor-Propagating+Cells+that+Resist+Castration&amp;rft.aulast=Qin+J%2C+Liu+X%2C+Laffin+B%2C+Chen+X%2C+Choy+G%2C+Jeter+CR%2C+Calhoun-Davis+T%2C+Li+H%2C+Palapattu+GS%2C+Pang+S%2C+Lin+K%2C+Huang+J%2C+Ivanov+I%2C+Li+W%2C+Suraneni+MV%2C+Tang+DG&amp;rft.au=Qin+J%2C+Liu+X%2C+Laffin+B%2C+Chen+X%2C+Choy+G%2C+Jeter+CR%2C+Calhoun-Davis+T%2C+Li+H%2C+Palapattu+GS%2C+Pang+S%2C+Lin+K%2C+Huang+J%2C+Ivanov+I%2C+Li+W%2C+Suraneni+MV%2C+Tang+DG&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cell.com%2Fcell-stem-cell%2Fabstract%2FS1934-5909%2812%2900126-9%3Fscript%3Dtrue&amp;rft_id=info%3Adoi%2F10.1016%2Fj.stem.2012.03.009&amp;rft_id=info%3Apmc%2F3348510&amp;rft_id=info%3Apmid%2F22560078&amp;rft.issue=5&amp;rft.jtitle=Cell+Stem+Cell&amp;rft.pages=556-69&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-126"><span class="mw-cite-backlink"><b><a href="#cite_ref-126">^</a></b></span> <span class="reference-text"><span class="citation journal">Maitland NJ, Collins AT (2008). <a rel="nofollow" class="external text" href="http://jco.ascopubs.org/content/26/17/2862.short">"Prostate cancer stem cells—a new target for therapy"</a>. <i>Journal of Clinical Oncology</i> <b>26</b> (17): 2862–70. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1200%2FJCO.2007.15.1472">10.1200/JCO.2007.15.1472</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18539965">18539965</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Prostate+cancer+stem+cells%E2%80%94a+new+target+for+therapy&amp;rft.aulast=Maitland+NJ%2C+Collins+AT&amp;rft.au=Maitland+NJ%2C+Collins+AT&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjco.ascopubs.org%2Fcontent%2F26%2F17%2F2862.short&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2007.15.1472&amp;rft_id=info%3Apmid%2F18539965&amp;rft.issue=17&amp;rft.jtitle=Journal+of+Clinical+Oncology&amp;rft.pages=2862-70&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=26" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-127"><span class="mw-cite-backlink"><b><a href="#cite_ref-127">^</a></b></span> <span class="reference-text"><span class="citation journal">Attard G, Richards J, de Bono JS (2011). <a rel="nofollow" class="external text" href="http://clincancerres.aacrjournals.org/content/17/7/1649.long">"New strategies in metastatic prostate cancer: targeting the androgen receptor signaling pathway"</a>. <i>Clinical Cancer Research</i> <b>17</b> (7): 1649–57. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1158%2F1078-0432.CCR-10-0567">10.1158/1078-0432.CCR-10-0567</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3513706">3513706</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21372223">21372223</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=New+strategies+in+metastatic+prostate+cancer%3A+targeting+the+androgen+receptor+signaling+pathway&amp;rft.au=Attard+G%2C+Richards+J%2C+de+Bono+JS&amp;rft.aulast=Attard+G%2C+Richards+J%2C+de+Bono+JS&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fclincancerres.aacrjournals.org%2Fcontent%2F17%2F7%2F1649.long&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-10-0567&amp;rft_id=info%3Apmc%2F3513706&amp;rft_id=info%3Apmid%2F21372223&amp;rft.issue=7&amp;rft.jtitle=Clinical+Cancer+Research&amp;rft.pages=1649-57&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Rane2012-128"><span class="mw-cite-backlink"><b><a href="#cite_ref-Rane2012_128-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rane JK, Pellacani D, Maitland NJ (2012). <a rel="nofollow" class="external text" href="http://www.nature.com/nrurol/journal/vaop/ncurrent/full/nrurol.2012.157.html">"Advanced prostate cancer—a case for adjuvant differentiation therapy"</a>. <i>Nature Reviews Urology</i> <b>9</b> (10): 595–602. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fnrurol.2012.157">10.1038/nrurol.2012.157</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22890299">22890299</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Advanced+prostate+cancer%E2%80%94a+case+for+adjuvant+differentiation+therapy&amp;rft.aulast=Rane+JK%2C+Pellacani+D%2C+Maitland+NJ&amp;rft.au=Rane+JK%2C+Pellacani+D%2C+Maitland+NJ&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nature.com%2Fnrurol%2Fjournal%2Fvaop%2Fncurrent%2Ffull%2Fnrurol.2012.157.html&amp;rft_id=info%3Adoi%2F10.1038%2Fnrurol.2012.157&amp;rft_id=info%3Apmid%2F22890299&amp;rft.issue=10&amp;rft.jtitle=Nature+Reviews+Urology&amp;rft.pages=595-602&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-129"><span class="mw-cite-backlink"><b><a href="#cite_ref-129">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.org/treatment/treatmentsandsideeffects/palliativecare/index">"Palliative or Supportive Care"</a>. American Cancer Society<span class="reference-accessdate">. Retrieved <span class="nowrap">20 August</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.btitle=Palliative+or+Supportive+Care&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.org%2Ftreatment%2Ftreatmentsandsideeffects%2Fpalliativecare%2Findex&amp;rft.pub=American+Cancer+Society&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-130"><span class="mw-cite-backlink"><b><a href="#cite_ref-130">^</a></b></span> <span class="reference-text"><span class="citation journal">Thompson, JC; Wood, J; Feuer, D (2007). "Prostate cancer: palliative care and pain relief.". <i>British medical bulletin</i> <b>83</b>: 341–54. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fbmb%2Fldm018">10.1093/bmb/ldm018</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17628024">17628024</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Prostate+cancer%3A+palliative+care+and+pain+relief.&amp;rft.au=Feuer%2C+D&amp;rft.aufirst=JC&amp;rft.aulast=Thompson&amp;rft.au=Thompson%2C+JC&amp;rft.au=Wood%2C+J&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fbmb%2Fldm018&amp;rft_id=info%3Apmid%2F17628024&amp;rft.jtitle=British+medical+bulletin&amp;rft.pages=341-54&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=83" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-131"><span class="mw-cite-backlink"><b><a href="#cite_ref-131">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.cancer.org/docroot/CRI/content/CRI_2_4_2X_What_are_the_risk_factors_for_prostate_cancer_36.asp">ACS&#160;:: What Are The Risk Factors for Prostate Cancer?</a><sup class="noprint Inline-Template"><span style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Link_rot" title="Wikipedia:Link rot"><span title="&#160;since August 2011">dead link</span></a></i>]</span></sup></span></li>
<li id="cite_note-pmid15714967-132"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15714967_132-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Wakai K (February 2005). "[Descriptive epidemiology of prostate cancer in Japan and Western countries]". <i>Nippon Rinsho</i> (in Japanese) <b>63</b> (2): 207–12. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15714967">15714967</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=%5BDescriptive+epidemiology+of+prostate+cancer+in+Japan+and+Western+countries%5D&amp;rft.aulast=Wakai+K&amp;rft.au=Wakai+K&amp;rft.date=February+2005&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F15714967&amp;rft.issue=2&amp;rft.jtitle=Nippon+Rinsho&amp;rft.pages=207-12&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=63" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid1259345-133"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid1259345_133-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Jaubert de Beaujeu M, Chavrier Y (January 1976). "[Deformations of the anterior thoracic wall (author's transl)]". <i>Ann Chir Thorac Cardiovasc</i> (in French) <b>15</b> (1): 1–6. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1259345">1259345</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=%5BDeformations+of+the+anterior+thoracic+wall+%28author%27s+transl%29%5D&amp;rft.au=Jaubert+de+Beaujeu+M%2C+Chavrier+Y&amp;rft.aulast=Jaubert+de+Beaujeu+M%2C+Chavrier+Y&amp;rft.date=January+1976&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F1259345&amp;rft.issue=1&amp;rft.jtitle=Ann+Chir+Thorac+Cardiovasc&amp;rft.pages=1-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid10585584-134"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10585584_134-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hsing AW, Tsao L, Devesa SS (January 2000). "International trends and patterns of prostate cancer incidence and mortality". <i>Int. J. Cancer</i> <b>85</b> (1): 60–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F%28SICI%291097-0215%2820000101%2985%3A1%3C60%3A%3AAID-IJC11%3E3.0.CO%3B2-B">10.1002/(SICI)1097-0215(20000101)85:1&lt;60::AID-IJC11&gt;3.0.CO;2-B</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10585584">10585584</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=International+trends+and+patterns+of+prostate+cancer+incidence+and+mortality&amp;rft.au=Hsing+AW%2C+Tsao+L%2C+Devesa+SS&amp;rft.aulast=Hsing+AW%2C+Tsao+L%2C+Devesa+SS&amp;rft.date=January+2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291097-0215%2820000101%2985%3A1%3C60%3A%3AAID-IJC11%3E3.0.CO%3B2-B&amp;rft_id=info%3Apmid%2F10585584&amp;rft.issue=1&amp;rft.jtitle=Int.+J.+Cancer&amp;rft.pages=60-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=85" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9120935-135"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9120935_135-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Osegbe DN (April 1997). "Prostate cancer in Nigerians: facts and nonfacts". <i>J. Urol.</i> <b>157</b> (4): 1340–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0022-5347%2801%2964966-8">10.1016/S0022-5347(01)64966-8</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9120935">9120935</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Prostate+cancer+in+Nigerians%3A+facts+and+nonfacts&amp;rft.aulast=Osegbe+DN&amp;rft.au=Osegbe+DN&amp;rft.date=April+1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0022-5347%2801%2964966-8&amp;rft_id=info%3Apmid%2F9120935&amp;rft.issue=4&amp;rft.jtitle=J.+Urol.&amp;rft.pages=1340-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=157" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid14571407-136"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid14571407_136-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Di Blasio CJ, Rhee AC, Cho D, Scardino PT, Kattan MW (October 2003). "Predicting clinical end points: treatment nomograms in prostate cancer". <i>Semin. Oncol.</i> <b>30</b> (5): 567–86. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0093-7754%2803%2900351-8">10.1016/S0093-7754(03)00351-8</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14571407">14571407</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Predicting+clinical+end+points%3A+treatment+nomograms+in+prostate+cancer&amp;rft.au=Di+Blasio+CJ%2C+Rhee+AC%2C+Cho+D%2C+Scardino+PT%2C+Kattan+MW&amp;rft.aulast=Di+Blasio+CJ%2C+Rhee+AC%2C+Cho+D%2C+Scardino+PT%2C+Kattan+MW&amp;rft.date=October+2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0093-7754%2803%2900351-8&amp;rft_id=info%3Apmid%2F14571407&amp;rft.issue=5&amp;rft.jtitle=Semin.+Oncol.&amp;rft.pages=567-86&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-137"><span class="mw-cite-backlink"><b><a href="#cite_ref-137">^</a></b></span> <span class="reference-text"><span class="citation journal">Huggins C, Steven RE, Hodges CV (1941). "Studies on prostatic cancer". <i>Arch. Surg.</i> <b>43</b> (2): 209–223. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Farchsurg.1941.01210140043004">10.1001/archsurg.1941.01210140043004</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Studies+on+prostatic+cancer&amp;rft.au=Huggins+C%2C+Steven+RE%2C+Hodges+CV&amp;rft.aulast=Huggins+C%2C+Steven+RE%2C+Hodges+CV&amp;rft.date=1941&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Farchsurg.1941.01210140043004&amp;rft.issue=2&amp;rft.jtitle=Arch.+Surg.&amp;rft.pages=209-223&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=43" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-138"><span class="mw-cite-backlink"><b><a href="#cite_ref-138">^</a></b></span> <span class="reference-text"><span class="citation journal">Hellerstedt BA, Pienta KJ (2002). "The current state of hormonal therapy for prostate cancer". <i>CA Cancer J Clin</i> <b>52</b> (3): 154–79. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3322%2Fcanjclin.52.3.154">10.3322/canjclin.52.3.154</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12018929">12018929</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=The+current+state+of+hormonal+therapy+for+prostate+cancer&amp;rft.au=Hellerstedt+BA%2C+Pienta+KJ&amp;rft.aulast=Hellerstedt+BA%2C+Pienta+KJ&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3322%2Fcanjclin.52.3.154&amp;rft_id=info%3Apmid%2F12018929&amp;rft.issue=3&amp;rft.jtitle=CA+Cancer+J+Clin&amp;rft.pages=154-79&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=52" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-139"><span class="mw-cite-backlink"><b><a href="#cite_ref-139">^</a></b></span> <span class="reference-text"><span class="citation journal">Feldman BJ, Feldman D (October 2001). "The development of androgen-independent prostate cancer". <i>Nature Reviews Cancer</i> <b>1</b> (1): 34–45. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2F35094009">10.1038/35094009</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11900250">11900250</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=The+development+of+androgen-independent+prostate+cancer&amp;rft.au=Feldman+BJ%2C+Feldman+D&amp;rft.aulast=Feldman+BJ%2C+Feldman+D&amp;rft.date=October+2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2F35094009&amp;rft_id=info%3Apmid%2F11900250&amp;rft.issue=1&amp;rft.jtitle=Nature+Reviews+Cancer&amp;rft.pages=34-45&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-140"><span class="mw-cite-backlink"><b><a href="#cite_ref-140">^</a></b></span> <span class="reference-text"><span class="citation journal">Eifler J. B., Feng Z., Lin B. M., Partin M. T., Humphreys E. B., Han M., Epstein J. I., Walsh P. C., Trock B. J. et al. (2013). <a rel="nofollow" class="external text" href="http://onlinelibrary.wiley.com/doi/10.1111/j.1464-410X.2012.11324.x/full">"An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011"</a>. <i>BJU International</i> <b>111</b>: 22–29. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1464-410X.2012.11324.x">10.1111/j.1464-410X.2012.11324.x</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=An+updated+prostate+cancer+staging+nomogram+%28Partin+tables%29+based+on+cases+from+2006+to+2011&amp;rft.au=Eifler+J.+B.%2C+Feng+Z.%2C+Lin+B.+M.%2C+Partin+M.+T.%2C+Humphreys+E.+B.%2C+Han+M.%2C+Epstein+J.+I.%2C+Walsh+P.+C.%2C+Trock+B.+J.&amp;rft.aulast=Eifler+J.+B.%2C+Feng+Z.%2C+Lin+B.+M.%2C+Partin+M.+T.%2C+Humphreys+E.+B.%2C+Han+M.%2C+Epstein+J.+I.%2C+Walsh+P.+C.%2C+Trock+B.+J.&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1111%2Fj.1464-410X.2012.11324.x%2Ffull&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1464-410X.2012.11324.x&amp;rft.jtitle=BJU+International&amp;rft.pages=22-29&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=111" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-141"><span class="mw-cite-backlink"><b><a href="#cite_ref-141">^</a></b></span> <span class="reference-text"><span class="citation journal">Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll PR (June 2005). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2948569">"The UCSF Cancer of the Prostate Risk Assessment (CAPRA) Score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy"</a>. <i>J. Urol.</i> <b>173</b> (6): 1938–42. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F01.ju.0000158155.33890.e7">10.1097/01.ju.0000158155.33890.e7</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2948569">2948569</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15879786">15879786</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=The+UCSF+Cancer+of+the+Prostate+Risk+Assessment+%28CAPRA%29+Score%3A+a+straightforward+and+reliable+preoperative+predictor+of+disease+recurrence+after+radical+prostatectomy&amp;rft.au=Cooperberg+MR%2C+Pasta+DJ%2C+Elkin+EP%2C+Litwin+MS%2C+Latini+DM%2C+Du+Chane+J%2C+Carroll+PR&amp;rft.aulast=Cooperberg+MR%2C+Pasta+DJ%2C+Elkin+EP%2C+Litwin+MS%2C+Latini+DM%2C+Du+Chane+J%2C+Carroll+PR&amp;rft.date=June+2005&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2948569&amp;rft_id=info%3Adoi%2F10.1097%2F01.ju.0000158155.33890.e7&amp;rft_id=info%3Apmc%2F2948569&amp;rft_id=info%3Apmid%2F15879786&amp;rft.issue=6&amp;rft.jtitle=J.+Urol.&amp;rft.pages=1938-42&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=173" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-142"><span class="mw-cite-backlink"><b><a href="#cite_ref-142">^</a></b></span> <span class="reference-text"><span class="citation journal">Cooperberg MR, Freedland SJ, Pasta DJ, Elkin EP, Presti JC, Amling CL, Terris MK, Aronson WJ, Kane CJ, Carroll PR (November 2006). "Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy". <i>Cancer</i> <b>107</b> (10): 2384–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fcncr.22262">10.1002/cncr.22262</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17039503">17039503</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Multiinstitutional+validation+of+the+UCSF+cancer+of+the+prostate+risk+assessment+for+prediction+of+recurrence+after+radical+prostatectomy&amp;rft.au=Cooperberg+MR%2C+Freedland+SJ%2C+Pasta+DJ%2C+Elkin+EP%2C+Presti+JC%2C+Amling+CL%2C+Terris+MK%2C+Aronson+WJ%2C+Kane+CJ%2C+Carroll+PR&amp;rft.aulast=Cooperberg+MR%2C+Freedland+SJ%2C+Pasta+DJ%2C+Elkin+EP%2C+Presti+JC%2C+Amling+CL%2C+Terris+MK%2C+Aronson+WJ%2C+Kane+CJ%2C+Carroll+PR&amp;rft.date=November+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fcncr.22262&amp;rft_id=info%3Apmid%2F17039503&amp;rft.issue=10&amp;rft.jtitle=Cancer&amp;rft.pages=2384-91&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=107" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-143"><span class="mw-cite-backlink"><b><a href="#cite_ref-143">^</a></b></span> <span class="reference-text"><span class="citation journal">May M, Knoll N, Siegsmund M, Fahlenkamp D, Vogler H, Hoschke B, Gralla O (November 2007). "Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients". <i>J. Urol.</i> <b>178</b> (5): 1957–62; discussion 1962. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.juro.2007.07.043">10.1016/j.juro.2007.07.043</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17868719">17868719</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Validity+of+the+CAPRA+score+to+predict+biochemical+recurrence-free+survival+after+radical+prostatectomy.+Results+from+a+european+multicenter+survey+of+1%2C296+patients&amp;rft.aulast=May+M%2C+Knoll+N%2C+Siegsmund+M%2C+Fahlenkamp+D%2C+Vogler+H%2C+Hoschke+B%2C+Gralla+O&amp;rft.au=May+M%2C+Knoll+N%2C+Siegsmund+M%2C+Fahlenkamp+D%2C+Vogler+H%2C+Hoschke+B%2C+Gralla+O&amp;rft.date=November+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.juro.2007.07.043&amp;rft_id=info%3Apmid%2F17868719&amp;rft.issue=5&amp;rft.jtitle=J.+Urol.&amp;rft.pages=1957-62%3B+discussion+1962&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=178" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-144"><span class="mw-cite-backlink"><b><a href="#cite_ref-144">^</a></b></span> <span class="reference-text"><span class="citation journal">Zhao KH, Hernandez DJ, Han M, Humphreys EB, Mangold LA, Partin AW (August 2008). "External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment score". <i>Urology</i> <b>72</b> (2): 396–400. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.urology.2007.11.165">10.1016/j.urology.2007.11.165</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18372031">18372031</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=External+validation+of+University+of+California%2C+San+Francisco%2C+Cancer+of+the+Prostate+Risk+Assessment+score&amp;rft.aulast=Zhao+KH%2C+Hernandez+DJ%2C+Han+M%2C+Humphreys+EB%2C+Mangold+LA%2C+Partin+AW&amp;rft.au=Zhao+KH%2C+Hernandez+DJ%2C+Han+M%2C+Humphreys+EB%2C+Mangold+LA%2C+Partin+AW&amp;rft.date=August+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.urology.2007.11.165&amp;rft_id=info%3Apmid%2F18372031&amp;rft.issue=2&amp;rft.jtitle=Urology&amp;rft.pages=396-400&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=72" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19509351-145"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19509351_145-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Cooperberg MR, Broering JM, Carroll PR (June 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2697208">"Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of Diagnosis"</a>. <i>J. Natl. Cancer Inst.</i> <b>101</b> (12): 878–87. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fjnci%2Fdjp122">10.1093/jnci/djp122</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2697208">2697208</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19509351">19509351</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Risk+Assessment+for+Prostate+Cancer+Metastasis+and+Mortality+at+the+Time+of+Diagnosis&amp;rft.au=Cooperberg+MR%2C+Broering+JM%2C+Carroll+PR&amp;rft.aulast=Cooperberg+MR%2C+Broering+JM%2C+Carroll+PR&amp;rft.date=June+2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2697208&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2Fdjp122&amp;rft_id=info%3Apmc%2F2697208&amp;rft_id=info%3Apmid%2F19509351&amp;rft.issue=12&amp;rft.jtitle=J.+Natl.+Cancer+Inst.&amp;rft.pages=878-87&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=101" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-146"><span class="mw-cite-backlink"><b><a href="#cite_ref-146">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.cdc.gov/nchs/fastats/prostate.htm">http://www.cdc.gov/nchs/fastats/prostate.htm</a></span></li>
<li id="cite_note-147"><span class="mw-cite-backlink"><b><a href="#cite_ref-147">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.cancer.gov/publications/patient-education/understanding-prostate-cancer-treatment">http://www.cancer.gov/publications/patient-education/understanding-prostate-cancer-treatment</a></span></li>
<li id="cite_note-148"><span class="mw-cite-backlink"><b><a href="#cite_ref-148">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.ncbi.nlm.nih.gov/pubmed/25849602">http://www.ncbi.nlm.nih.gov/pubmed/25849602</a></span></li>
<li id="cite_note-149"><span class="mw-cite-backlink"><b><a href="#cite_ref-149">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://healthncare.info/prostate-cancer-survival-rates-and-life-expectancy-in-canada/">http://healthncare.info/prostate-cancer-survival-rates-and-life-expectancy-in-canada/</a></span></li>
<li id="cite_note-150"><span class="mw-cite-backlink"><b><a href="#cite_ref-150">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html">"WHO Disease and injury country estimates"</a>. <i>World Health Organization</i>. 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">Nov 11,</span> 2009</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=WHO+Disease+and+injury+country+estimates&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.who.int%2Fhealthinfo%2Fglobal_burden_disease%2Festimates_country%2Fen%2Findex.html&amp;rft.jtitle=World+Health+Organization&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-151"><span class="mw-cite-backlink"><b><a href="#cite_ref-151">^</a></b></span> <span class="reference-text"><span class="citation book"><i>World Cancer Report 2014</i>. International Agency for Research on Cancer, World Health Organization. 2014. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-92-832-0432-9" title="Special:BookSources/978-92-832-0432-9">978-92-832-0432-9</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.btitle=World+Cancer+Report+2014&amp;rft.date=2014&amp;rft.genre=book&amp;rft.isbn=978-92-832-0432-9&amp;rft.pub=International+Agency+for+Research+on+Cancer%2C+World+Health+Organization&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-152"><span class="mw-cite-backlink"><b><a href="#cite_ref-152">^</a></b></span> <span class="reference-text"><span class="citation journal">Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011). "Global cancer statistics". <i><a href="/wiki/CA_%E2%80%93_A_Cancer_Journal_for_Clinicians" title="CA – A Cancer Journal for Clinicians">CA – A Cancer Journal for Clinicians</a></i> <b>61</b> (2): 69–90. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3322%2Fcaac.20107">10.3322/caac.20107</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21296855">21296855</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Global+cancer+statistics&amp;rft.au=Jemal+A%2C+Bray+F%2C+Center+MM%2C+Ferlay+J%2C+Ward+E%2C+Forman+D&amp;rft.aulast=Jemal+A%2C+Bray+F%2C+Center+MM%2C+Ferlay+J%2C+Ward+E%2C+Forman+D&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3322%2Fcaac.20107&amp;rft_id=info%3Apmid%2F21296855&amp;rft.issue=2&amp;rft.jtitle=CA+%E2%80%93+A+Cancer+Journal+for+Clinicians&amp;rft.pages=69-90&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=61" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Loz2012-153"><span class="mw-cite-backlink"><b><a href="#cite_ref-Loz2012_153-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY et al. (Dec 15, 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010". <i>Lancet</i> <b>380</b> (9859): 2095–128. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2812%2961728-0">10.1016/S0140-6736(12)61728-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23245604">23245604</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Global+and+regional+mortality+from+235+causes+of+death+for+20+age+groups+in+1990+and+2010%3A+a+systematic+analysis+for+the+Global+Burden+of+Disease+Study+2010&amp;rft.aulast=Lozano+R%2C+Naghavi+M%2C+Foreman+K%2C+Lim+S%2C+Shibuya+K%2C+Aboyans+V%2C+Abraham+J%2C+Adair+T%2C+Aggarwal+R%2C+Ahn+SY&amp;rft.au=Lozano+R%2C+Naghavi+M%2C+Foreman+K%2C+Lim+S%2C+Shibuya+K%2C+Aboyans+V%2C+Abraham+J%2C+Adair+T%2C+Aggarwal+R%2C+Ahn+SY&amp;rft.date=Dec+15%2C+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2812%2961728-0&amp;rft_id=info%3Apmid%2F23245604&amp;rft.issue=9859&amp;rft.jtitle=Lancet&amp;rft.pages=2095-128&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=380" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-prostates.com.au-154"><span class="mw-cite-backlink"><b><a href="#cite_ref-prostates.com.au_154-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.prostates.com.au/statistics/">Prostate Cancer Statistics - Australia. Retrieved on 16 September 2013</a></span></li>
<li id="cite_note-cancer.org-155"><span class="mw-cite-backlink">^ <a href="#cite_ref-cancer.org_155-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-cancer.org_155-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.cancer.org/docroot/CRI/content/CRI_2_2_2X_What_causes_prostate_cancer_36.asp?sitearea=">Overview: Prostate Cancer—What Causes Prostate Cancer?</a> American Cancer Society (2 May 2006). Retrieved on 5 April 2007</span></li>
<li id="cite_note-Prostate_Cancer_FAQs-156"><span class="mw-cite-backlink">^ <a href="#cite_ref-Prostate_Cancer_FAQs_156-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Prostate_Cancer_FAQs_156-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.hsc.stonybrook.edu/som/urology/urology_cp_prostatecancer.cfm">Prostate Cancer FAQs.</a> State University of New York School of Medicine Department of Urology (31 August 2006). Retrieved on 5 April 2007</span></li>
<li id="cite_note-157"><span class="mw-cite-backlink"><b><a href="#cite_ref-157">^</a></b></span> <span class="reference-text"><span class="citation journal">Lee MM, Gomez SL, Chang JS, Wey M, Wang RT, Hsing AW (Jul 2003). "Soy and isoflavone consumption in relation to prostate cancer risk in China". <i>Cancer Epidemiol Biomarkers Prev.</i> <b>12</b> (7): 665–8. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12869409">12869409</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Soy+and+isoflavone+consumption+in+relation+to+prostate+cancer+risk+in+China&amp;rft.aulast=Lee+MM%2C+Gomez+SL%2C+Chang+JS%2C+Wey+M%2C+Wang+RT%2C+Hsing+AW&amp;rft.au=Lee+MM%2C+Gomez+SL%2C+Chang+JS%2C+Wey+M%2C+Wang+RT%2C+Hsing+AW&amp;rft.date=Jul+2003&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F12869409&amp;rft.issue=7&amp;rft.jtitle=Cancer+Epidemiol+Biomarkers+Prev.&amp;rft.pages=665-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-158"><span class="mw-cite-backlink"><b><a href="#cite_ref-158">^</a></b></span> <span class="reference-text"><span class="citation journal">Potosky AL, Miller BA, Albertsen PC, Kramer BS (February 1995). "The role of increasing detection in the rising incidence of prostate cancer". <i>JAMA</i> <b>273</b> (7): 548–52. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Fjama.273.7.548">10.1001/jama.273.7.548</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7530782">7530782</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=The+role+of+increasing+detection+in+the+rising+incidence+of+prostate+cancer&amp;rft.aulast=Potosky+AL%2C+Miller+BA%2C+Albertsen+PC%2C+Kramer+BS&amp;rft.au=Potosky+AL%2C+Miller+BA%2C+Albertsen+PC%2C+Kramer+BS&amp;rft.date=February+1995&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.273.7.548&amp;rft_id=info%3Apmid%2F7530782&amp;rft.issue=7&amp;rft.jtitle=JAMA&amp;rft.pages=548-52&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=273" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-159"><span class="mw-cite-backlink"><b><a href="#cite_ref-159">^</a></b></span> <span class="reference-text">Hanno P.M., Malcowicz S. B., Wein A. J., "Clinical Manual of Urology" McGraw Hill 2001</span></li>
<li id="cite_note-160"><span class="mw-cite-backlink"><b><a href="#cite_ref-160">^</a></b></span> <span class="reference-text"><span class="citation journal">Homma Y, Kawabe K, Tsukamoto T, Yamanaka H, Okada K, Okajima E, Yoshida O, Kumazawa J, Gu FL, Lee C, Hsu TC, dela Cruz RC, Tantiwang A, Lim PH, Sheikh MA, Bapat SD, Marshall VR, Tajima K, Aso Y (1997). "Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the international prostate symptom score". <i>International Journal of Urology</i> <b>4</b> (1): 40–46. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1442-2042.1997.tb00138.x">10.1111/j.1442-2042.1997.tb00138.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9179665">9179665</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Epidemiologic+survey+of+lower+urinary+tract+symptoms+in+Asia+and+Australia+using+the+international+prostate+symptom+score&amp;rft.au=Homma+Y%2C+Kawabe+K%2C+Tsukamoto+T%2C+Yamanaka+H%2C+Okada+K%2C+Okajima+E%2C+Yoshida+O%2C+Kumazawa+J%2C+Gu+FL%2C+Lee+C%2C+Hsu+TC%2C+dela+Cruz+RC%2C+Tantiwang+A%2C+Lim+PH%2C+Sheikh+MA%2C+Bapat+SD%2C+Marshall+VR%2C+Tajima+K%2C+Aso+Y&amp;rft.aulast=Homma+Y%2C+Kawabe+K%2C+Tsukamoto+T%2C+Yamanaka+H%2C+Okada+K%2C+Okajima+E%2C+Yoshida+O%2C+Kumazawa+J%2C+Gu+FL%2C+Lee+C%2C+Hsu+TC%2C+dela+Cruz+RC%2C+Tantiwang+A%2C+Lim+PH%2C+Sheikh+MA%2C+Bapat+SD%2C+Marshall+VR%2C+Tajima+K%2C+Aso+Y&amp;rft.date=1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1442-2042.1997.tb00138.x&amp;rft_id=info%3Apmid%2F9179665&amp;rft.issue=1&amp;rft.jtitle=International+Journal+of+Urology&amp;rft.pages=40-46&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-161"><span class="mw-cite-backlink"><b><a href="#cite_ref-161">^</a></b></span> <span class="reference-text"><span class="citation journal">Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F (April 2013). "Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012". <i>European journal of cancer (Oxford, England&#160;: 1990)</i> <b>49</b> (6): 1374–403. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.ejca.2012.12.027">10.1016/j.ejca.2012.12.027</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23485231">23485231</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Cancer+incidence+and+mortality+patterns+in+Europe%3A+estimates+for+40+countries+in+2012&amp;rft.au=Ferlay+J%2C+Steliarova-Foucher+E%2C+Lortet-Tieulent+J%2C+Rosso+S%2C+Coebergh+JW%2C+Comber+H%2C+Forman+D%2C+Bray+F&amp;rft.aulast=Ferlay+J%2C+Steliarova-Foucher+E%2C+Lortet-Tieulent+J%2C+Rosso+S%2C+Coebergh+JW%2C+Comber+H%2C+Forman+D%2C+Bray+F&amp;rft.date=April+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ejca.2012.12.027&amp;rft_id=info%3Apmid%2F23485231&amp;rft.issue=6&amp;rft.jtitle=European+journal+of+cancer+%28Oxford%2C+England+%3A+1990%29&amp;rft.pages=1374-403&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=49" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-162"><span class="mw-cite-backlink"><b><a href="#cite_ref-162">^</a></b></span> <span class="reference-text"><span class="citation journal">Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (March 2008). "Cancer Statistics, 2008". <i>CA Cancer J Clin</i> <b>58</b> (2): 71–96. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3322%2FCA.2007.0010">10.3322/CA.2007.0010</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18287387">18287387</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Cancer+Statistics%2C+2008&amp;rft.au=Jemal+A%2C+Siegel+R%2C+Ward+E%2C+Hao+Y%2C+Xu+J%2C+Murray+T%2C+Thun+MJ&amp;rft.aulast=Jemal+A%2C+Siegel+R%2C+Ward+E%2C+Hao+Y%2C+Xu+J%2C+Murray+T%2C+Thun+MJ&amp;rft.date=March+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3322%2FCA.2007.0010&amp;rft_id=info%3Apmid%2F18287387&amp;rft.issue=2&amp;rft.jtitle=CA+Cancer+J+Clin&amp;rft.pages=71-96&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=58" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-163"><span class="mw-cite-backlink"><b><a href="#cite_ref-163">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancerresearchuk.org/cancer-info/cancerstats/types/prostate/">"Prostate cancer statistics"</a>. <i>Cancer Research UK</i><span class="reference-accessdate">. Retrieved <span class="nowrap">3 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Prostate+cancer+statistics&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cancerresearchuk.org%2Fcancer-info%2Fcancerstats%2Ftypes%2Fprostate%2F&amp;rft.jtitle=Cancer+Research+UK&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-164"><span class="mw-cite-backlink"><b><a href="#cite_ref-164">^</a></b></span> <span class="reference-text">Bostwick, David G.; Eble, John N. (2007). <i>Urological Surgical Pathology</i>. St. Louis: Mosby. p. 468. <a href="/wiki/Special:BookSources/0323019706" class="internal mw-magiclink-isbn">ISBN 0-323-01970-6</a>.</span></li>
<li id="cite_note-165"><span class="mw-cite-backlink"><b><a href="#cite_ref-165">^</a></b></span> <span class="reference-text"><span class="citation book">Woloshin, Steve; Schwartz, Lisa A. (2011). <i>Overdiagnosed: Making People Sick in the Pursuit of Health</i>. USA: Beacon Press. pp.&#160;45–60. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-8070-2200-4" title="Special:BookSources/0-8070-2200-4">0-8070-2200-4</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.aulast=Woloshin%2C+Steve%3B+Schwartz%2C+Lisa+A.&amp;rft.au=Woloshin%2C+Steve%3B+Schwartz%2C+Lisa+A.&amp;rft.btitle=Overdiagnosed%3A+Making+People+Sick+in+the+Pursuit+of+Health&amp;rft.date=2011&amp;rft.genre=book&amp;rft.isbn=0-8070-2200-4&amp;rft.pages=45-60&amp;rft.place=USA&amp;rft.pub=Beacon+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-166"><span class="mw-cite-backlink"><b><a href="#cite_ref-166">^</a></b></span> <span class="reference-text"><span class="citation journal">Adams J (1853). "The case of scirrhous of the prostate gland with corresponding affliction of the lymphatic glands in the lumbar region and in the pelvis". <i>Lancet</i> <b>1</b>: 393.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=The+case+of+scirrhous+of+the+prostate+gland+with+corresponding+affliction+of+the+lymphatic+glands+in+the+lumbar+region+and+in+the+pelvis&amp;rft.au=Adams+J&amp;rft.aulast=Adams+J&amp;rft.date=1853&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.pages=393&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-167"><span class="mw-cite-backlink"><b><a href="#cite_ref-167">^</a></b></span> <span class="reference-text"><span class="citation journal">Lytton B (June 2001). "Prostate cancer: a brief history and the discovery of hormonal ablation treatment". <i>The Journal of Urology</i> <b>165</b> (6 Pt 1): 1859–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0022-5347%2805%2966228-3">10.1016/S0022-5347(05)66228-3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11371867">11371867</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Prostate+cancer%3A+a+brief+history+and+the+discovery+of+hormonal+ablation+treatment&amp;rft.aulast=Lytton+B&amp;rft.au=Lytton+B&amp;rft.date=June+2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0022-5347%2805%2966228-3&amp;rft_id=info%3Apmid%2F11371867&amp;rft.issue=6+Pt+1&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.pages=1859-62&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=165" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-168"><span class="mw-cite-backlink"><b><a href="#cite_ref-168">^</a></b></span> <span class="reference-text"><span class="citation journal">Young HH (1905). "Four cases of radical prostatectomy". <i>Johns Hopkins Bull.</i> <b>16</b>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Four+cases+of+radical+prostatectomy&amp;rft.aulast=Young+HH&amp;rft.au=Young+HH&amp;rft.date=1905&amp;rft.genre=article&amp;rft.jtitle=Johns+Hopkins+Bull.&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-169"><span class="mw-cite-backlink"><b><a href="#cite_ref-169">^</a></b></span> <span class="reference-text"><span class="citation journal">Walsh PC, Lepor H, Eggleston JC (1983). "Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations". <i>The Prostate</i> <b>4</b> (5): 473–85. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fpros.2990040506">10.1002/pros.2990040506</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6889192">6889192</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Radical+prostatectomy+with+preservation+of+sexual+function%3A+anatomical+and+pathological+considerations&amp;rft.aulast=Walsh+PC%2C+Lepor+H%2C+Eggleston+JC&amp;rft.au=Walsh+PC%2C+Lepor+H%2C+Eggleston+JC&amp;rft.date=1983&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fpros.2990040506&amp;rft_id=info%3Apmid%2F6889192&amp;rft.issue=5&amp;rft.jtitle=The+Prostate&amp;rft.pages=473-85&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-170"><span class="mw-cite-backlink"><b><a href="#cite_ref-170">^</a></b></span> <span class="reference-text"><span class="citation journal">Huggins CB, Hodges CV (1941). "Studies on prostate cancer: 1. The effects of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate". <i>Cancer Res</i> <b>1</b>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Studies+on+prostate+cancer%3A+1.+The+effects+of+castration%2C+of+estrogen+and+androgen+injection+on+serum+phosphatases+in+metastatic+carcinoma+of+the+prostate&amp;rft.au=Huggins+CB%2C+Hodges+CV&amp;rft.aulast=Huggins+CB%2C+Hodges+CV&amp;rft.date=1941&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1" class="Z3988"><span style="display:none;">&#160;</span></span><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources"><span title="This citation requires a reference to the specific page or range of pages in which the material appears. (September 2010)">page&#160;needed</span></a></i>]</sup></span></li>
<li id="cite_note-171"><span class="mw-cite-backlink"><b><a href="#cite_ref-171">^</a></b></span> <span class="reference-text"><span class="citation journal">Schally AV, Kastin AJ, Arimura A (November 1971). "Hypothalamic follicle-stimulating hormone (FSH) and luteinizing hormone (LH)-regulating hormone: structure, physiology, and clinical studies". <i>Fertility and Sterility</i> <b>22</b> (11): 703–21. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/4941683">4941683</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Hypothalamic+follicle-stimulating+hormone+%28FSH%29+and+luteinizing+hormone+%28LH%29-regulating+hormone%3A+structure%2C+physiology%2C+and+clinical+studies&amp;rft.aulast=Schally+AV%2C+Kastin+AJ%2C+Arimura+A&amp;rft.au=Schally+AV%2C+Kastin+AJ%2C+Arimura+A&amp;rft.date=November+1971&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F4941683&amp;rft.issue=11&amp;rft.jtitle=Fertility+and+Sterility&amp;rft.pages=703-21&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-172"><span class="mw-cite-backlink"><b><a href="#cite_ref-172">^</a></b></span> <span class="reference-text"><span class="citation journal">Tolis G, Ackman D, Stellos A, Mehta A, Labrie F, Fazekas AT, Comaru-Schally AM, Schally AV (March 1982). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC346035">"Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i> <b>79</b> (5): 1658–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1073%2Fpnas.79.5.1658">10.1073/pnas.79.5.1658</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC346035">346035</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6461861">6461861</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Tumor+growth+inhibition+in+patients+with+prostatic+carcinoma+treated+with+luteinizing+hormone-releasing+hormone+agonists&amp;rft.aulast=Tolis+G%2C+Ackman+D%2C+Stellos+A%2C+Mehta+A%2C+Labrie+F%2C+Fazekas+AT%2C+Comaru-Schally+AM%2C+Schally+AV&amp;rft.au=Tolis+G%2C+Ackman+D%2C+Stellos+A%2C+Mehta+A%2C+Labrie+F%2C+Fazekas+AT%2C+Comaru-Schally+AM%2C+Schally+AV&amp;rft.date=March+1982&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC346035&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.79.5.1658&amp;rft_id=info%3Apmc%2F346035&amp;rft_id=info%3Apmid%2F6461861&amp;rft.issue=5&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A&amp;rft.pages=1658-62&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=79" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-173"><span class="mw-cite-backlink"><b><a href="#cite_ref-173">^</a></b></span> <span class="reference-text"><span class="citation journal">Denmeade SR, Isaacs JT (May 2002). "A history of prostate cancer treatment". <i>Nature Reviews Cancer</i> <b>2</b> (5): 389–96. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fnrc801">10.1038/nrc801</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12044015">12044015</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=A+history+of+prostate+cancer+treatment&amp;rft.au=Denmeade+SR%2C+Isaacs+JT&amp;rft.aulast=Denmeade+SR%2C+Isaacs+JT&amp;rft.date=May+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fnrc801&amp;rft_id=info%3Apmid%2F12044015&amp;rft.issue=5&amp;rft.jtitle=Nature+Reviews+Cancer&amp;rft.pages=389-96&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-174"><span class="mw-cite-backlink"><b><a href="#cite_ref-174">^</a></b></span> <span class="reference-text"><span class="citation journal">Scott WW, Johnson DE, Schmidt JE, Gibbons RP, Prout GR, Joiner JR, Saroff J, Murphy GP (December 1975). "Chemotherapy of advanced prostatic carcinoma with cyclophosphamide or 5-fluorouracil: results of first national randomized study". <i>The Journal of Urology</i> <b>114</b> (6): 909–11. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1104900">1104900</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Chemotherapy+of+advanced+prostatic+carcinoma+with+cyclophosphamide+or+5-fluorouracil%3A+results+of+first+national+randomized+study&amp;rft.aulast=Scott+WW%2C+Johnson+DE%2C+Schmidt+JE%2C+Gibbons+RP%2C+Prout+GR%2C+Joiner+JR%2C+Saroff+J%2C+Murphy+GP&amp;rft.au=Scott+WW%2C+Johnson+DE%2C+Schmidt+JE%2C+Gibbons+RP%2C+Prout+GR%2C+Joiner+JR%2C+Saroff+J%2C+Murphy+GP&amp;rft.date=December+1975&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F1104900&amp;rft.issue=6&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.pages=909-11&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=114" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Businessweek_2007-06-13-175"><span class="mw-cite-backlink">^ <a href="#cite_ref-Businessweek_2007-06-13_175-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Businessweek_2007-06-13_175-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Businessweek_2007-06-13_175-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Businessweek_2007-06-13_175-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation web">Arnst, Catherine (2007-06-13). <a rel="nofollow" class="external text" href="http://www.businessweek.com/technology/content/jun2007/tc20070612_953676.htm">"A Gender Gap in Cancer"</a>. Businessweek.com<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-08-29</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.au=Arnst%2C+Catherine&amp;rft.aufirst=Catherine&amp;rft.aulast=Arnst&amp;rft.btitle=A+Gender+Gap+in+Cancer&amp;rft.date=2007-06-13&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.businessweek.com%2Ftechnology%2Fcontent%2Fjun2007%2Ftc20070612_953676.htm&amp;rft.pub=Businessweek.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-176"><span class="mw-cite-backlink"><b><a href="#cite_ref-176">^</a></b></span> <span class="reference-text"><span class="citation news">Browne, Anthony (2001-10-07). <a rel="nofollow" class="external text" href="http://www.guardian.co.uk/society/2001/oct/07/cancercare">"Cancer bias puts breasts first"</a>. <i>The Guardian</i> (London).</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Cancer+bias+puts+breasts+first&amp;rft.au=Browne%2C+Anthony&amp;rft.aufirst=Anthony&amp;rft.aulast=Browne&amp;rft.date=2001-10-07&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.guardian.co.uk%2Fsociety%2F2001%2Foct%2F07%2Fcancercare&amp;rft.jtitle=The+Guardian&amp;rft.place=London&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-177"><span class="mw-cite-backlink"><b><a href="#cite_ref-177">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.timesonline.co.uk/tol/news/uk/article579050.ece">Men lose out in battle for cancer cash - Times Online</a><sup class="noprint Inline-Template"><span style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Link_rot" title="Wikipedia:Link rot"><span title="&#160;since August 2011">dead link</span></a></i>]</span></sup></span></li>
<li id="cite_note-178"><span class="mw-cite-backlink"><b><a href="#cite_ref-178">^</a></b></span> <span class="reference-text"><span class="citation book"><a rel="nofollow" class="external text" href="https://books.google.com/?id=mRkqAAAAYAAJ&amp;dq=prostate+cancer+misandry&amp;q=prostate#search_anchor"><i>Does feminism discriminate against ... - Google Books</i></a>. Books.google.co.uk. 2008-07-24. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-19-531283-6" title="Special:BookSources/978-0-19-531283-6">978-0-19-531283-6</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2011-08-29</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.btitle=Does+feminism+discriminate+against+...+-+Google+Books&amp;rft.date=2008-07-24&amp;rft.genre=book&amp;rft_id=https%3A%2F%2Fbooks.google.com%2F%3Fid%3DmRkqAAAAYAAJ%26dq%3Dprostate%2Bcancer%2Bmisandry%26q%3Dprostate%23search_anchor&amp;rft.isbn=978-0-19-531283-6&amp;rft.pub=Books.google.co.uk&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-179"><span class="mw-cite-backlink"><b><a href="#cite_ref-179">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external autonumber" href="http://www.timesonline.co.uk/tol/news/uk/article579050.ece">[1]</a><sup class="noprint Inline-Template"><span style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Link_rot" title="Wikipedia:Link rot"><span title="&#160;since August 2011">dead link</span></a></i>]</span></sup></span></li>
<li id="cite_note-180"><span class="mw-cite-backlink"><b><a href="#cite_ref-180">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://dailycaller.com/2010/10/05/breast-cancer-receives-much-more-research-funding-publicity-than-prostate-cancer-despite-similar-number-of-victims/">"Breast cancer receives much more research funding, publicity than prostate cancer despite similar number of victims"</a>. The Daily Caller. 2010-10-05<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-08-29</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.btitle=Breast+cancer+receives+much+more+research+funding%2C+publicity+than+prostate+cancer+despite+similar+number+of+victims&amp;rft.date=2010-10-05&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fdailycaller.com%2F2010%2F10%2F05%2Fbreast-cancer-receives-much-more-research-funding-publicity-than-prostate-cancer-despite-similar-number-of-victims%2F&amp;rft.pub=The+Daily+Caller&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-181"><span class="mw-cite-backlink"><b><a href="#cite_ref-181">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.msnbc.msn.com/id/7258393/ns/health-cancer/">"Prostate cancer in shadow of female counterpart - Health - Cancer - msnbc.com"</a>. MSNBC. 2005-03-28<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-08-29</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.btitle=Prostate+cancer+in+shadow+of+female+counterpart+-+Health+-+Cancer+-+msnbc.com&amp;rft.date=2005-03-28&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.msnbc.msn.com%2Fid%2F7258393%2Fns%2Fhealth-cancer%2F&amp;rft.pub=MSNBC&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-CT.gov-182"><span class="mw-cite-backlink"><b><a href="#cite_ref-CT.gov_182-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.clinicaltrials.gov/ct2/results?intr=%22MDV3100%22">http://www.clinicaltrials.gov/ct2/results?intr=%22MDV3100%22</a> ClinicalTrials.gov listing of MDV3100 articles</span></li>
<li id="cite_note-urlAlgeta.com-183"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlAlgeta.com_183-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://algeta.com/xml_press_underside.asp?xml=http://cws.huginonline.com/A/134655/PR/201106/1521246.xml&amp;m=34572&amp;s=34686&amp;ss=&amp;d=2011-06-06">"Positive Outcome of Interim Analysis of pivotal Alpharadin study: Primary endpoint met in Phase III ALSYMPCA study"</a>. <i>Press Release</i>. Algeta.com. 2011-06-06<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-07-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Positive+Outcome+of+Interim+Analysis+of+pivotal+Alpharadin+study%3A+Primary+endpoint+met+in+Phase+III+ALSYMPCA+study&amp;rft.date=2011-06-06&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Falgeta.com%2Fxml_press_underside.asp%3Fxml%3Dhttp%3A%2F%2Fcws.huginonline.com%2FA%2F134655%2FPR%2F201106%2F1521246.xml%26m%3D34572%26s%3D34686%26ss%3D%26d%3D2011-06-06&amp;rft.jtitle=Press+Release&amp;rft.pub=Algeta.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-184"><span class="mw-cite-backlink"><b><a href="#cite_ref-184">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm352363.htm">http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm352363.htm</a></span></li>
<li id="cite_note-Primary_source_cited_in_1st_review-185"><span class="mw-cite-backlink">^ <a href="#cite_ref-Primary_source_cited_in_1st_review_185-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Primary_source_cited_in_1st_review_185-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Primary_source_cited_in_1st_review_185-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ghosh J, Myers CE (October 1998). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC23752">"Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells"</a>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <b>95</b> (22): 13182–13187. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1073%2Fpnas.95.22.13182">10.1073/pnas.95.22.13182</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC23752">23752</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9789062">9789062</a>. <q>Inhibition of 5-lipoxygenase by MK886 completely blocks 5-HETE production and induces massive apoptosis in both hormone-responsive (LNCaP) and -nonresponsive (PC3) human prostate cancer cells. This cell death is very rapid</q></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Inhibition+of+arachidonate+5-lipoxygenase+triggers+massive+apoptosis+in+human+prostate+cancer+cells&amp;rft.au=Ghosh+J%2C+Myers+CE&amp;rft.aulast=Ghosh+J%2C+Myers+CE&amp;rft.date=October+1998&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC23752&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.95.22.13182&amp;rft_id=info%3Apmc%2F23752&amp;rft_id=info%3Apmid%2F9789062&amp;rft.issue=22&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.pages=13182-13187&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=95" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-MEDRS_review_1-186"><span class="mw-cite-backlink">^ <a href="#cite_ref-MEDRS_review_1_186-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MEDRS_review_1_186-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MEDRS_review_1_186-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Greene ER, Huang S, Serhan CN, Panigrahy D (November 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4051344">"Regulation of inflammation in cancer by eicosanoids"</a>. <i>Prostaglandins Other Lipid Mediat.</i> <b>96</b> (1-4): 27–36. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.prostaglandins.2011.08.004">10.1016/j.prostaglandins.2011.08.004</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4051344">4051344</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21864702">21864702</a>. <q>The 5-lipoxygenase (5-LOX) pathway is implicated in the development and progression of human cancers. 5-LOX, whose crystal structure was recently identified (118), is a key enzyme in metabolizing arachidonic acid to leukotrienes. 5-LOX can be induced by pro-inflammatory stimuli and is expressed in epithelial cancers including lung, prostate, breast, and colon (113). Hence, 5-LOX inhibitors have been targeted for their chemopreventive effects. Inhibition of 5-LOX activity is shown to block prostate cancer cell proliferation as well as carcinogen-induced lung tumorigenesis (119, 120).&#160;... Both 5-HETE and 12-HETE are also products of lipoxygenase and are involved in tumor progression (12). Exogenous 5-HETE can stimulate the proliferation of prostate cancer cells and act as a survival factor (137, 138). These results require relatively high concentrations (at a concentration of 10 μM). Blocking the formation of 5-HETE, by inhibiting 5-lipoxygenase, results in massive apoptosis of human prostate cancer cells (139).</q></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Regulation+of+inflammation+in+cancer+by+eicosanoids&amp;rft.au=Greene+ER%2C+Huang+S%2C+Serhan+CN%2C+Panigrahy+D&amp;rft.aulast=Greene+ER%2C+Huang+S%2C+Serhan+CN%2C+Panigrahy+D&amp;rft.date=November+2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4051344&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prostaglandins.2011.08.004&amp;rft_id=info%3Apmc%2F4051344&amp;rft_id=info%3Apmid%2F21864702&amp;rft.issue=1-4&amp;rft.jtitle=Prostaglandins+Other+Lipid+Mediat.&amp;rft.pages=27-36&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=96" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-MEDRS_review_2-187"><span class="mw-cite-backlink">^ <a href="#cite_ref-MEDRS_review_2_187-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MEDRS_review_2_187-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MEDRS_review_2_187-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Bishayee K, Khuda-Bukhsh AR (September 2013). "5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy". <i>Acta Biochim. Biophys. Sin. (Shanghai)</i> <b>45</b> (9): 709–719. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fabbs%2Fgmt064">10.1093/abbs/gmt064</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23752617">23752617</a>. <q>Recent studies demonstrated the involvement of growth factors, such as epidermal growth factor (EGF) and neurotensin in the 5-LOX-mediated tumor progression in prostate cancer [22,23]. Recent studies with 5-LOX siRNA [10] and specific blocker of 5-LOX [24] revealed the relation of this gene with the tumor cell proliferation.&#160;... Meclofenamate sodium (MS) is known for its anti-inflammatory activity, and apart from this, Boctor et al. [37] reported that it caused reduction in the formation of 5-HETE in human leucocytes when used. MS can thus be considered a dual inhibitor of 5-LOX and COX pathways of arachidonic acid cascade. Further investigation with this substance revealed that it could interfere with the LT receptors in the lung carcinoma [38]. In a recent study, a group of scientists have shown the effect of MS on prostate cancer cells both in vitro and in vivo [39], and their result suggests a profound reduction in the tumor growth and cancer metastasis.&#160;... While the commonly used inhibitors produced strong cytotoxicity, notably, zileuton, the only commercialized 5-LOX inhibitor, failed to induce an anti-proliferative or cytotoxic response in all other types of tumor cells where 5-LOX was in inactive state (e.g. HeLa cells); however, where 5-LOX was in active state, zileuton could effectively inhibit progression, as in case of prostate cancer.</q></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=5-lipoxygenase+antagonist+therapy%3A+a+new+approach+towards+targeted+cancer+chemotherapy&amp;rft.au=Bishayee+K%2C+Khuda-Bukhsh+AR&amp;rft.aulast=Bishayee+K%2C+Khuda-Bukhsh+AR&amp;rft.date=September+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fabbs%2Fgmt064&amp;rft_id=info%3Apmid%2F23752617&amp;rft.issue=9&amp;rft.jtitle=Acta+Biochim.+Biophys.+Sin.+%28Shanghai%29&amp;rft.pages=709-719&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=45" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-188"><span class="mw-cite-backlink"><b><a href="#cite_ref-188">^</a></b></span> <span class="reference-text"><span class="citation journal">Linja MJ, Savinainen KJ, Saramäki OR, Tammela TL, Vessella RL, Visakorpi T (May 2001). <a rel="nofollow" class="external text" href="http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&amp;pmid=11325816">"Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer"</a>. <i>Cancer Research</i> <b>61</b> (9): 3550–5. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11325816">11325816</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Amplification+and+overexpression+of+androgen+receptor+gene+in+hormone-refractory+prostate+cancer&amp;rft.aulast=Linja+MJ%2C+Savinainen+KJ%2C+Saram%C3%A4ki+OR%2C+Tammela+TL%2C+Vessella+RL%2C+Visakorpi+T&amp;rft.au=Linja+MJ%2C+Savinainen+KJ%2C+Saram%C3%A4ki+OR%2C+Tammela+TL%2C+Vessella+RL%2C+Visakorpi+T&amp;rft.date=May+2001&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcancerres.aacrjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D11325816&amp;rft_id=info%3Apmid%2F11325816&amp;rft.issue=9&amp;rft.jtitle=Cancer+Research&amp;rft.pages=3550-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=61" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-189"><span class="mw-cite-backlink"><b><a href="#cite_ref-189">^</a></b></span> <span class="reference-text"><span class="citation journal">Ford OH, Gregory CW, Kim D, Smitherman AB, Mohler JL (November 2003). "Androgen receptor gene amplification and protein expression in recurrent prostate cancer". <i>The Journal of Urology</i> <b>170</b> (5): 1817–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F01.ju.0000091873.09677.f4">10.1097/01.ju.0000091873.09677.f4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14532783">14532783</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Androgen+receptor+gene+amplification+and+protein+expression+in+recurrent+prostate+cancer&amp;rft.au=Ford+OH%2C+Gregory+CW%2C+Kim+D%2C+Smitherman+AB%2C+Mohler+JL&amp;rft.aulast=Ford+OH%2C+Gregory+CW%2C+Kim+D%2C+Smitherman+AB%2C+Mohler+JL&amp;rft.date=November+2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F01.ju.0000091873.09677.f4&amp;rft_id=info%3Apmid%2F14532783&amp;rft.issue=5&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.pages=1817-21&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=170" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-190"><span class="mw-cite-backlink"><b><a href="#cite_ref-190">^</a></b></span> <span class="reference-text"><span class="citation journal">Kokontis J, Takakura K, Hay N, Liao S (March 1994). <a rel="nofollow" class="external text" href="http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&amp;pmid=7511045">"Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation"</a>. <i>Cancer Research</i> <b>54</b> (6): 1566–73. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7511045">7511045</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Increased+androgen+receptor+activity+and+altered+c-myc+expression+in+prostate+cancer+cells+after+long-term+androgen+deprivation&amp;rft.au=Kokontis+J%2C+Takakura+K%2C+Hay+N%2C+Liao+S&amp;rft.aulast=Kokontis+J%2C+Takakura+K%2C+Hay+N%2C+Liao+S&amp;rft.date=March+1994&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcancerres.aacrjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D7511045&amp;rft_id=info%3Apmid%2F7511045&amp;rft.issue=6&amp;rft.jtitle=Cancer+Research&amp;rft.pages=1566-73&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=54" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-191"><span class="mw-cite-backlink"><b><a href="#cite_ref-191">^</a></b></span> <span class="reference-text"><span class="citation journal">Umekita Y, Hiipakka RA, Kokontis JM, Liao S (October 1996). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC38139">"Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i> <b>93</b> (21): 11802–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1073%2Fpnas.93.21.11802">10.1073/pnas.93.21.11802</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC38139">38139</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8876218">8876218</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Human+prostate+tumor+growth+in+athymic+mice%3A+inhibition+by+androgens+and+stimulation+by+finasteride&amp;rft.aulast=Umekita+Y%2C+Hiipakka+RA%2C+Kokontis+JM%2C+Liao+S&amp;rft.au=Umekita+Y%2C+Hiipakka+RA%2C+Kokontis+JM%2C+Liao+S&amp;rft.date=October+1996&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC38139&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.93.21.11802&amp;rft_id=info%3Apmc%2F38139&amp;rft_id=info%3Apmid%2F8876218&amp;rft.issue=21&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A&amp;rft.pages=11802-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=93" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-192"><span class="mw-cite-backlink"><b><a href="#cite_ref-192">^</a></b></span> <span class="reference-text"><span class="citation journal">Kokontis JM, Hsu S, Chuu CP, Dang M, Fukuchi J, Hiipakka RA, Liao S (December 2005). "Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity". <i>The Prostate</i> <b>65</b> (4): 287–98. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fpros.20285">10.1002/pros.20285</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16015608">16015608</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Role+of+androgen+receptor+in+the+progression+of+human+prostate+tumor+cells+to+androgen+independence+and+insensitivity&amp;rft.au=Kokontis+JM%2C+Hsu+S%2C+Chuu+CP%2C+Dang+M%2C+Fukuchi+J%2C+Hiipakka+RA%2C+Liao+S&amp;rft.aulast=Kokontis+JM%2C+Hsu+S%2C+Chuu+CP%2C+Dang+M%2C+Fukuchi+J%2C+Hiipakka+RA%2C+Liao+S&amp;rft.date=December+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fpros.20285&amp;rft_id=info%3Apmid%2F16015608&amp;rft.issue=4&amp;rft.jtitle=The+Prostate&amp;rft.pages=287-98&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=65" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15865048-193"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15865048_193-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Iyer M, Salazar FB, Lewis X, Zhang L, Wu L, Carey M, Gambhir SS (February 2005). "Non-invasive imaging of a transgenic mouse model using a prostate-specific two-step transcriptional amplification strategy". <i>Transgenic Res.</i> <b>14</b> (1): 47–55. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs11248-004-2836-1">10.1007/s11248-004-2836-1</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15865048">15865048</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Non-invasive+imaging+of+a+transgenic+mouse+model+using+a+prostate-specific+two-step+transcriptional+amplification+strategy&amp;rft.au=Iyer+M%2C+Salazar+FB%2C+Lewis+X%2C+Zhang+L%2C+Wu+L%2C+Carey+M%2C+Gambhir+SS&amp;rft.aulast=Iyer+M%2C+Salazar+FB%2C+Lewis+X%2C+Zhang+L%2C+Wu+L%2C+Carey+M%2C+Gambhir+SS&amp;rft.date=February+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs11248-004-2836-1&amp;rft_id=info%3Apmid%2F15865048&amp;rft.issue=1&amp;rft.jtitle=Transgenic+Res.&amp;rft.pages=47-55&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=14" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid21364037-194"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21364037_194-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Morgan R, Boxall A, Bhatt A, Bailey M, Hindley R, Langley S, Whitaker HC, Neal DE, Ismail M, Whitaker H, Annels N, Michael A, Pandha H (March 2011). "Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer". <i>Clin. Cancer Res.</i> <b>17</b> (5): 1090–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1158%2F1078-0432.CCR-10-2410">10.1158/1078-0432.CCR-10-2410</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21364037">21364037</a>. <a rel="nofollow" class="external text" href="http://www.bbc.co.uk/news/health-12610972">Lay summary</a> – <i>BBC News</i>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Engrailed-2+%28EN2%29%3A+a+tumor+specific+urinary+biomarker+for+the+early+diagnosis+of+prostate+cancer&amp;rft.aulast=Morgan+R%2C+Boxall+A%2C+Bhatt+A%2C+Bailey+M%2C+Hindley+R%2C+Langley+S%2C+Whitaker+HC%2C+Neal+DE%2C+Ismail+M%2C+Whitaker+H%2C+Annels+N%2C+Michael+A%2C+Pandha+H&amp;rft.au=Morgan+R%2C+Boxall+A%2C+Bhatt+A%2C+Bailey+M%2C+Hindley+R%2C+Langley+S%2C+Whitaker+HC%2C+Neal+DE%2C+Ismail+M%2C+Whitaker+H%2C+Annels+N%2C+Michael+A%2C+Pandha+H&amp;rft.date=March+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-10-2410&amp;rft_id=info%3Apmid%2F21364037&amp;rft.issue=5&amp;rft.jtitle=Clin.+Cancer+Res.&amp;rft.pages=1090-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid21176272-195"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21176272_195-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Bourdoumis A, Papatsoris AG, Chrisofos M, Efstathiou E, Skolarikos A, Deliveliotis C (2010). "The novel prostate cancer antigen 3 (PCA3) biomarker". <i>Int Braz J Urol</i> <b>36</b> (6): 665–8; discussion 669. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1590%2FS1677-55382010000600003">10.1590/S1677-55382010000600003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21176272">21176272</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=The+novel+prostate+cancer+antigen+3+%28PCA3%29+biomarker&amp;rft.au=Bourdoumis+A%2C+Papatsoris+AG%2C+Chrisofos+M%2C+Efstathiou+E%2C+Skolarikos+A%2C+Deliveliotis+C&amp;rft.aulast=Bourdoumis+A%2C+Papatsoris+AG%2C+Chrisofos+M%2C+Efstathiou+E%2C+Skolarikos+A%2C+Deliveliotis+C&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1590%2FS1677-55382010000600003&amp;rft_id=info%3Apmid%2F21176272&amp;rft.issue=6&amp;rft.jtitle=Int+Braz+J+Urol&amp;rft.pages=665-8%3B+discussion+669&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=36" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17437801-196"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17437801_196-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hansel DE, DeMarzo AM, Platz EA, Jadallah S, Hicks J, Epstein JI, Partin AW, Netto GJ (May 2007). "Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies". <i>J. Urol.</i> <b>177</b> (5): 1736–40. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.juro.2007.01.013">10.1016/j.juro.2007.01.013</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17437801">17437801</a>. <a rel="nofollow" class="external text" href="http://www.msnbc.msn.com/id/18328032/site/newsweek/">Lay summary</a> – <i>Newsweek</i>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Early+prostate+cancer+antigen+expression+in+predicting+presence+of+prostate+cancer+in+men+with+histologically+negative+biopsies&amp;rft.au=Hansel+DE%2C+DeMarzo+AM%2C+Platz+EA%2C+Jadallah+S%2C+Hicks+J%2C+Epstein+JI%2C+Partin+AW%2C+Netto+GJ&amp;rft.aulast=Hansel+DE%2C+DeMarzo+AM%2C+Platz+EA%2C+Jadallah+S%2C+Hicks+J%2C+Epstein+JI%2C+Partin+AW%2C+Netto+GJ&amp;rft.date=May+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.juro.2007.01.013&amp;rft_id=info%3Apmid%2F17437801&amp;rft.issue=5&amp;rft.jtitle=J.+Urol.&amp;rft.pages=1736-40&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=177" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19946524-197"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19946524_197-0">^</a></b></span> <span class="reference-text"><span class="citation journal">van Weert HC, Pingen F (2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2783109">"Recurrent thromboflebitis as a warning sign for cancer: a case report"</a>. <i>Cases J</i> <b>2</b>: 153. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1186%2F1757-1626-2-153">10.1186/1757-1626-2-153</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2783109">2783109</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19946524">19946524</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Recurrent+thromboflebitis+as+a+warning+sign+for+cancer%3A+a+case+report&amp;rft.aulast=van+Weert+HC%2C+Pingen+F&amp;rft.au=van+Weert+HC%2C+Pingen+F&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2783109&amp;rft_id=info%3Adoi%2F10.1186%2F1757-1626-2-153&amp;rft_id=info%3Apmc%2F2783109&amp;rft_id=info%3Apmid%2F19946524&amp;rft.jtitle=Cases+J&amp;rft.pages=153&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-198"><span class="mw-cite-backlink"><b><a href="#cite_ref-198">^</a></b></span> <span class="reference-text"><span class="citation journal">Nilsson BO, Carlsson L, Larsson A, Ronquist G (2001). "Autoantibodies to prostasomes as new markers for prostate cancer". <i>Ups. J. Med. Sci.</i> <b>106</b> (1): 43–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3109%2F2000-1967-171">10.3109/2000-1967-171</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11817562">11817562</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer&amp;rft.atitle=Autoantibodies+to+prostasomes+as+new+markers+for+prostate+cancer&amp;rft.aulast=Nilsson+BO%2C+Carlsson+L%2C+Larsson+A%2C+Ronquist+G&amp;rft.au=Nilsson+BO%2C+Carlsson+L%2C+Larsson+A%2C+Ronquist+G&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3109%2F2000-1967-171&amp;rft_id=info%3Apmid%2F11817562&amp;rft.issue=1&amp;rft.jtitle=Ups.+J.+Med.+Sci.&amp;rft.pages=43-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=106" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=36" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="metadata plainlinks mbox-small" style="padding:0.25em 0.5em 0.5em 0.75em;border:1px solid #aaa;background:#f9f9f9;">
<tr>
<td colspan="2" style="padding-bottom:0.75em;border-bottom:1px solid #aaa;text-align:center;">
<div style="clear:both;">Find more about<br />
<b>Prostate cancer</b><br />
at Wikipedia's <a href="/wiki/Wikipedia:Wikimedia_sister_projects" title="Wikipedia:Wikimedia sister projects">sister projects</a></div>
</td>
</tr>
<tr style="height:25px;">
<td style="padding-top:0.75em;"><a href="//en.wiktionary.org/wiki/Special:Search/Prostate_cancer" title="Search Wiktionary"><img alt="Search Wiktionary" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/f8/Wiktionary-logo-en.svg/23px-Wiktionary-logo-en.svg.png" width="23" height="25" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/f8/Wiktionary-logo-en.svg/35px-Wiktionary-logo-en.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f8/Wiktionary-logo-en.svg/46px-Wiktionary-logo-en.svg.png 2x" data-file-width="1000" data-file-height="1089" /></a></td>
<td style="padding-top:0.75em;"><a href="//en.wiktionary.org/wiki/Special:Search/Prostate_cancer" class="extiw" title="wikt:Special:Search/Prostate cancer">Definitions</a> from Wiktionary</td>
</tr>
<tr style="height:25px;">
<td><a href="//commons.wikimedia.org/wiki/Special:Search/Prostate_cancer" title="Search Commons"><img alt="Search Commons" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/18px-Commons-logo.svg.png" width="18" height="25" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/28px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/37px-Commons-logo.svg.png 2x" data-file-width="1024" data-file-height="1376" /></a></td>
<td><a href="//commons.wikimedia.org/wiki/Special:Search/Prostate_cancer" class="extiw" title="c:Special:Search/Prostate cancer">Media</a> from Commons</td>
</tr>
<tr style="height:25px;">
<td><a href="//en.wikinews.org/wiki/Special:Search/Prostate_cancer" title="Search Wikinews"><img alt="Search Wikinews" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/24/Wikinews-logo.svg/25px-Wikinews-logo.svg.png" width="25" height="14" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/24/Wikinews-logo.svg/38px-Wikinews-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/24/Wikinews-logo.svg/50px-Wikinews-logo.svg.png 2x" data-file-width="759" data-file-height="415" /></a></td>
<td><a href="//en.wikinews.org/wiki/Special:Search/Prostate_cancer" class="extiw" title="n:Special:Search/Prostate cancer">News stories</a> from Wikinews</td>
</tr>
<tr style="height:25px;">
<td><a href="//en.wikiquote.org/wiki/Special:Search/Prostate_cancer" title="Search Wikiquote"><img alt="Search Wikiquote" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/21px-Wikiquote-logo.svg.png" width="21" height="25" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/32px-Wikiquote-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/42px-Wikiquote-logo.svg.png 2x" data-file-width="300" data-file-height="355" /></a></td>
<td><a href="//en.wikiquote.org/wiki/Special:Search/Prostate_cancer" class="extiw" title="q:Special:Search/Prostate cancer">Quotations</a> from Wikiquote</td>
</tr>
<tr style="height:25px;">
<td><a href="//en.wikisource.org/wiki/Special:Search/Prostate_cancer" title="Search Wikisource"><img alt="Search Wikisource" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/24px-Wikisource-logo.svg.png" width="24" height="25" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/36px-Wikisource-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/48px-Wikisource-logo.svg.png 2x" data-file-width="410" data-file-height="430" /></a></td>
<td><a href="//en.wikisource.org/wiki/Special:Search/Prostate_cancer" class="extiw" title="s:Special:Search/Prostate cancer">Source texts</a> from Wikisource</td>
</tr>
<tr style="height:25px;">
<td><a href="//en.wikibooks.org/wiki/Special:Search/Prostate_cancer" title="Search Wikibooks"><img alt="Search Wikibooks" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikibooks-logo.svg/25px-Wikibooks-logo.svg.png" width="25" height="25" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikibooks-logo.svg/38px-Wikibooks-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikibooks-logo.svg/50px-Wikibooks-logo.svg.png 2x" data-file-width="300" data-file-height="300" /></a></td>
<td><a href="//en.wikibooks.org/wiki/Special:Search/Prostate_cancer" class="extiw" title="b:Special:Search/Prostate cancer">Textbooks</a> from Wikibooks</td>
</tr>
<tr style="height:25px;">
<td><a href="//en.wikiversity.org/wiki/Special:Search/Prostate_cancer" title="Search Wikiversity"><img alt="Search Wikiversity" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/1b/Wikiversity-logo-en.svg/25px-Wikiversity-logo-en.svg.png" width="25" height="23" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/1b/Wikiversity-logo-en.svg/38px-Wikiversity-logo-en.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1b/Wikiversity-logo-en.svg/50px-Wikiversity-logo-en.svg.png 2x" data-file-width="1000" data-file-height="900" /></a></td>
<td><a href="//en.wikiversity.org/wiki/Special:Search/Prostate_cancer" class="extiw" title="v:Special:Search/Prostate cancer">Learning resources</a> from Wikiversity</td>
</tr>
</table>
<ul>
<li><a rel="nofollow" class="external text" href="https://www.dmoz.org/Health/Conditions_and_Diseases/Cancer/Genitourinary/Prostate">Prostate cancer</a> at <a href="/wiki/DMOZ" title="DMOZ">DMOZ</a></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks hlist collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Male_genital_neoplasia" title="Template:Male genital neoplasia"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Male_genital_neoplasia" title="Template talk:Male genital neoplasia"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Male_genital_neoplasia&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">
<ul>
<li><a href="/wiki/Neoplasm" title="Neoplasm">Tumors</a>: male <a href="/wiki/Urogenital_neoplasm" title="Urogenital neoplasm">urogenital neoplasia</a> (<a href="/wiki/ICD-10_Chapter_II:_Neoplasms#.28C50.E2.80.93C58.29_Malignant_neoplasms.2C_breast_and_female_genital_organs" title="ICD-10 Chapter II: Neoplasms">C60–C63/D29</a>, <a href="/wiki/List_of_ICD-9_codes_140%E2%80%93239:_neoplasms#Malignant_neoplasm_of_genitourinary_organs_.28179.E2.80.93189.29" title="List of ICD-9 codes 140–239: neoplasms">185–187/222</a>)</li>
</ul>
</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Male_internal_genitalia" title="Male internal genitalia" class="mw-redirect">Internal</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Testicular_cancer" title="Testicular cancer">Testicles</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Sex_cord-gonadal_stromal_tumour" title="Sex cord-gonadal stromal tumour" class="mw-redirect">Sex cord-<br />
gonadal stromal</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Sertoli-Leydig_cell_tumour" title="Sertoli-Leydig cell tumour" class="mw-redirect">Sertoli-Leydig cell tumour</a>
<ul>
<li><a href="/wiki/Sertoli_cell_tumour" title="Sertoli cell tumour">Sertoli cell tumour</a></li>
<li><a href="/wiki/Leydig_cell_tumour" title="Leydig cell tumour">Leydig cell tumour</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Germ_cell_tumor" title="Germ cell tumor">Germ cell</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Germ_cell_tumor#Germinomatous" title="Germ cell tumor">G</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Seminoma" title="Seminoma">Seminoma</a>
<ul>
<li><a href="/wiki/Spermatocytic_seminoma" title="Spermatocytic seminoma">Spermatocytic seminoma</a></li>
<li><a href="/wiki/Intratubular_germ_cell_neoplasia" title="Intratubular germ cell neoplasia">Intratubular germ cell neoplasia</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Germ_cell_tumor#Nongerminomatous" title="Germ cell tumor">NG</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Embryonal_carcinoma" title="Embryonal carcinoma">Embryonal carcinoma</a></li>
<li><a href="/wiki/Endodermal_sinus_tumor" title="Endodermal sinus tumor">Endodermal sinus tumor</a></li>
<li><a href="/wiki/Gonadoblastoma" title="Gonadoblastoma">Gonadoblastoma</a></li>
<li><a href="/wiki/Teratoma" title="Teratoma">Teratoma</a></li>
<li><a href="/wiki/Choriocarcinoma" title="Choriocarcinoma">Choriocarcinoma</a></li>
<li><a href="/wiki/Embryoma" title="Embryoma">Embryoma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><strong class="selflink">Prostate</strong></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Adenocarcinoma#Urogenital" title="Adenocarcinoma">Adenocarcinoma</a></li>
<li><a href="/wiki/High-grade_prostatic_intraepithelial_neoplasia" title="High-grade prostatic intraepithelial neoplasia">High-grade prostatic intraepithelial neoplasia</a>
<ul>
<li><a href="/wiki/High-grade_prostatic_intraepithelial_neoplasia" title="High-grade prostatic intraepithelial neoplasia">HGPIN</a></li>
</ul>
</li>
<li><a href="/wiki/Small-cell_carcinoma#Prostate" title="Small-cell carcinoma">Small-cell carcinoma</a></li>
<li><a href="/wiki/Transitional_cell_carcinoma#Prostate" title="Transitional cell carcinoma">Transitional cell carcinoma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Male_external_genitalia" title="Male external genitalia" class="mw-redirect">External</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Penile_cancer" title="Penile cancer">Penis</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Penile_cancer" title="Penile cancer">Carcinoma</a>
<ul>
<li><a href="/wiki/Extramammary_Paget%27s_disease" title="Extramammary Paget's disease">Extramammary Paget's disease</a></li>
</ul>
</li>
<li><a href="/wiki/Bowen%27s_disease" title="Bowen's disease">Bowen's disease</a></li>
<li><a href="/wiki/Bowenoid_papulosis" title="Bowenoid papulosis">Bowenoid papulosis</a></li>
<li><a href="/wiki/Erythroplasia_of_Queyrat" title="Erythroplasia of Queyrat">Erythroplasia of Queyrat</a></li>
<li><a href="/wiki/Hirsuties_coronae_glandis" title="Hirsuties coronae glandis">Hirsuties coronae glandis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Reproductive_medicine_navs" title="Template:Reproductive medicine navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Reproductive_medicine_navs" title="Template talk:Reproductive medicine navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Reproductive_medicine_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Reproductive_medicine" title="Reproductive medicine">reproductive medicine</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Anatomy
<ul>
<li><a href="/wiki/Template:Male_reproductive_system" title="Template:Male reproductive system">male</a></li>
<li><a href="/wiki/Template:Female_reproductive_system" title="Template:Female reproductive system">female</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Human_reproductive_physiology" title="Template:Human reproductive physiology">Physiology</a>
<ul>
<li><a href="/wiki/Template:Menstrual_cycle" title="Template:Menstrual cycle">menstrual cycle</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Development_of_urinary_and_reproductive_systems" title="Template:Development of urinary and reproductive systems">Development</a>
<ul>
<li><a href="/wiki/Template:Sex_determination_and_differentiation" title="Template:Sex determination and differentiation">sex determination and differentiation</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Infections
<ul>
<li><a href="/wiki/Template:STD_and_STI" title="Template:STD and STI">STD and STI</a></li>
</ul>
</li>
<li>Congenital
<ul>
<li><a href="/wiki/Template:Male_congenital_anomalies_of_genital_organs" title="Template:Male congenital anomalies of genital organs">male</a></li>
<li><a href="/wiki/Template:Female_congenital_anomalies_of_genital_organs" title="Template:Female congenital anomalies of genital organs">female</a></li>
</ul>
</li>
<li>Neoplasms and cancer
<ul>
<li><a href="/wiki/Template:Male_genital_neoplasia" title="Template:Male genital neoplasia">male</a></li>
<li><a href="/wiki/Template:Female_genital_neoplasia" title="Template:Female genital neoplasia">female</a></li>
<li><a href="/wiki/Template:Gonadal_tumors,_paraganglioma,_and_glomus" title="Template:Gonadal tumors, paraganglioma, and glomus">gonadal</a></li>
<li><a href="/wiki/Template:Germ_cell_tumors" title="Template:Germ cell tumors">germ cell</a></li>
</ul>
</li>
<li>Other
<ul>
<li><a href="/wiki/Template:Male_diseases_of_the_pelvis_and_genitals" title="Template:Male diseases of the pelvis and genitals">male</a></li>
<li><a href="/wiki/Template:Female_diseases_of_the_pelvis_and_genitals" title="Template:Female diseases of the pelvis and genitals">female</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Reproductive_system_symptoms_and_signs" title="Template:Reproductive system symptoms and signs">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_reproductive_system" title="Template:Eponymous medical signs for reproductive system">eponymous</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Procedures
<ul>
<li><a href="/wiki/Template:Male_genital_procedures" title="Template:Male genital procedures">male</a></li>
<li><a href="/wiki/Template:Female_genital_procedures" title="Template:Female genital procedures">female</a></li>
</ul>
</li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Drugs_used_in_benign_prostatic_hypertrophy" title="Template:Drugs used in benign prostatic hypertrophy">benign prostatic hypertrophy</a></li>
<li><a href="/wiki/Template:Drugs_for_erectile_dysfunction_and_PE" title="Template:Drugs for erectile dysfunction and PE">erectile dysfunction and premature ejaculation</a></li>
<li><a href="/wiki/Template:Sexual_dysfunction_pharmacotherapies" title="Template:Sexual dysfunction pharmacotherapies">sexual dysfunction</a></li>
<li><a href="/wiki/Template:Gynecological_anti-infectives_and_antiseptics" title="Template:Gynecological anti-infectives and antiseptics">infection</a>
<ul>
<li><i><a href="/wiki/Template:Microbicides_for_sexually_transmitted_diseases" title="Template:Microbicides for sexually transmitted diseases">STDs</a></i></li>
</ul>
</li>
<li>hormones
<ul>
<li><i><a href="/wiki/Template:Androgens_and_antiandrogens" title="Template:Androgens and antiandrogens">androgens</a></i></li>
<li><i><a href="/wiki/Template:Estrogens_and_antiestrogens" title="Template:Estrogens and antiestrogens">estrogens</a></i></li>
<li><i><a href="/wiki/Template:Progestogens_and_antiprogestogens" title="Template:Progestogens and antiprogestogens">progestogens</a></i></li>
<li><i><a href="/wiki/Template:Gonadotropins_and_GnRH" title="Template:Gonadotropins and GnRH">GnRH</a></i></li>
<li><i><a href="/wiki/Template:Prolactin_inhibitors_and_anti-inflammatory_products_for_vaginal_administration" title="Template:Prolactin inhibitors and anti-inflammatory products for vaginal administration">prolactin</a></i></li>
</ul>
</li>
</ul>
</li>
<li><a href="/wiki/Template:Assisted_reproductive_technology" title="Template:Assisted reproductive technology">Assisted reproduction</a></li>
<li><a href="/wiki/Template:Birth_control_methods" title="Template:Birth control methods">Birth control</a>
<ul>
<li><a href="/wiki/Template:Hormonal_contraceptives" title="Template:Hormonal contraceptives">hormonal</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks hlist navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Help:Authority_control" title="Help:Authority control">Authority control</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Integrated_Authority_File" title="Integrated Authority File">GND</a>: <span class="uid"><a rel="nofollow" class="external text" href="http://d-nb.info/gnd/4047511-6">4047511-6</a></span></li>
<li><a href="/wiki/National_Diet_Library" title="National Diet Library">NDL</a>: <span class="uid"><a rel="nofollow" class="external text" href="http://id.ndl.go.jp/auth/ndlna/00575400">00575400</a></span></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1224
CPU time usage: 1.422 seconds
Real time usage: 1.552 seconds
Preprocessor visited node count: 11465/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 478266/2097152 bytes
Template argument size: 4374/2097152 bytes
Highest expansion depth: 12/40
Expensive parser function count: 5/500
Lua time usage: 0.648/10.000 seconds
Lua memory usage: 4.23 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00% 1327.921      1 - -total
 69.04%  916.751      1 - Template:Reflist
 35.13%  466.528    138 - Template:Cite_journal
  8.39%  111.419     29 - Template:Cite_web
  5.80%   77.027      1 - Template:Infobox_disease
  5.16%   68.503      1 - Template:Infobox
  4.05%   53.715      6 - Template:Navbox
  3.80%   50.417      6 - Template:Fix
  3.40%   45.138     11 - Template:Category_handler
  2.81%   37.317     12 - Template:Cite_book
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:88078-0!*!0!!en!4!* and timestamp 20150711194257 and revision id 671009944
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Prostate_cancer&amp;oldid=671009944">https://en.wikipedia.org/w/index.php?title=Prostate_cancer&amp;oldid=671009944</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Male_genital_neoplasia" title="Category:Male genital neoplasia">Male genital neoplasia</a></li><li><a href="/wiki/Category:Neoplastic_and_hyperplastic_prostate_disorders" title="Category:Neoplastic and hyperplastic prostate disorders">Neoplastic and hyperplastic prostate disorders</a></li><li><a href="/wiki/Category:Histopathology" title="Category:Histopathology">Histopathology</a></li><li><a href="/wiki/Category:Prostate_cancer" title="Category:Prostate cancer">Prostate cancer</a></li><li><a href="/wiki/Category:Infectious_causes_of_cancer" title="Category:Infectious causes of cancer">Infectious causes of cancer</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_French-language_sources_(fr)" title="Category:CS1 French-language sources (fr)">CS1 French-language sources (fr)</a></li><li><a href="/wiki/Category:CS1_Chinese-language_sources_(zh)" title="Category:CS1 Chinese-language sources (zh)">CS1 Chinese-language sources (zh)</a></li><li><a href="/wiki/Category:All_articles_with_dead_external_links" title="Category:All articles with dead external links">All articles with dead external links</a></li><li><a href="/wiki/Category:Articles_with_dead_external_links_from_August_2011" title="Category:Articles with dead external links from August 2011">Articles with dead external links from August 2011</a></li><li><a href="/wiki/Category:CS1_Japanese-language_sources_(ja)" title="Category:CS1 Japanese-language sources (ja)">CS1 Japanese-language sources (ja)</a></li><li><a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">CS1 maint: Explicit use of et al.</a></li><li><a href="/wiki/Category:Wikipedia_articles_needing_page_number_citations_from_September_2010" title="Category:Wikipedia articles needing page number citations from September 2010">Wikipedia articles needing page number citations from September 2010</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_2009" title="Category:Articles containing potentially dated statements from 2009">Articles containing potentially dated statements from 2009</a></li><li><a href="/wiki/Category:All_articles_containing_potentially_dated_statements" title="Category:All articles containing potentially dated statements">All articles containing potentially dated statements</a></li><li><a href="/wiki/Category:Articles_with_specifically_marked_weasel-worded_phrases_from_July_2011" title="Category:Articles with specifically marked weasel-worded phrases from July 2011">Articles with specifically marked weasel-worded phrases from July 2011</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_July_2011" title="Category:Articles with unsourced statements from July 2011">Articles with unsourced statements from July 2011</a></li><li><a href="/wiki/Category:Articles_with_DMOZ_links" title="Category:Articles with DMOZ links">Articles with DMOZ links</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li><li><a href="/wiki/Category:Wikipedia_articles_with_GND_identifiers" title="Category:Wikipedia articles with GND identifiers">Wikipedia articles with GND identifiers</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Prostate+cancer&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Prostate+cancer" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Prostate_cancer"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Prostate_cancer"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Prostate_cancer" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Prostate_cancer&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Prostate_cancer" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Prostate_cancer" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Prostate_cancer&amp;oldid=671009944" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Prostate_cancer&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q181257" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Prostate_cancer&amp;id=671009944" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Prostate+cancer">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Prostate+cancer&amp;oldid=671009944&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Prostate_cancer&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-af"><a href="//af.wikipedia.org/wiki/Prostaatkanker" title="Prostaatkanker – Afrikaans" lang="af" hreflang="af">Afrikaans</a></li><li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D8%B3%D8%B1%D8%B7%D8%A7%D9%86_%D8%A7%D9%84%D8%A8%D8%B1%D9%88%D8%B3%D8%AA%D8%A7%D8%AA%D8%A7" title="سرطان البروستاتا – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-bn"><a href="//bn.wikipedia.org/wiki/%E0%A6%AA%E0%A7%8D%E0%A6%B0%E0%A7%8B%E0%A6%B8%E0%A7%8D%E0%A6%9F%E0%A7%87%E0%A6%9F_%E0%A6%95%E0%A7%8D%E0%A6%AF%E0%A6%BE%E0%A6%A8%E0%A7%8D%E0%A6%B8%E0%A6%BE%E0%A6%B0" title="প্রোস্টেট ক্যান্সার – Bengali" lang="bn" hreflang="bn">বাংলা</a></li><li class="interlanguage-link interwiki-be"><a href="//be.wikipedia.org/wiki/%D0%A0%D0%B0%D0%BA_%D0%BF%D1%80%D0%B0%D0%B4%D1%81%D1%82%D0%B0%D0%BB%D1%91%D0%B2%D0%B0%D0%B9_%D0%B7%D0%B0%D0%BB%D0%BE%D0%B7%D1%8B" title="Рак прадсталёвай залозы – Belarusian" lang="be" hreflang="be">Беларуская</a></li><li class="interlanguage-link interwiki-be-x-old"><a href="//be-x-old.wikipedia.org/wiki/%D0%A0%D0%B0%D0%BA_%D0%BF%D0%B0%D0%B4%D0%BA%D0%B0%D1%80%D1%8D%D0%BD%D1%8C%D0%BD%D1%96%D1%86%D1%8B" title="Рак падкарэньніцы – беларуская (тарашкевіца)‎" lang="be-x-old" hreflang="be-x-old">Беларуская (тарашкевіца)‎</a></li><li class="interlanguage-link interwiki-bg"><a href="//bg.wikipedia.org/wiki/%D0%A0%D0%B0%D0%BA_%D0%BD%D0%B0_%D0%BF%D1%80%D0%BE%D1%81%D1%82%D0%B0%D1%82%D0%B0%D1%82%D0%B0" title="Рак на простатата – Bulgarian" lang="bg" hreflang="bg">Български</a></li><li class="interlanguage-link interwiki-ca badge-Q17437798 badge-goodarticle" title="good article"><a href="//ca.wikipedia.org/wiki/C%C3%A0ncer_de_pr%C3%B2stata" title="Càncer de pròstata – Catalan" lang="ca" hreflang="ca">Català</a></li><li class="interlanguage-link interwiki-cs"><a href="//cs.wikipedia.org/wiki/Karcinom_prostaty" title="Karcinom prostaty – Czech" lang="cs" hreflang="cs">Čeština</a></li><li class="interlanguage-link interwiki-da"><a href="//da.wikipedia.org/wiki/Prostatakr%C3%A6ft" title="Prostatakræft – Danish" lang="da" hreflang="da">Dansk</a></li><li class="interlanguage-link interwiki-de badge-Q17437796 badge-featuredarticle" title="featured article"><a href="//de.wikipedia.org/wiki/Prostatakrebs" title="Prostatakrebs – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-dv"><a href="//dv.wikipedia.org/wiki/%DE%95%DE%B0%DE%83%DE%AE%DE%90%DE%B0%DE%93%DE%AD%DE%93%DE%B0_%DE%86%DE%AC%DE%82%DE%B0%DE%90%DE%A6%DE%83%DE%AA" title="ޕްރޮސްޓޭޓް ކެންސަރު – Divehi" lang="dv" hreflang="dv">ދިވެހިބަސް</a></li><li class="interlanguage-link interwiki-el"><a href="//el.wikipedia.org/wiki/%CE%9A%CE%B1%CF%81%CE%BA%CE%AF%CE%BD%CE%BF%CF%82_%CF%84%CE%BF%CF%85_%CF%80%CF%81%CE%BF%CF%83%CF%84%CE%AC%CF%84%CE%B7" title="Καρκίνος του προστάτη – Greek" lang="el" hreflang="el">Ελληνικά</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/C%C3%A1ncer_de_pr%C3%B3stata" title="Cáncer de próstata – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-eo"><a href="//eo.wikipedia.org/wiki/Prostata_kancero" title="Prostata kancero – Esperanto" lang="eo" hreflang="eo">Esperanto</a></li><li class="interlanguage-link interwiki-eu"><a href="//eu.wikipedia.org/wiki/Prostatako_minbizi" title="Prostatako minbizi – Basque" lang="eu" hreflang="eu">Euskara</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D8%B3%D8%B1%D8%B7%D8%A7%D9%86_%D9%BE%D8%B1%D9%88%D8%B3%D8%AA%D8%A7%D8%AA" title="سرطان پروستات – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Cancer_de_la_prostate" title="Cancer de la prostate – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-ga"><a href="//ga.wikipedia.org/wiki/Ailse_phr%C3%B3stataigh" title="Ailse phróstataigh – Irish" lang="ga" hreflang="ga">Gaeilge</a></li><li class="interlanguage-link interwiki-gl"><a href="//gl.wikipedia.org/wiki/Cancro_de_pr%C3%B3stata" title="Cancro de próstata – Galician" lang="gl" hreflang="gl">Galego</a></li><li class="interlanguage-link interwiki-ko"><a href="//ko.wikipedia.org/wiki/%EC%A0%84%EB%A6%BD%EC%84%A0%EC%95%94" title="전립선암 – Korean" lang="ko" hreflang="ko">한국어</a></li><li class="interlanguage-link interwiki-hy"><a href="//hy.wikipedia.org/wiki/%D5%87%D5%A1%D5%A3%D5%A1%D5%B6%D5%A1%D5%AF%D5%A1%D5%A3%D5%A5%D5%B2%D5%B1%D5%AB_%D6%84%D5%A1%D5%B2%D6%81%D5%AF%D5%A5%D5%B2" title="Շագանակագեղձի քաղցկեղ – Armenian" lang="hy" hreflang="hy">Հայերեն</a></li><li class="interlanguage-link interwiki-hr"><a href="//hr.wikipedia.org/wiki/Rak_prostate" title="Rak prostate – Croatian" lang="hr" hreflang="hr">Hrvatski</a></li><li class="interlanguage-link interwiki-id"><a href="//id.wikipedia.org/wiki/Kanker_prostat" title="Kanker prostat – Indonesian" lang="id" hreflang="id">Bahasa Indonesia</a></li><li class="interlanguage-link interwiki-it badge-Q17437798 badge-goodarticle" title="good article"><a href="//it.wikipedia.org/wiki/Carcinoma_della_prostata" title="Carcinoma della prostata – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%A1%D7%A8%D7%98%D7%9F_%D7%94%D7%A2%D7%A8%D7%9E%D7%95%D7%A0%D7%99%D7%AA" title="סרטן הערמונית – Hebrew" lang="he" hreflang="he">עברית</a></li><li class="interlanguage-link interwiki-jv"><a href="//jv.wikipedia.org/wiki/Kanker_prostat" title="Kanker prostat – Javanese" lang="jv" hreflang="jv">Basa Jawa</a></li><li class="interlanguage-link interwiki-la"><a href="//la.wikipedia.org/wiki/Cancer_prostatae" title="Cancer prostatae – Latin" lang="la" hreflang="la">Latina</a></li><li class="interlanguage-link interwiki-lv"><a href="//lv.wikipedia.org/wiki/Prostatas_v%C4%93zis" title="Prostatas vēzis – Latvian" lang="lv" hreflang="lv">Latviešu</a></li><li class="interlanguage-link interwiki-lt"><a href="//lt.wikipedia.org/wiki/Prostatos_v%C4%97%C5%BEys" title="Prostatos vėžys – Lithuanian" lang="lt" hreflang="lt">Lietuvių</a></li><li class="interlanguage-link interwiki-hu"><a href="//hu.wikipedia.org/wiki/Prosztatar%C3%A1k" title="Prosztatarák – Hungarian" lang="hu" hreflang="hu">Magyar</a></li><li class="interlanguage-link interwiki-mr"><a href="//mr.wikipedia.org/wiki/%E0%A4%AA%E0%A5%8C%E0%A4%B0%E0%A5%81%E0%A4%B7_%E0%A4%97%E0%A5%8D%E0%A4%B0%E0%A4%82%E0%A4%A5%E0%A5%80%E0%A4%9A%E0%A4%BE_%E0%A4%95%E0%A4%B0%E0%A5%8D%E0%A4%95%E0%A4%B0%E0%A5%8B%E0%A4%97" title="पौरुष ग्रंथीचा कर्करोग – Marathi" lang="mr" hreflang="mr">मराठी</a></li><li class="interlanguage-link interwiki-ms"><a href="//ms.wikipedia.org/wiki/Barah_prostat" title="Barah prostat – Malay" lang="ms" hreflang="ms">Bahasa Melayu</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Prostaatkanker" title="Prostaatkanker – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E5%89%8D%E7%AB%8B%E8%85%BA%E7%99%8C" title="前立腺癌 – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-no"><a href="//no.wikipedia.org/wiki/Prostatakreft" title="Prostatakreft – Norwegian" lang="no" hreflang="no">Norsk bokmål</a></li><li class="interlanguage-link interwiki-or"><a href="//or.wikipedia.org/wiki/%E0%AC%AA%E0%AD%8D%E0%AC%B0%E0%AD%8B%E0%AC%B8%E0%AD%8D%E0%AC%9F%E0%AD%87%E0%AC%9F_%E0%AC%95%E0%AC%B0%E0%AD%8D%E0%AC%95%E0%AC%9F" title="ପ୍ରୋସ୍ଟେଟ କର୍କଟ – Oriya" lang="or" hreflang="or">ଓଡ଼ିଆ</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Rak_gruczo%C5%82u_krokowego" title="Rak gruczołu krokowego – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/C%C3%A2ncer_de_pr%C3%B3stata" title="Câncer de próstata – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-ro"><a href="//ro.wikipedia.org/wiki/Cancer_de_prostat%C4%83" title="Cancer de prostată – Romanian" lang="ro" hreflang="ro">Română</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%A0%D0%B0%D0%BA_%D0%BF%D1%80%D0%B5%D0%B4%D1%81%D1%82%D0%B0%D1%82%D0%B5%D0%BB%D1%8C%D0%BD%D0%BE%D0%B9_%D0%B6%D0%B5%D0%BB%D0%B5%D0%B7%D1%8B" title="Рак предстательной железы – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-simple"><a href="//simple.wikipedia.org/wiki/Prostate_cancer" title="Prostate cancer – Simple English" lang="simple" hreflang="simple">Simple English</a></li><li class="interlanguage-link interwiki-sk"><a href="//sk.wikipedia.org/wiki/Rakovina_prostaty" title="Rakovina prostaty – Slovak" lang="sk" hreflang="sk">Slovenčina</a></li><li class="interlanguage-link interwiki-sl"><a href="//sl.wikipedia.org/wiki/Rak_prostate" title="Rak prostate – Slovenian" lang="sl" hreflang="sl">Slovenščina</a></li><li class="interlanguage-link interwiki-sh"><a href="//sh.wikipedia.org/wiki/Rak_prostate" title="Rak prostate – Serbo-Croatian" lang="sh" hreflang="sh">Srpskohrvatski / српскохрватски</a></li><li class="interlanguage-link interwiki-fi badge-Q17437796 badge-featuredarticle" title="featured article"><a href="//fi.wikipedia.org/wiki/Eturauhasen_sy%C3%B6p%C3%A4" title="Eturauhasen syöpä – Finnish" lang="fi" hreflang="fi">Suomi</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Prostatacancer" title="Prostatacancer – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="interlanguage-link interwiki-tl"><a href="//tl.wikipedia.org/wiki/Kanser_sa_prostata" title="Kanser sa prostata – Tagalog" lang="tl" hreflang="tl">Tagalog</a></li><li class="interlanguage-link interwiki-ta"><a href="//ta.wikipedia.org/wiki/%E0%AE%AE%E0%AF%81%E0%AE%A9%E0%AF%8D%E0%AE%A9%E0%AE%BF%E0%AE%B1%E0%AF%8D%E0%AE%95%E0%AF%81%E0%AE%9E%E0%AF%8D%E0%AE%9A%E0%AF%81%E0%AE%B0%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AE%BF_%E0%AE%AA%E0%AF%81%E0%AE%B1%E0%AF%8D%E0%AE%B1%E0%AF%81%E0%AE%A8%E0%AF%8B%E0%AE%AF%E0%AF%8D" title="முன்னிற்குஞ்சுரப்பி புற்றுநோய் – Tamil" lang="ta" hreflang="ta">தமிழ்</a></li><li class="interlanguage-link interwiki-th"><a href="//th.wikipedia.org/wiki/%E0%B8%A1%E0%B8%B0%E0%B9%80%E0%B8%A3%E0%B9%87%E0%B8%87%E0%B8%95%E0%B9%88%E0%B8%AD%E0%B8%A1%E0%B8%A5%E0%B8%B9%E0%B8%81%E0%B8%AB%E0%B8%A1%E0%B8%B2%E0%B8%81" title="มะเร็งต่อมลูกหมาก – Thai" lang="th" hreflang="th">ไทย</a></li><li class="interlanguage-link interwiki-tr"><a href="//tr.wikipedia.org/wiki/Prostat_kanseri" title="Prostat kanseri – Turkish" lang="tr" hreflang="tr">Türkçe</a></li><li class="interlanguage-link interwiki-uk"><a href="//uk.wikipedia.org/wiki/%D0%A0%D0%B0%D0%BA_%D0%BF%D1%80%D0%BE%D1%81%D1%82%D0%B0%D1%82%D0%B8" title="Рак простати – Ukrainian" lang="uk" hreflang="uk">Українська</a></li><li class="interlanguage-link interwiki-vi"><a href="//vi.wikipedia.org/wiki/Ung_th%C6%B0_tuy%E1%BA%BFn_ti%E1%BB%81n_li%E1%BB%87t" title="Ung thư tuyến tiền liệt – Vietnamese" lang="vi" hreflang="vi">Tiếng Việt</a></li><li class="interlanguage-link interwiki-zh-yue"><a href="//zh-yue.wikipedia.org/wiki/%E5%89%8D%E5%88%97%E8%85%BA%E7%99%8C" title="前列腺癌 – Cantonese" lang="zh-yue" hreflang="zh-yue">粵語</a></li><li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E5%89%8D%E5%88%97%E8%85%BA%E7%99%8C" title="前列腺癌 – Chinese" lang="zh" hreflang="zh">中文</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q181257#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 11 July 2015, at 19:42.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Prostate_cancer&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":142,"wgHostname":"mw1028"});
}</script>
	</body>
</html>
